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The opportunistic pathogen Pseudomonas aeruginosa secretes a class of colorful redox-active small 
molecules known as phenazines. Numerous functions have been proposed for phenazines, 
including antibiotic activity, virulence, cell-to-cell signaling, iron acquisition, and survival. This 
thesis delves into mechanisms of the latter role, that of long-term survival under oxidant-limiting 
conditions. Using a diverse array of methods, I investigated how phenazines support survival and 
how cells transfer electrons to phenazines, as well as the downstream effects that phenazines have 
on P. aeruginosa. 
Direct measurements of NAD(H), ATP, the membrane potential, and fermentation products 
revealed that phenazines promote redox homeostasis and subsequently ATP synthesis. The ATP 
is used to maintain a membrane potential through the reverse action of the ATP synthase 
complex. Even though P. aeruginosa does not ferment on sugars, phenazines enable the anaerobic 
oxidation of glucose to acetate, suggesting P. aeruginosa may have previously under-appreciated 
metabolic flexibility in the absence of terminal electron acceptors. Activity assays with proteins 
purified natively from P. aeruginosa showed that glucose oxidation might be enabled in vivo by the 
pyruvate dehydrogenase complex, which can directly reduce phenazines using pyruvate as an 
electron donor. Liquid chromatography and mass spectrometry of culture supernatants showed 
that phenazines alter the chain length distribution of secreted quinolones, which may have 
indirect downstream signaling effects. Based on this result, combined with data from survival 
experiments, I hypothesize that phenazine-mediated redox homeostasis promotes β-oxidation 
and that fatty acid metabolism contributes to long-term survival. Further analysis also showed that 
P. aeruginosa cultures contain several previously-unreported sulfonated phenazines. In its natural 
environment, P. aeruginosa undoubtedly encounters other microbial species that consume or 
modify its phenazines. At least one of these, a Mycobacterium, contains a pyocyanin demethylating 
v 
enzyme. The X-ray crystal structure of this protein revealed a novel reaction mechanism wherein 
the substrate is its own electron acceptor. Together, this work illuminates some of the many ways 
phenazines shape microbial communities in both clinical and environmental contexts.
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C h a p t e r  1  
INTRODUCTION 
One of the most unknowingly influential stories in modern microbiology began in 1859 as an 
inauspicious anecdote (1) (translated from French): 
M. Fordos communicates the result of his researches on the cause of the blue coloring which is 
sometimes observed in pus secreted by wounds under certain unknown conditions of disease. 
Our colleague has succeeded in isolating from this pus a coloring matter of a peculiar 
nature...which he designates under the name of pyocyanin. 
Contemporaneously with Pasteur’s classic experiments disproving spontaneous generation, 
Fordos noted a special relationship between pyocyanin and air (2) (translated from French): 
The dissolution of pyocyanin, still containing pus, loses its color from one day to another, if it is 
preserved in a mouth-flask; but it is sufficient to agitate it in the air in order to restore its 
original color. The same discoloration phenomenon occurs if the blue solution is heated in a test 
tube with a few drops of sodium sulphide solution and the blue color is reproduced by stirring 
the liquor in air. These facts prove that the pyocyanin can, like several coloring matters, become 
colorless, under the influence of the desoxidants, and then resume its blue color in contact with 
the oxygen of the air, and explain how a colorless pus can nevertheless color in blue dressing 
cloths. 
The origin of pyocyanin was clarified when Gessard isolated a pyocyanin-producing bacterium 
(3,4) known today as Pseudomonas aeruginosa. The modern species name is derived from aerugo, 
the Latin word for the blue-green rust of copper, reflecting the coloration that pyocyanin confers 
upon P. aeruginosa cultures. 
Pyocyanin’s color-changing properties caught the attention of Leonor Michaelis (of Michaelis–
Menten kinetics fame) and Ernst Friedheim, who characterized its redox properties and 
concluded that, in addition to the blue, red, and colorless forms described by Fordos (2), 
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pyocyanin could reversibly adopt a fourth green color (5). The green color represented 
unequivocal evidence that pyocyanin participates in one-electron redox reactions (6), the first 
known biological molecule of its kind. Combined with observations that pyocyanin stimulates 
oxygen consumption and carbon dioxide production (7,8), Friedheim and Michaelis speculated 
that pyocyanin is involved in cellular respiration in P. aeruginosa—and, by extension, that one-
electron transfers are essential in biology, a radical notion for the time. With development of the 
kinetic framework for which Michaelis is now famous, the original work with pyocyanin was 
extended to quinones and flavins (9), and so our modern understanding of enzyme kinetics and 
cellular respiration traces back to the colorful properties of pyocyanin. 
In the following years, pyocyanin attracted interest as an antimicrobial compound owing to its 
ability to generate reactive oxygen species (10). As a phenazine derivative, pyocyanin shares 
properties with other phenazines produced by diverse bacteria and archaea. The precursor to all 
known bacterial phenazines, phenazine-1-carboxylic acid, can even be found in the literature by 
its alternate name tubermycin B (11), reflecting its activity against Mycobacterium tuberculosis. The 
search for new antimicrobial compounds has dominated phenazine research in recent decades, 
and the original findings pertaining to bacterial respiration were largely ignored. Until recently, 
there were surprisingly few studies into the biological function of natural phenazines. 
The Newman group has since revisited phenazine biology with a renewed interest in the 
physiological functions of phenazines. Motivated by the discovery that phenazines promote iron 
acquisition (12,13) and anaerobic survival (14), along with converging work demonstrating 
extracellular electron transfer in Shewanella species, we have pursued the hypothesis that 
phenazines can act as a sort of “molecular snorkel” for oxidant-limited cells (15). This idea bears 
striking resemblance to the original work by Friedheim and Michaelis, who developed their ideas 
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without even a clear picture of the electron transport chain, and we have made considerable 
progress thanks to a more rigorous biochemical foundation from decades of prior research. 
My own research has focused on the effects that endogenous phenazines have on the metabolism 
of P. aeruginosa. I have strived to explain how phenazines promote anaerobic survival, from a 
physiological perspective down to a mechanistic biochemical one. This seemingly simple question 
has carried me on a journey through myriad approaches including electrochemistry, membrane 
potential measurements, metabolomics, protein purification and X-ray crystallography, and more. 
Overview 
Before diving into the specifics of phenazines, Chapter 2 reviews the concept of extracellular 
electron transfer in the environment. It explains our rationale for believing that phenazines are but 
one example of a diverse set of functionally similar molecules. We explore the environments where 
electron shuttling might be a viable survival strategy, taking biosynthetic costs and steady-state 
diffusion into account. Drawing on our experience with phenazines, we also discuss more specific 
mechanisms of electron shuttle reduction and oxidation. 
Chapter 3 focuses more specifically on P. aeruginosa and the physiological mechanisms by which 
phenazine-1-carboxylic acid promotes anaerobic survival. By comparing cultures surviving with 
phenazines to those surviving via fermentation on pyruvate or arginine, I demonstrate that ATP 
synthesis is coupled to redox homeostasis and that ATP is required for survival. The ATP is 
required to maintain a proton-motive force by operating the ATP synthase complex in reverse. 
This study was enabled by a method to directly detect the membrane potential in P. aeruginosa. 
The physiological effect of phenazines is related to redox homeostasis, which then promotes ATP 
synthesis and maintenance of the membrane potential. 
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In Chapter 4, I seek a more detailed biochemical mechanism to explain the results from Chapter 
3. By fractionating P. aeruginosa lysate and purifying proteins, I show that the pyruvate 
dehydrogenase and α-ketoglutarate dehydrogenase complexes from P. aeruginosa can directly 
reduce phenazines. These enzymes of central metabolism are directly involved in the findings 
from Chapter 4, providing a satisfying connection between the physiological and biochemical 
results. I also report the X-ray crystal structure of the enzyme dihydrolipoamide dehydrogenase 
to 1.35 Å, the highest resolution structure of this enzyme to date. 
While Chapter 4 focuses on a specific subset of enzymes, the data suggest that P. aeruginosa 
contains multiple enzymes that can catalyze phenazine reduction. Such a result always raises the 
prospect that the activity is an in vitro artifact. In hopes of further quantifying the metabolic effects 
of phenazines, and possibly pinpointing the relevant phenazine reductases in vivo, in Chapter 5 I 
develop a set of metabolomics methods for characterizing P. aeruginosa. Preliminary results from 
analyzing culture supernatants suggest there is a peculiar relationship between pyocyanin and 
pyruvate that still requires further study. From the detection of 4-hydroxy-2-alkylquinolones and 
unknown glycerophospholipids, I suggest that pyocyanin affects fatty acid metabolism in P. 
aeruginosa. I also describe several novel sulfonated phenazines that may prove to be useful markers 
of sulfur metabolism in situ. 
Chapter 6 returns to the environment and considers the interactions between P. aeruginosa and 
other species. While working on the X-ray crystal structures from Chapter 4, a postdoctoral 
scholar in the lab discovered and purified a pyocyanin demethylating enzyme from a species of 
Mycobacterium. Working together, we successfully crystallized and solved the structure of this 
enzyme. The structure revealed a reaction mechanism unique amongst demethylases where the 
phenazine substrate is its own electron acceptor. 
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Finally, Chapter 7 provides my concluding thoughts and some areas I feel are exciting avenues for 
future work. 
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C h a p t e r  2  
BACKGROUND 
This chapter is adapted from an upcoming publication: 
Glasser, N. R.*, Saunders, S.*, and Newman, D. K. (2017) The colorful world of extracellular 
electron shuttles. Annual Review of Microbiology. In Press. 
*contributed equally 
Abstract 
Descriptions of the changeable, striking colors associated with secreted natural products date back 
well over a century. These molecules can serve as extracellular electron shuttles (EES) that permit 
microbes to access substrates at a distance. In this review, we argue that the colorful world of EES 
has too-long been neglected. Rather than simply serving as a diagnostic attribute of a particular 
microbial strain, redox-active natural products likely play fundamental, underappreciated roles in 
the biology of their producers, particularly those that inhabit biofilms. Here, we describe the 
chemical diversity and potential distribution of EES producers and users, discuss the costs 
associated with their biosynthesis, and critically evaluate strategies for their economical usage. We 
hope this review will inspire efforts to identify and explore the importance of EES cycling by a 
wide range of microorganisms, so that their contributions to shaping microbial communities can 
be better assessed and exploited. 
Introduction 
The microbial world is nothing if not colorful. Colorful figuratively, in that microbes accomplish 
stunning metabolic feats, which, increasingly, are being recognized for their important roles in 
promoting human health (1,2), shaping the composition of the atmosphere, lithosphere, and 
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hydrosphere (3), and biotechnological potential (4), to list only a few examples. Colorful literally, 
in that they produce a spectacular range of pigments, representing every rainbow hue. This latter 
aspect of microbial identity is often the first thing one notices about a strain when it is streaked 
upon a plate, whether its pigments are tightly associated with its colonies or rapidly diffuse away. 
Flipping through Bergey’s Manual of Systematic Bacteriology (5), one can find numerous 
examples of organisms that have been named after the colors they produce (e.g. Pseudomonas 
aeruginosa (6), Pseudoalteromonas luteoviolacia (7), Streptomyces coelicolor (8), etc.), yet the 
biological functions of these defining pigments are seldom discussed. Both old (9) and emerging 
evidence (10-12), however, suggests that literal colorfulness may underpin figurative colorfulness, 
particularly when the pigment in question has the property of changing color.  
Color changes are often indicative of redox-reactions, and the redox properties of many colorful 
excreted metabolites confer upon them rich potential (bio)chemical reactivity. Such reactivity, 
when combined with their ability to cycle in and out of the cells that produce them, permit these 
molecules to serve as extracellular electron shuttles (EES). While we use the word “extracellular” 
to draw attention to the fact that these metabolites can leave the cell in their reduced state to 
transfer electrons to a distant extracellular oxidant, equally important to the definition of 
microbial electron shuttles is that they can return to the cell in the oxidized state, whereupon they 
are re-reduced (Fig. 1a). It is the cycling of EES and their facilitation of electron transfer both 
within and without the cell that underpins their important physiological functions. Several years 
ago, we made a distinction between two types of EES, classifying them according to whether 
microorganisms produce them (endogenous) or whether they are already present in an 
environment (exogenous) (12). Endogenous EES, for example, include microbial metabolites 
that are often considered to be redox-active antibiotics (11); exogenous EES include a chemically 
heterogeneous fraction of organic compounds derived from the degradation of microbial and 
plant matter (13,14).  
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Figure 1. The colorful world of EES. (a) Action at a distance. Cells can perform redox 
chemistry on small molecules, which then diffuse, or electrically conduct, to 
extracellular substrates that can be many cell lengths away. (b) The colorful world of 
microbes as illustrated by Streptomyces coelicolor, producing the blue molecule 
actinorhodin whose structure is shown. (c) One molecule, four colors. The color of 
pyocyanin depends on both the pH and reduction potential. The tubes pictured each 
contain approximately 200 μM pyocyanin in water. The radical and fully reduced forms 
can be prepared by titrating pyocyanin with sodium dithionite, producing to an 
immediate and stunning color change. 
EES are particularly relevant to situations where microbes have limited access to a critical 
substrate. For example, an electron acceptor for catabolism might be poorly soluble, as is the case 
for minerals in many groundwater and sedimentary systems or electrodes in biofuel applications. 
Alternatively, the substrate might be locally depleted due to rapid consumption by other cells, 
outpacing its diffusion, as is the case for oxygen in biofilms, be they on the surface of a corroding 
steel pipeline or in the mucus-filled lungs of an individual living with cystic fibrosis (15-18). 
Finally, the substrate might be utilized by another organism in an intimate syntrophic partnership, 
requiring the passage of electrons between different cell types to catalyze an important 
biogeochemical reaction, such as the anaerobic oxidation of methane achieved by mixed archaeal-
bacterial aggregates (19,20). In all of these cases, extracellular electron transfer permits the 
microbes at a distance from the terminal electron acceptor to remain metabolically active.  
Cycling of EES represents a strategy whereby microbes can facilitate extracellular electron 















2 H+ + 2 e−
H+ + e−
e−














organisms transfer electrons to or from minerals have revealed that many possess outer membrane 
cytochromes that are critically important for these processes (21). Whether and/or how electrons 
traverse through “nanowires” or “cables” or some type of extracellular matrix is still being debated 
(22-25). We simply note that in some organisms such as the mineral-reducing bacteria Shewanella 
and Geobacter, the proteinaceous machinery that is required for extracellular electron transfer can 
interact with and reduce EES of different types (26-30). Thus, it is important to be mindful of the 
potential involvement of EES in any context where extracellular electron transfer matters—be it 
the soil of the rhizosphere to the inflamed tissues of chronic infections. Moreover, due to their 
versatile redox activity, EES can play other important biological roles, such as serving as signaling 
molecules and promoting iron acquisition (31-34). 
In this review, we focus our discussion primarily on colorful, endogenous EES, drawing upon our 
experience studying phenazines produced by Pseudomonas aeruginosa (11,12,31-47) (Fig. 1c). 
We use phenazines for illustrative purposes only, to pique the reader’s curiosity about what other 
molecules may have similar physiological functions. We critically discuss costs of EES 
biosynthesis, as well as bioenergetic concerns related to the cell biology of their reduction and 
potential loss to the environment. Underpinning this review is the conviction that recent advances 
in mass spectrometry, imaging, and sequencing have the potential to enable dramatic progress in 
understanding the importance of endogenous EES across diverse microbial systems.  
Diversity of Endogenous EES and Organisms 
How many endogenous EES exist in nature and which organisms produce them? We are only at 
the threshold of being able to answer this question. The two most well-characterized EES-
producing organisms are Pseudomonas aeruginosa and Shewanella oneidensis, known for their use 
of phenazines and flavins, respectively (28,40,44,48,49). Other putative EES-producing 
organisms, Lactoccocus lactis, Sphingomonas xenophaga, and Klebsiella pneumonia, are reported to 
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utilize quinone shuttles (see Table 1) (50-54). A few other observations in the literature hint at 
the production of EES by diverse organisms, including Geothrix and Geobacter species (26,55), 
yet in most cases the molecular nature of the putative EES is unknown. Though many secreted 
redox-active natural products have been well known for decades, such as indigoidine, only 
recently have their physiological functions begun to be explored (56). Because these types of 
natural products are genetically encoded in biosynthetic clusters, bioinformatic analysis predicts 
that EES production by microorganisms may be extensive (Fig. 2). In this section, we discuss the 
chemical diversity and potential distribution of EES-producers and users as predicted by current 
bioinformatics platforms. We emphasize these are predictions, which must be validated 
experimentally (Sidebar 1). 
11 
Molecule Structure Midpoint 
potential 
(mV) 
Log Kow* Organism Ref 
2-amino-3-dicarboxy-
1,4-naphthoquinone  
−71 0.15 Lactococcus lactis (50)
4-amino-1,2-
naphthoquinone 
















−177 2.17 Pseudomonas, 
Streptomyces 
(38)




Table 1. Putative EES. 
* Log Kow was predicted from Chemspider database (53,54).  
Chemical diversity of EES 
Much like their intracellular cousins (e.g. NAD(P)H, FAD, and quinones), EES are distinguished 
by the presence of conjugated bonds, often in the form of heterocyclic aromatic rings. It is this 
system of conjugated bonds that confers color upon EES. Generally, conjugated bonds are also 
the molecular origin of an electron shuttle’s redox activity, as double bonds can be chemically 
reduced and rearranged at biologically-accessible reduction potentials. Rearrangement of the 
conjugated bond system necessarily entails a change in the molecule’s absorption spectrum, and 
12 
so a shuttle’s redox activity is inextricably linked to its vibrant and interconvertible colors (Fig. 
1c). 
Unlike intracellular redox-active metabolites, the endogenous EES described in the literature to 
date generally lack modifications such as adenylation or lipidation. Instead, they can be decorated 
with functional groups (e.g. amines, carboxylic acids, amides) that tune physical and chemical 
properties such as the reduction potential, charge state, or solubility. Advances in mass 
spectrometry and natural product discovery are only beginning to unearth the rich combinatorial 
diversity of these modifications—as of February 2017, the Dictionary of Natural Products 
contains over 190 unique phenazine derivatives, 1200 quinones, 1600 napthoquinones, and 2200 
anthraquinones (58). While the growth of natural products databases has far outpaced our ability 
to empirically study the functions of these molecules, computational chemistry has shown recent 
progress in predicting their properties such as reduction potential (59). We anticipate that a 
convergence of metabolomics and computational chemistry, together with the on-going detailed 
study of select molecules such as phenazines, will implicate many of these redox-active natural 
products as ubiquitous and diverse EES. 
Phylogenetic diversity  
To predict which organisms may produce or utilize EES, we may consider the phylogenetic 
distribution of genes used to produce or interact with known EES. We might speculate that most 
organisms could shuttle electrons, since S. oneidensis uses a common cofactor, FMN (48). 
However, it is unclear how many could use flavins in an analogous manner, so we will instead focus 
on more specialized natural products. As an example, we will see that biosynthetic clusters for 
phenazines are widespread, as well as the redox transcription factor, SoxR, which can sense 
phenazines.  
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Biosynthetic clusters. Biosynthetic clusters are organized sets of genes that encode enzymes to 
produce specific metabolites. Bioinformatic tools are rapidly improving our ability to identify 
specific natural products (e.g. AntiSmash) (60). The authors of the IMG-ABC database 
showcased their toolkit with phenazines by identifying ~1000 genomes that contained at least 6 
of 7 genes required for phenazine biosynthesis. These species included the well-known phenazine 
producers Streptomyces and Pseudomonads, but also Alphaproteobacteria, Betaproteobacteria, 
and other Actinobacteria. It was suggested that a much wider set of species probably produces 
phenazines than previously thought, and that these new putative producers likely synthesize 
phenazines with novel chemical structures (61). As the accuracy of these type of bioinformatics 
tools advance, we may be able to predict an organism’s ability to make EES from its genome with 
reasonable confidence.  
SoxR redox sensors. One way to identify potential EES users is to search genomes for machinery 
that can sense them. Presently, the best-known example is the SoxR transcription factor. SoxR was 
originally studied in E. coli for its role in upregulating the oxidative stress response upon exposure 
to superoxide generating molecules. It was discovered that SoxR sensed redox-active molecules 
through a Fe-S cluster bound by a unique cysteine motif, and its activation prompted sequence 
specific binding and transcriptional activation (62). Studies outside of the Enterobacteriacae then 
showed that SoxR did not upregulate the oxidative stress response in P. aeruginosa (63) and 
Streptomyces coelicolor (64), but that it responded to endogenous redox-active molecules (37,65) 
and upregulated factors likely to be involved in their cycling. Comparative genomic analysis found 
that SoxR is widely distributed through the Bacteria, and it predicted that most organisms do not 
conform to the original E. coli oxidative stress paradigm (37).  
Today the IMG database contains ~15,000 bacterial genomes with high-confidence SoxR 
homologues out of ~47,000 total bacterial genomes (66), approximately the same proportion as 
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the stress sigma factor RpoS. Fig. 2 shows that SoxR homologues are present in 10 bacterial phyla, 
and that the most representatives are in orders of Proteobacteria and Actinobacteria (67,68). It 
should be noted that homologues can be found in majorities of Pseudomonadales (2308 
genomes) and Streptomycetes (402 genomes), which are well known for their production of 
natural products (often redox active). Strikingly, SoxR homologues are also identified in the 
emerging and established pathogens of the Mycobacteria (~400 genomes), the agriculturally 
important Rhizobia (493 genomes) and Frankia (33 genomes), and recently discovered phyla (6 
genomes). Whether these organisms use SoxR to sense endogenous EES remains to be 
determined, but it suggests they might sense exogenous EES at a minimum. It is even possible that 
organisms could upregulate their own EES processing machinery to “cheat,” analogous to 
organisms that steal exogenous siderophores (69). 
 
Figure 2. Phylogenetic distribution of SoxR, a transcription factor that senses redox-
active metabolites. The phylogenetic tree shows all bacterial orders containing at least 
one genome with a SoxR homolog in the IMG database (SoxR TIGRfam 01950 (14)). 
The gray bars represent the percentage of genomes from each order that contain SoxR, 
with the absolute numbers listed below. The phyla represented are (1) Actinobacteria, 
(2) Fermicutes, (3) Chloroflexi, (4) Cyanobacteria, (5) Deinococcus, (6) 
Proteobacteria, with each subphylum labeled separately, (7) Planctomycetes, (8) 
Verrumicrobia, (9) Bacteroidetes, (10) Acidobacteria. The tree was generated using 
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While the diversity of redox-active metabolites, biosynthetic clusters, and redox sensing 
homologues satisfy important preconditions for potential widespread EES usage in the microbial 
world, the numbers we have presented come with two important caveats. First, not all secreted 
redox-active molecules can serve as EES due to redox-potential constraints (see Sidebar 2). 
Second, though we have good reason to think that SoxR is a robust predictor of an organism’s 
ability to sense EES, it is just one of many possible transcription factors used to sense, modify, and 
transport small redox-active molecules (37,70). Our bioinformatic analysis only suggests the 
potential for widespread production and usage of EES in the microbial world, which we hope will 
stimulate experimental follow-up (Sidebar 1). 
Costs of EES Biosynthesis 
At first glance, electron shuttles might appear expensive to produce, especially for a molecule that 
can be lost to diffusion or used by competitors in a microbial community. We discuss strategies 
for overcoming diffusive losses later, but here we wish to critically ask whether shuttles are 
‘expensive’. While a cell certainly loses carbon material by secreting a shuttle, the cost should not 
be compared to the energy that might be gained from fully oxidizing it to CO2. It is, after all, 
precisely the condition of oxidant-limitation where EES are important. In a microenvironment 
where organic carbon is abundant, but oxidants are limited or absent, there is essentially no 
opportunity cost to discarding carbon. Based on biosynthetic pathways, what is the cost of 
producing EES? 
All the known phenazine-producing bacteria use the same biosynthetic pathway, reviewed in 
detail elsewhere (71), in which two molecules of chorismate are modified and condensed to 
produce the core phenazine ring. Chorismate synthesis begins with two ATP equivalents and 
requires two additional ATP equivalents for completion (72), and so the core phenazine molecule 
requires a total of 8 ATP. Some quinones require only a single ATP in their conversion from 
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chorismate (72). Riboflavin synthesis requires only one ATP in its conversion from guanosine 
triphosphate (73), and including the precursors its cost has been estimated at up to 25 ATP per 
molecule (49). For these representative examples, the energy required to synthesize a shuttle is 
on the order of 5 to 25 ATP per molecule. How does this compare to other cellular processes? In 
protein synthesis, the addition of a single amino acid to a nascent peptide chain requires an 
estimated 4.5–7.9 ATP per amino acid (74), while RNA transcription further requires one ATP 
equivalent per nucleotide, and so the biosynthetic proteins themselves may represent a significant 
portion of a shuttle’s cost. A quantitative analysis in Shewanella illustrates that its endogenous 
shuttles, flavin derivatives, cost less than 0.1% of a cell’s energy budget to secrete at the necessary 
concentration (as low as 250 nM) (49).  
The striking conclusion is that for a redox-limited microbial community, shuttle synthesis may 
pose only a minor metabolic cost. Furthermore, bacteria are known to carefully regulate 
production of secreted molecules. Xavier et al. coined the term metabolic prudence to describe 
how P. aeruginosa specifically secretes carbon-rich rhamnolipids (used for swarming motility) 
when excess carbon is available and the cost of production is low (75). This regulation ensures 
that secreting cells are more fit than cheaters in competition experiments, because cost is 
minimized while the benefit of swarming remains high. Examples from P. aeruginosa and 
Salmonella typhimurium suggest that metabolic prudence is a broadly-used strategy for regulating 
secretions under diverse nutritional conditions, such as iron, phosphate, or nitrogen limitation 
(76,77). We expect metabolically prudent regulation could further reduce the effective cost of 
EES under oxidant limitation. 
Cell Biology of Electron Shuttling 
The biochemical reduction of EES poses a unique topological challenge. Perhaps the best-
elucidated mechanism of extracellular electron transport (EET) is in Shewanella oneidensis MR-1, 
17 
which has been reviewed in detail elsewhere (48,78). This organism uses the Mtr pathway, which 
is distinguished by a set of proteins that directly transfer electrons through the inner membrane, 
across the periplasm, and to the outside of the outer membrane where they directly reduce 
extracellular shuttles (Fig. 3a). The reduction of quinone by NADH dehydrogenase can be 
accompanied by the translocation of up to four protons across the inner-membrane (79), thus 
directly contributing to the proton motive force. In contrast, many other membrane-bound 
quinone reductases, such as succinate dehydrogenase or lactate dehydrogenase, are not known to 




Figure 3. The topology of electron shuttle reduction and oxidation. Filled blue 
hexagons represent oxidized shuttle, and open white hexagons represent reduced 
shuttle. (a) The Mtr system in S. oneidensis MR-1. Shuttles are reduced extracellularly 
and do not need to re-enter the cell. (b) A model of phenazine reduction in P. 
aeruginosa that allows for energy conservation by electron shuttling. By substituting for 
NAD+ in the pyruvate dehydrogenase complex (PDH), phenazines enable the 
synthesis of acetyl-CoA, which can drive ATP synthesis through the enzymes 
phosphate transacetylase and acetate kinase (44,46). Efflux of reduced phenazines by 
MexGHI-OpmD (70) may be coupled to proton translocation. (c) A condition where 
electron shuttling is costly. Operating the NADH dehydrogenase in reverse can 
consume the protonmotive force to drive shuttle reduction. Extracellular reduction of 
some minerals, such as Fe(OH)3, can alkalize of the medium, possibly depleting the 
protonmotive force further and causing pH stress for the cell. 
In contrast to Shewanella, specific pathways of extracellular electron transfer in other systems, such 
as phenazine shuttling in P. aeruginosa, remain ambiguous. Recent work from our laboratory 
shows that cytoplasmic (flavo)proteins can catalyze phenazine reduction in P. aeruginosa (46). 









































NAD+ in the pyruvate and α-ketoglutarate dehydrogenase complexes. This activity may allow 
phenazines to promote ATP synthesis during glucose oxidation by increasing the flux through 
pyruvate dehydrogenase and acetate kinase (46) (Fig. 3b). Similar findings have been observed 
in fermenting organisms, where the presence of humic substances or analogs increases the ratio 
of oxidized-to-reduced products (80), presumably increasing the ATP yield of fermentation. 
The invocation of cytoplasmic EES reduction has interesting implications with respect to the 
proton-motive force. Upon reduction, phenazines, quinones, and flavins all take on two protons 
at circumneutral pH (Fig. 1c). The subsequent secretion and oxidation of the reduced shuttle 
would therefore release those two protons outside the cell, essentially translocating two protons 
across the inner membrane (Fig. 3b). If this shuttle does not require active transport into our out 
of the cell, redox cycling of a shuttle could drive the generation of a proton motive force. 
Conversely, shuttles that accept electrons from the cytoplasmic face of NADH dehydrogenase 
might consume the proton motive force, such as the artificial compound paraquat (81) (Fig. 3c). 
Though progress is being made on phenazine transport systems (70), where different phenazines 
are reduced and how they enter the appropriate efflux pump machinery remain open questions. 
The take-away message is that the subcellular localization of shuttle reduction greatly influences 
the energy that can be conserved, and we expect future work will elucidate new and interesting 
mechanisms to accompany the Mtr system. 
Finally, while we have focused here on the mechanisms of EES reduction, electron transfer entails 
a subtler point with respect to the terminal electron acceptor. The reduction potential of minerals, 
and the kinetics of their reduction by shuttles (38), depends strongly on pH, and so the free energy 
available to a cell necessarily depends on its microenvironment. Moreover, mineral reduction is 
accompanied by alkalization (Fig. 3c), which further inhibits the available free energy and may 
even negatively affect the proton motive force if it happens close to the cell. From a cell’s 
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perspective, the energy that can be conserved via electron shuttling may depend on the pH-
buffering capacity of its environment and the rate of proton diffusion. 
EES in the Extracellular Environment 
In addition to defining the constraints that shape intracellular EES biosynthesis and processing, 
central to any predictive understanding of EES usage is knowledge of what happens to EES once 
they leave the cell. Because most bacteria live in biofilms (82,83), we will consider the extracellular 
environment to be a self-produced matrix of EPS and water. Here we explore under what 
conditions EES can be efficiently recycled. 
Shuttle diffusion  
Two studies have shown that diffusion can theoretically explain electron shuttling-supported 
metabolism in a closed system (84,85). In any environment, the flux of reduced EES away from 
cells (Jred) (toward electron acceptor) is driven by the concentration gradient that forms as cells 
reduce EES and the electron acceptor oxidizes them. Simultaneously, the concentration gradient 
of oxidized EES drives flux (Jox) back to the cells that use EES to run their metabolism (Fig. 4a). 
We adapted a simple model of 3D diffusion, where an inner sphere of cells shuttle electrons to an 
outer sphere of electron acceptor, analogous to P. aeruginosa biofilms limited for oxygen (Fig. 4c) 
(86-89). Using realistic values of phenazine diffusion coefficients (~10-9–10-10 m2/s), 
concentrations (>10μM) and metabolic requirements (Mmin), the model produces redox 
gradients that can drive sufficient flux of oxidized EES to support survival (Fig. 4d), in agreement 
with observed phenazine mediated survival (43,44,85). 
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Figure 4. Mechanisms of electron transfer by EES. (a) Diffusion only. The reduced EES 
can diffuse down its concentration gradient to an electron acceptor, while the oxidized 
form simultaneously returns along its own concentration gradient. At steady state 
(∂c/∂t = 0), the concentration gradients are linear in this closed one-dimensional 
system. (b) The self-exchange rate (khop) allows electrons to hop between oxidized and 
reduced EES. If khop is significantly faster than the rate of diffusion, electron hopping 
will accelerate the apparent diffusion of electrons. EES diffusion can also co-occur. (c) 
In three dimensions, with an inner sphere of cells and an outer sphere of electron 
acceptor, the concentration gradient at steady state is non-linear. The gradient is steeper 
near the inner sphere, allowing for higher flux than in the one-dimensional case. (d) 
Results of a closed steady-state model of EES diffusion in three dimensions, with 
different EES concentrations and diffusion coefficients. Representative aqueous 
diffusion coefficients are listed below the plot (86,88-90). The numbers in each box 
correspond to the modeled flux of oxidized EES (Jox) through the surface area (Amin) of 
the inner sphere, in units of molecules per second. Green indicates regions where 
diffusion can account for the minimum flux needed for cells to survive, while orange 
indicates regions where diffusion is too slow. The number of molecules per second 
needed to support the inner sphere with volume Vmin was calculated to be 1.5 × 107 
molecules/s based on published parameters for Mmin, the minimum energy required for 
survival in P. aeruginosa (85). The inner sphere radius was rmin = 10 μm and the outer 
sphere radius was rmax = 100 μm. For simplification, we have taken the diffusion 
constants of the oxidized and reduced EES (Dred and Dox) to be equivalent, and the 
rates of EES reduction and oxidation (kred and kox) to be instant. 
a   One-dimensional diffusion c   Three-dimensional diffusion d Survival in three dimensions
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Electron hopping as an alternative to shuttle diffusion 
But what about in an open system, which more accurately models environments where EES 
operate? An attractive mechanism that might prevent EES loss in an open system is electron 
hopping between EES bound in the biofilm matrix (84,91). Such conduction would avoid the 
conflict between turnover and loss within the shuttle diffusion model and might better explain 
electron shuttling in open systems. The flux of hopping electrons from the cells to the acceptor is 
considered a diffusive process, which is driven by the concentration gradient of electrons (i.e. 
redox gradient) (92). In this scenario, EES are bound within the extracellular matrix, and electrons 
propagate from cells to the terminal metabolic electron acceptor (e.g. O2) by sequential electron-
transfer reactions among the EES, allowing EES retention and reuse (Fig. 4b). Hopping steps 
(khop) are expected to happen rapidly compared to shuttle diffusion (D) (93,94). 
Significant theoretical and experimental work has already been done to describe electron hopping 
in electrode-grown biofilms of Geobacter sulfurreducens. Such biofilms, which can exceed tens of 
microns in thickness, utilize the underlying electrode, poised at a sufficiently oxidizing potential, 
as the terminal metabolic acceptor. Cells not in direct contact with the electrode can transport 
their respired electrons to the electrode via hopping through a proposed network of c-type 
cytochromes as opposed to EES. This model is supported experimentally by measurements of 
biofilm electrical conductivity (23,91,92,95-100). Much of the theory comes from models of 
synthetic redox polymers and proteins that contain bound redox cofactors (24,91,101-103). This 
work provides a proof-of-principle that motivates experiments to test for electron hopping in 
other biofilms where EES may dominate extracellular electron transfer.  
Evolutionary strategies that maintain EES in open environments 
Regardless of the electron transfer mechanism, sufficient concentrations of EES must be 
maintained for viability. What strategies do microbes take in producing and maintaining public 
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goods in open environments? We view EES as public goods because they are secreted molecules 
that benefit nearby individuals as well as the producer cell (104). Kin selection theory posits that 
public good production can evolve when individuals’ actions increase not only their own 
reproductive success, but also the success of genetically related individuals (104). Microbes are 
therefore more likely to produce public goods when they are highly related to their neighbors, the 
direct and indirect benefits are high, and the cost of production is low (105).  
In this context, it makes sense that EES would be regulated by quorum sensing (QS) molecules, 
signals that direct population behaviors when cell numbers are high. QS molecules can provide 
cells with information on nearby relatives and diffusion conditions (106). By dividing quickly and 
producing an extracellular matrix, many bacteria can establish highly-related microcolonies that 
favor the evolution of public goods (105). Laboratory studies show that producers of the 
siderophore, pyoverdine, outcompete non-producer mutants when populations are highly 
related, but not when strains are mixed (69,107). Because QS molecules are secreted into the 
environment and subject to diffusion, they enable cells to distinguish between closed and open 
systems (108). A good example of QS-regulation of EES production can be found in how 
Pseudomonas species regulate phenazine production (31). 
Other strategies that can facilitate the viability of EES utilization relate to mechanisms of 
privatization, such as physical retention or a requirement for special machinery to utilize the 
secreted molecule (104). Physical retention can be achieved via noncovalent interactions 
between small molecule and biofilm components, which in the case of EES, could conceivably 
also provide a scaffold for electron hopping. Marine microbes that retain siderophores by 
embedding them in the outer membrane with lipophilic sidechains (109) provide an example of 
selective retention of a secreted metabolite near producing cells. Other chemical mechanisms may 
facilitate retention, however, such as electrostatic attraction between EES and specific 
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components of a biofilm matrix. This may help rationalize co-regulation of EES and exopolymeric 
substances (EPS), as in the case of phenazines, eDNA and particular types of EPS (43,110,111). 
Discrimination can be achieved with highly specific receptors for siderophores and QS molecules 
that enable only producers to uptake their secreted products (104,112,113). Another strategy is 
to make the public good itself toxic, which requires specialized detoxification systems (114). 
Interestingly, many EES were first identified as antibiotics (11,56), and special proteins are 
required to deal with their toxic byproducts (115).  
Outlook 
This is an exciting time to care about microbes that change color. The explosion of computational 
platforms that can predict structures and properties of natural products, combined with the 
exponential growth of genomic databases, is ushering in a golden age for EES discovery. Based on 
these databases, and lessons learned from experimental systems where redox-active pigment 
production and utilization have been well documented, the available evidence suggests that EES 
are likely to be widespread and play underappreciated roles in the physiology of diverse microbes.  
Going forward, it will be important to prioritize systematic screens to test for EES production and 
usage. Sidebar 1 provides an example of how one can approach this, yet innovations that would 
enable high-throughput screens are needed to stimulate the search process. While such 
technologies could be developed by individual labs at universities, an opportunity for efficient 
scale-up exists if national labs that are interested in metabolomics, such as the Joint Genome 
Institute (66,116,117), take on this challenge. The creation of pipelines to interface metabolomics 
with complementary bioinformatics and physiological screens would greatly accelerate EES 
discovery. In our view, the identification of genetically-tractable EES-producing microbes should 
be a priority for future research. Genetically-tractable systems are now more achievable than ever 
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before (118,119), and thus the isolation of EES-producing or utilizing microbes has the potential 
to quickly reach a mechanistic-level of understanding.  
Identification of machinery that sense and process EES across diverse microorganisms will permit 
the type of comparative analysis needed to enable general principles to be resolved. For example, 
the better we understand the conservation of EES transporters or sensors, the more confidently 
we will be able to scan genomes to predict EES production or usage by new isolates. In this way, 
we will be able to learn whether the strategies that govern EES cycling by the handful of organisms 
that have been studied in detail to date represent special cases or broader paradigms. Generally, 
metabolic strategies fall into a limited number of categories that are viable for cells, thus it will be 
exciting to discovery the range of strategies that can be used by organisms that employ EES for 
energy generation and other purposes. 
Finally, we end by noting that much of what we understand about microbial metabolism springs 
from research that has been done when nutrients are replete. Yet microbial existence in the natural 
world is usually limited by a variety of substrates (120), and it is in this context we believe EES 
will prove to be important. Not only can EES enable energy generation in oxidant-limited 
biofilms, which are ubiquitous (82,83), but the broader reactivity of EES can impact the fate and 
transport of pollutants in soils and sediments (14,121,122). From both fundamental and applied 
viewpoints, a broader and deeper understanding of EES production, sensing and utilization thus 
stands to improve our ability to rationalize and control the composition and activities of microbial 
communities across a variety of natural, engineered, and clinical environments. 
Sidebars 
Sidebar 1. How to characterize a putative EES 
What criteria establish that a molecule functions as an EES? Based on our definition, the molecule 
must 1) facilitate extracellular electron transfer, 2) undergo multiple redox cycles, and 3) provide 
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a physiological benefit to its producer via cycling. The following steps can be used to determine 
whether a particular secreted metabolite is an EES. 
Find a tractable extracellular electron transfer phenotype and implicate a soluble EES. 
Quantifiable extracellular electron transfer phenotypes can be detected in assays with minerals 
(33), electrodes (40,44,123), or soluble electron acceptors (11,124). Secreted EES can be 
implicated by demonstrating electron acceptor reduction in the absence of direct cell contact 
using different strategies, such as separation by agar, permeable membranes, glass frits, or 
compartments in microfluidic devices.  
Isolate and characterize the EES molecule. Once an EES phenotype is established, the 
responsible molecule can be purified using chromatography and other standard separation 
methods from organic chemistry. Its spectral properties, biotic and abiotic reactivity, and redox 
potential can then be measured using different types of spectroscopy (UV–vis, EPR) and cyclic 
voltammetry, respectively (e.g. (9,38,125)). 
Genetically inhibit EES biosynthesis. Because EES are not essential under all conditions, it is 
possible to isolate mutants defective in their production. Such mutants can offer insights into EES 
biosynthesis, regulation, and even cycling mechanisms (e.g. (35,40,126)). Control over EES 
production, which is enabled by mutant strains, is necessary to rigorously determine the 
physiological benefits of an EES. 
Measure EES turnover. EES uptake and reduction can be quantified using biosynthetic mutants 
in the presence of a defined EES concentration and oxidant (e.g.(40)). The molecule can be 
defined as an EES if it enables a super-stoichiometric reaction with the distal electron acceptor. 
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Sidebar 2. How does redox-potential define an EES? 
The essence of a shuttle is summarized by its midpoint reduction potential, a broad generalization 
of a compound’s ability to act as electron acceptor or donor. To avoid misusing this parameter, 
one must remain cognizant that it is descriptive of standard conditions for reactions heading 
towards thermodynamic equilibrium, conditions that rarely describe biological systems. 
Importantly, many redox reactions involve proton exchange, and so the true reduction potential 
depends on the environmental pH. A distinction must also be drawn between the one- and two-
electron potentials of a shuttle, which can vary by hundreds of millivolts—this difference has even 
been exploited by some microorganisms to drive the reduction of low-potential acceptors in a 
process known as electron bifurcation (127,128). Moreover, the reduction potential says nothing 
about the kinetics or chemical sensibility of the reaction. A striking example of this distinction is 
the thermodynamic favorability of biological nitrogen fixation (129), a process that nonetheless 
requires catalysis and energy input to proceed at rates that support life. Conversely, the artificial 
redox cycling drug paraquat has a midpoint potential below that of most intracellular donors, 
rendering paraquat reduction thermodynamically unfavorable at standard conditions; even so, the 
paraquat radical reacts with oxygen at a rate that is nearly diffusion-limited (130), allowing 
paraquat to drive redox cycling under biological conditions. And so, while a shuttle’s reduction 
potential is a core physical parameter that captures the essence of redox cycling, it must be 
carefully considered with respect to the environmental conditions, reaction kinetics, and other 
chemical properties. A rigorous quantitative prediction of these effects remains an ongoing 




Extracellular electron shuttles (EES): A self-produced small molecule that enables a microbe to 
perform EET by reversibly accepting metabolic electrons and donating them to extracellular 
electron acceptors. Note these molecules can also act as electron donors to metabolism (131).  
Biosynthetic clusters: organized sets of genes that encode enzymes to produce specific 
metabolites. 
Redox gradient: A concentration gradient of electrons across a field of redox-active molecules. 
This gradient can drive physical diffusion of the molecules in different redox states, or electron 
diffusion via electron transfer between redox-active molecules. 
Public goods: Secreted molecules that benefit nearby individuals that did not originally produce 
the molecules. 
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C h a p t e r  3  
PHYSIOLOGY OF PHENAZINE-MEDIATED SURVIVAL 
This chapter is adapted from: 
Glasser, N. R., Kern, S. E., and Newman, D. K. (2014) Phenazine redox cycling enhances 
anaerobic survival in Pseudomonas aeruginosa by facilitating generation of ATP and a proton-
motive force. Molecular Microbiology 92, 399-412. 
Abstract 
While many studies have explored the growth of Pseudomonas aeruginosa, comparatively few have 
focused on its survival. Previously, we reported that endogenous phenazines support the 
anaerobic survival of P. aeruginosa, yet the physiological mechanism underpinning survival was 
unknown. Here, we demonstrate that phenazine redox cycling enables P. aeruginosa to oxidize 
glucose and pyruvate into acetate, which promotes survival by coupling acetate and ATP synthesis 
through the activity of acetate kinase. By measuring intracellular NAD(H) and ATP 
concentrations, we show that survival is correlated with ATP synthesis, which is tightly coupled 
to redox homeostasis during pyruvate fermentation but not during arginine fermentation. We also 
show that ATP hydrolysis is required to generate a proton-motive force using the ATP synthase 
complex during fermentation. Together, our results suggest that phenazines enable maintenance 
of the proton-motive force by promoting redox homeostasis and ATP synthesis. Our results 
demonstrate the more general principle that small redox-active molecules, such as phenazines, 
can broaden the metabolic versatility of microorganisms by facilitating redox homeostasis. 
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Introduction 
Pseudomonas aeruginosa is an opportunistic pathogen that forms both acute and chronic 
infections. It is well known to form biofilms in diverse environments, and microbial stasis within 
biofilms is thought to complicate the treatment of many persistent infections. For example, cells 
at the base of P. aeruginosa biofilms enter a dormant state with decreased levels of transcription 
and translation, and they undergo physiological adaptations to hypoxic conditions (1,2). These 
cells are substantially more resistant to antibiotics than actively growing cells (2). Moreover, 
nutrient deprivation triggers active responses for P. aeruginosa that increase antibiotic resistance 
in growth-arrested cells (3). Even under active growth, many bacterial species, including P. 
aeruginosa, maintain a small population of phenotypically resistant cells called persisters (4). The 
persister state is thought to be controlled by stochastic changes in cell physiology and metabolism 
(4-6). Together, these subpopulations of resistant non-replicating cells can serve as reservoirs for 
recurrent infections (4). Our incomplete understanding of the metabolic changes underpinning 
microbial quiescence thus limits our ability to treat chronic infections. 
In addition to forming biofilms and persister cells during infections, pseudomonads synthesize a 
class of redox-active pigments collectively termed phenazines (7,8). Phenazines are important 
virulence factors (9) that serve as antibiotics towards microbial competitors (10) and damage 
mammalian cells (11). Phenazines can benefit P. aeruginosa by serving as signaling molecules 
(12), regulating persister cell formation (13), influencing colony morphology (14,15), and 
promoting iron acquisition and biofilm development (16). 
We previously reported that micromolar concentrations of phenazines can support anaerobic 
survival by transferring electrons to an extracellular oxidant (17). Although the physiological basis 
for this survival mechanism was unknown, phenazine redox cycling was correlated with a more 
oxidized intracellular environment for planktonic cultures (18,19) and colony biofilms (15), 
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suggesting that phenazines alter metabolism. P. aeruginosa is thought to form biofilms within the 
lungs of cystic fibrosis patients (20,21), and in many patients, the lung sputum contains 
phenazines at concentrations that can support anaerobic survival (17,22,23). Phenazines are 
positively correlated with the progression of P. aeruginosa lung infections (23), and so they may 
directly alter the physiology of P. aeruginosa infections in situ. 
Here, we sought to elucidate the physiological basis for phenazine-promoted anaerobic survival 
in P. aeruginosa. We discovered that phenazines facilitate the conversion of glucose and pyruvate 
into acetate. Our data support a model where phenazines dissipate excess reducing equivalents, 
allowing for the coupling of acetate and ATP synthesis through the activity of acetate kinase. ATP 
is required for survival, in part to maintain the proton-motive force through the ATP synthase 
complex. Our results highlight the interplay between redox homeostasis and ATP synthesis in the 
context of long-term survival, and illuminate the important role extracellular redox active 
metabolites can play in facilitating core metabolism. 
Results 
Phenazine redox cycling requires the activity of acetate kinase to promote survival 
Phenazine redox cycling occurs when a phenazine molecule undergoes alternating reduction and 
oxidation reactions, resulting in the transfer of electrons from the reductant (e.g. NAD(P)H) to 
the oxidant (e.g. oxygen). Phenazines can cross cell membranes, enabling the transfer of reducing 
equivalents from inside the cell to the extracellular environment. We have previously shown that 
this transfer of reducing equivalents can promote anaerobic survival (17). We found that a carbon 
source, specifically glucose, is required for anaerobic survival in the presence of oxidized 
phenazines (17). To understand how phenazines promote anaerobic survival, we began by 
exploring the role of glucose. 
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Figure 1. Metabolic pathways in P. aeruginosa. Multiple arrowheads indicate that 
several reaction steps have been condensed for clarity. Boxes indicate the enzyme that 
catalyzes each reaction. (A) Glucose oxidation via the Entner-Doudoroff pathway. For 
clarity, the pathway is abbreviated to the key intermediates of glycolysis. (B) Pyruvate 
fermentation (Eschbach et al., 2004). LdhA, lactate dehydrogenase; Pdh, pyruvate 
dehydrogenase; Pta, phosphate acetyltransferase; AckA, acetate kinase. (C) The 
arginine deiminase pathway (Vander Wauven et al., 1984). ArcA, arginine deiminase; 
ArcB, ornithine carbamoyltransferase; ArcC, carbamate kinase.  
To metabolize glucose, P. aeruginosa uses the Entner-Doudoroff pathway to convert one glucose 
molecule into two pyruvate molecules (Figure 1a). This process is coupled to the synthesis of one 
net ATP molecule and two excess reducing equivalents (NAD(P)H) (Figure 1a). Pyruvate can 
be further converted into acetate to produce additional ATP and reducing equivalents (Figure 
1b). To sustain anaerobic glycolysis, P. aeruginosa must regenerate the oxidants (i.e. NAD+ and 
NADP+) that were consumed during pyruvate and acetate synthesis. We therefore hypothesized 
that phenazines, by dissipating excess reducing equivalents, might promote the oxidation of 
glucose into acetate during anaerobic glycolysis. In this model, acetate synthesis is coupled to ATP 
synthesis through the activity of acetate kinase (Figure 1b), and it is the ATP synthesis that we 















































To address this hypothesis, we tested mutants with markerless deletions of pyruvate metabolism 
genes in a phenazine redox cycling survival assay. In this experiment, early stationary phase cells 
were resuspended in anoxic MOPS-buffered minimal medium containing glucose as the sole 
carbon and energy source. To control the concentration of phenazines, we used strains with 
deletions in both phenazine biosynthetic operons (ΔphzA1-G1 ΔphzA2-G2, abbreviated 
Δphz1/2) (12) and added phenazine-1-carboxylic acid (PCA) back to the culture at a 
physiologically relevant concentration (75 μM) (23). We chose PCA because it is the biosynthetic 
precursor of all other phenazines in P. aeruginosa and other pseudomonads (24,25), and also 
because it is synthesized whether oxygen is present or not. While oxygen and ferric iron are likely 
oxidants of phenazines in infection environments (26), we instead supplied an electrode poised 
at a potential sufficient to oxidize phenazines in our culture vessels (E0 = +207 mV). 
 
Figure 2. Phenazine redox cycling in P. aeruginosa PA14 ∆phz1/2. Cells were grown 
aerobically in LB to an OD500 of 2.8 and then pelleted, washed, and resuspended in 
anoxic MOPS-buffered minimal medium with 20 mM glucose. Where noted in the 
‘potential’ column of the legend, cultures also included 75 μM PCA and an electrode 
poised at a potential to oxidize any reduced PCA. Results are typical of at least three 
independent experiments. (A) Survival of strains with deletions of pyruvate 
metabolism genes. 100% survival represents approximately 7 × 108 CFU/mL. (B) 
HPLC traces from culture supernatants after three days of phenazine cycling as in panel 
A. Peaks were identified by comparing retention times to known standards. The dashed 
gray arrow indicates the retention time of lactate, which was not observed in this 
experiment. Question marks (?) indicate unidentified products. Asterisks (*) indicate 
trace contaminants that were present from the start of the experiment. 
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Consistent with the fact that P. aeruginosa is not known to ferment glucose, cultures declined to 
about 0.0001% viability after seven days when provided with glucose alone (Figure 2a). As 
previously reported (17), the addition of phenazines and an extracellular oxidizing potential 
improved anaerobic survival to 10% after seven days (Figure 2a). A strain lacking lactate 
dehydrogenase, ΔldhA, was not impaired in survival relative to the Δphz1/2 parent strain (Figure 
2a). However, strains lacking acetate kinase that are unable to generate ATP by converting 
pyruvate into acetate, ΔackA and ΔackA-pta, failed to survive relative to the parent strain, with 
only about 0.001% of cells remaining viable after seven days (Figure 2a). 
We detected current through the extracellular electrode only when phenazines were present 
(Supplemental Figure 1), consistent with the model that phenazines mediate electron transfer 
from inside the cells to the electrode. After three days of survival, before we observed a loss in 
viability (Figure 2a), the Δphz1/2 strain transferred a total charge of 11 C to the electrode. Using 
the relationship Q = 2F(acv), where Q is the total charge transferred (11 C), F is Faraday’s 
constant (96,485 C mole−1), c is the concentration of PCA (7.5 × 10−5 M), v is the reaction volume 
(0.1 L), and a is the average number of redox cycles, we calculated an average of 8 redox cycles 
per molecule of PCA, a value similar to previous measurements (17). 
To test if acetate is produced during phenazine redox cycling, we used high performance liquid 
chromatography (HPLC) to directly measure the secreted metabolic products in our experiment. 
We detected the production of acetate, succinate, and two additional unknown products whose 
identification is a work in progress. Consistent with our hypothesis, cultures with oxidized 
phenazines produced more acetate than did cultures without phenazines (Figure 2b). After three 
days, in duplicate measurement, the Δphz1/2 strain produced 5.9 × 10−8 nanomoles CFU−1 (350 
μM) and 5.0 × 10−8 nanomoles CFU−1 (330 μM) of acetate with phenazine redox cycling but only 
1.3 × 10−8 nanomoles CFU−1 (78 μM) and 2.1 × 10−8 nanomoles CFU−1 (130 μM) of acetate 
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without phenazine redox cycling. Succinate and one unknown compound were produced in 
approximately equal amounts irrespective of phenazines (Figure 2a), with the Δphz1/2 strain 
producing 2.4 × 10−8 nanomoles CFU−1 of succinate after three days with oxidized phenazines. 
The other unknown product was produced in greater amounts in cultures with oxidized 
phenazines than in cultures without phenazines (Figure 2a). 
We expected that acetate would be synthesized by acetate kinase (Figure 1b), which couples 
acetate synthesis to ATP synthesis. To our surprise, the ΔackA and ΔackA-pta mutants produced 
similar amounts of acetate as the parent strain during phenazine redox cycling with glucose 
(Figure 2b), suggesting that acetate kinase is not the only active acetate-producing enzyme in our 
experiment. The P. aeruginosa PA14 genome contains the gene poxB, which codes for a putative 
pyruvate oxidase that converts pyruvate to acetate and CO2 without directly generating ATP or 
NADH (27). Using quantitative reverse-transcription PCR, we detected poxB transcripts during 
exponential growth, early stationary phase, and after resuspension in anaerobic MOPS-buffered 
minimal medium with glucose and 75 μM oxidized PCA. We also measured an increase in the 
relative abundance of pyruvate oxidase transcripts to control gene transcripts (pyruvate 
dehydrogenase and the housekeeping genes clpX and recA) after resuspension in minimal medium 
when compared to exponential growth (Supplemental Figure 2). Pyruvate oxidase, encoded by 
poxB, may therefore account for the observed acetate synthesis in the ΔackA and ΔackA-pta 
mutants during phenazine redox cycling. Pyruvate oxidase may also account for some acetate 
synthesis in the WT strain. 
Together, the survival defect of the ΔackA and ΔackA-pta mutants (Figure 2a) demonstrates that 
the activity of acetate kinase is essential for long-term survival in our phenazine redox cycling 
experiment. As the ΔackA and ΔackA-pta mutants still produce acetate (Figure 2b), it is unlikely 
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that acetate itself is sufficient for survival. Instead, our data are consistent with a model where ATP 
synthesis by acetate kinase is required for anaerobic survival. 
Phenazine redox cycling promotes ATP synthesis during pyruvate fermentation 
In keeping with the fact that the Δphz1/2 ΔldhA mutant survived as well as the parent strain 
Δphz1/2 (Figure 2a), we did not observe lactate synthesis during phenazine redox cycling with 
glucose (Figure 2b). This suggests that lactate dehydrogenase is not used to maintain redox 
homeostasis during anaerobic glycolysis. In contrast, lactate dehydrogenase is required for 
survival during pyruvate fermentation (28). During pyruvate fermentation, P. aeruginosa converts 
pyruvate into succinate, lactate, and acetate (Figure 1b). This process supports anaerobic survival 
but not growth (28) and uses acetate kinase to synthesize ATP (Figure 1b). If phenazine redox 
cycling is a general mechanism for maintaining redox homeostasis, we predicted that phenazine 
redox cycling should support redox homeostasis and ATP synthesis during pyruvate 
fermentation. 
To test this prediction, we measured the anaerobic survival of the Δphz1/2 ΔldhA strain using 
pyruvate as the sole carbon and energy source. As expected, this strain was unable to survive by 
fermenting pyruvate (Figure 3a). Consistent with our prediction, however, the addition of PCA 
and an extracellular oxidizing potential improved the survival of the Δphz1/2 ΔldhA strain during 
pyruvate fermentation (Figure 3a). 
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Figure 3. Pyruvate fermentation in the PA14 ∆phz1/2 ∆ldhA strain with 40 mM 
pyruvate. Cultures were incubated without phenazines or an oxidizing potential (open 
squares) or with 75 μM PCA and an oxidizing potential (closed squares). Error bars 
indicate the standard error of three independent experiments. (A) Survival of the 
∆phz1/2 ∆ldhA strain during pyruvate fermentation. 100% survival represents 
approximately 1.4 × 109 CFU/mL. (B) Acetate produced during pyruvate 
fermentation in the ∆phz1/2 ∆ldhA strain. The amount of acetate produced in each 
experiment was normalized to the CFU measurement at day 0. Error bars are present 
but smaller than the data points. (C) ATP concentrations during pyruvate 
fermentation in the ∆phz1/2 ∆ldhA strain. 
In our model of survival, redox homeostasis allows for additional acetate and ATP synthesis 
through the oxidative branch of the pyruvate fermentation pathway (Figure 1b). To further 
confirm this model, we used HPLC to measure acetate synthesis during pyruvate fermentation. 
The Δphz1/2 ΔldhA strain produced more acetate when provided with phenazines and an 
extracellular oxidizing potential (Figure 3b). We observed a difference in acetate production 
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before the Δphz1/2 ΔldhA cultures began to lose viability (on day 3), suggesting that the 
difference in acetate synthesis was not simply due to a difference in survival. 
To confirm that phenazine redox cycling provides an energetic benefit to P. aeruginosa, we also 
measured the ATP concentrations of cultures with and without phenazine redox cycling. 
Consistent with a coupling between acetate and ATP synthesis, Δphz1/2 ΔldhA cultures with 
oxidized phenazines maintained higher ATP concentrations than those without phenazines 
(Figure 3c). This difference was again observed before the cultures began to lose viability, 
suggesting that the difference in ATP concentration was not simply a consequence of cell death. 
ATP synthesis is limited by redox homeostasis during pyruvate fermentation 
Our model suggests that, by helping to maintain redox homeostasis, phenazines promote the 
conversion of pyruvate to acetate through the activity of acetate kinase. This model predicts that 
redox homeostasis is the limiting factor for ATP synthesis during pyruvate fermentation. From 
the stoichiometry of pyruvate fermentation, acetate and lactate synthesis are coupled through the 
common cofactor NAD(H) (Figure 1b). Sustained pyruvate oxidation to acetate, and thus ATP 
synthesis, requires the regeneration of NADH to NAD+, which can be accomplished by the 
activity of lactate dehydrogenase. To determine whether this is indeed the case, we compared the 
concentration of relevant metabolites during pyruvate fermentation for wild type (WT) P. 
aeruginosa PA14 and different mutant strains. 
To initiate pyruvate fermentation, we cultured PA14 using pyruvate as the sole carbon source 
aerobically, shifted the cells to an anoxic environment, and washed and resuspended the cells in 
fresh anoxic medium. As expected, anaerobic WT cultures with pyruvate survived for at least 
seven days, while cultures without pyruvate quickly declined in viability (Figure 4a). In contrast 
to previous studies with PAO1 (28,29), which demonstrated nearly complete survival, in our 
study we observed only 50% survival after 7 days of anaerobic incubation with pyruvate. 
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Figure 4. Survival with pyruvate fermentation in P. aeruginosa. Where shown, error bars 
indicate the standard error of three independent experiments. (A) Anaerobic survival 
for wild type PA14 (WT), PA14 ΔldhA (ΔldhA), PA14 ΔackA (ΔackA), and PA14 
ΔackA-pta (ΔackA-pta) in the presence of 40 mM pyruvate (+pyruvate, closed points). 
WT PA14 without pyruvate is shown for comparison (−pyruvate, open points). 100% 
survival represents approximately 4 × 108 CFU/mL. Results are typical of least three 
independent experiments. (B) The [NADH]/[NAD+] ratio after 24 hours of pyruvate 
fermentation in PA14 WT, ∆ldhA, and ∆ackA. (C) ATP concentrations from the same 
experiments shown in panel B. 
As expected, mutants deficient in the conversion of pyruvate to acetate, ΔackA and ΔackA-pta, 
displayed a survival defect during pyruvate fermentation (Figure 4a). A mutant deficient in the 
conversion of pyruvate to lactate, ΔldhA, had a survival defect similar to that of the ΔackA mutant 
(Figure 4a). To our surprise, a mutant unable to convert acetyl-CoA to acetyl-phosphate, ΔackA-







































































between the ΔackA and ΔackA-pta mutants might result from a difference in intracellular acetyl-
phosphate concentrations, as acetyl-phosphate can serve as a phosphate donor in signaling 
pathways (30). Alternatively, the ΔackA-pta mutant might accumulate acetyl-CoA, starving other 
essential pathways that require coenzyme A. Similar results have been observed in E. coli, where 
the expression of a pathway to consume acetyl-CoA enhances the survival of a Δpta mutant in 
stationary phase (31). 
We used ion chromatography to confirm the biosynthesis of acetate, lactate, and succinate from 
pyruvate as previously reported (28) (Supplemental Figure 3). As expected, both the ΔackA-pta 
and ΔldhA mutants produced significantly less acetate than the WT strain (Supplemental Figure 
3), suggesting that the ΔldhA mutant is limited in its ability to generate acetate and ATP using 
acetate kinase. 
To confirm that the ΔldhA strain is impaired in redox homeostasis and ATP synthesis, we 
measured the NAD+, NADH, and ATP concentrations in cultures fermenting pyruvate. After 24 
hours of anaerobic incubation with pyruvate as the sole carbon and energy source, both the WT 
strain and ∆ackA mutant maintained an [NADH]/[NAD+] ratio of approximately 1 (Figure 4b). 
In contrast, the ∆ldhA mutant contained a more reduced intracellular environment with an 
[NADH]/[NAD+] ratio of approximately 2 (Figure 4b). The ΔldhA mutant also contained 
significantly less total NAD(H) than the WT strain and ΔackA mutant (Supplemental Figure 4). 
In support of our model, both the ∆ldhA and ∆ackA mutants contained significantly less ATP 
than the WT strain (Figure 4c). 
The reduced acetate synthesis and depleted ATP concentration in the ∆ldhA mutant suggest that 
the ∆ldhA mutant is unable to synthesize ATP through acetate kinase. The elevated 
[NADH]/[NAD+] ratio suggests that acetate and ATP synthesis are limited by redox 
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homeostasis, corroborating the fact that phenazine redox cycling improves survival in the 
∆phz1/2 ∆ldhA mutant during pyruvate fermentation (Figure 3a). 
Arginine supports anaerobic ATP synthesis and survival independently of redox state 
The survival defects of the ΔackA and ∆ldhA mutants during pyruvate fermentation suggest that 
ATP synthesis is an essential component of survival in P. aeruginosa. To test this hypothesis using 
an independent anaerobic metabolism that produces ATP, we investigated survival using arginine 
as the sole carbon and energy source. Arginine is used as an ATP source during anaerobic growth 
through the arginine deiminase pathway (32) (Figure 1c). Previous work has shown that mutants 
in the arginine deiminase pathway have reduced anaerobic survival in undefined complex media 
(29), but to our knowledge there have been no reports of arginine alone serving as a sufficient 
energy source for survival. 
To determine whether arginine is sufficient for anaerobic survival, we cultured P. aeruginosa PA14 
aerobically using arginine as the sole carbon source, shifted the cells to an anoxic environment, 
and washed and resuspended the cells in fresh anoxic medium with arginine. As with pyruvate, 
arginine alone was sufficient as an energy source to promote anaerobic survival (Figure 5a). WT 
PA14 dropped to 30% viability after one day of anaerobic incubation and slowly decreased in 
viability to 15% after seven days. In contrast, cells incubated without arginine declined to 0.1% 
viability after seven days (Figure 5a). A transposon insertion mutant in the arginine deiminase 
pathway, arcC::MAR2xT7 (33), rapidly declined in viability to 0.02% after seven days despite the 
presence of arginine (Figure 5a). Similar results were obtained with a second independent 
transposon insertion mutant, arcA::MAR2xT7, disrupting another gene in the same pathway 
(Figure 1c) (data not shown). This demonstrates that arginine is sufficient to promote anaerobic 
survival through the arginine deiminase pathway. 
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Figure 5. Survival with the arginine deiminase pathway in P. aeruginosa. Where shown, 
error bars indicate the standard error of three independent experiments (A) Anaerobic 
survival for wild type PA14 (WT) and PA14 arcC::MAR2xT7 (arc::) in the presence 
of 40 mM arginine. WT PA14 without arginine is shown for comparison (−arginine, 
open points). 100% survival represents approximately 4 × 108 CFU/mL. Results are 
typical of at least three independent experiments. (B) The [NADH]/[NAD+] ratio 
after 24 hours of anaerobic incubation with arginine in PA14 WT and 
arcC::MAR2xT7. (C) ATP concentrations from the same experiments shown in panel 
B. 
To confirm that disrupting the arginine deiminase pathway also disrupted ATP synthesis, we 
measured NAD+, NADH, and ATP concentrations in cultures incubated with arginine. After 4 
hours of anaerobic incubation with arginine as the sole carbon and energy source, both the WT 
strain and arcC::MAR2xT7 mutant maintained similarly high [NADH]/[NAD+] ratios of 


































































ATP than the WT strain (Figure 5c), consistent with the disruption of the ATP-generating step 
in the arginine deiminase pathway. The ability of the WT strain to anaerobically generate ATP 
from arginine, despite an elevated [NADH]/[NAD+] ratio, is consistent with the fact that the 
arginine deiminase pathway does not involve redox reactions (Figure 1c). 
Together, these measurements are consistent with the hypothesis that ATP synthesis, rather than 
the [NADH]/[NAD+] ratio itself, is essential for long-term anaerobic survival in P. aeruginosa. 
Although redox homeostasis is essential when it is coupled to ATP synthesis, as in glycolysis and 
pyruvate fermentation, survival correlates most directly with ATP synthesis itself. 
ATP synthesis is required to maintain the proton-motive force using the F1FO-ATPase complex 
during fermentation 
The requirement for ATP suggests that P. aeruginosa consumes ATP during long-term survival. 
During fermentation in many bacteria, the F1FO-ATPase complex, also known as ATP synthase, 
hydrolyses ATP to extrude protons from the cytoplasm to the periplasm, thereby generating a 
proton-motive force (PMF) (34). Previous studies have highlighted numerous reasons why a 
PMF might be required for survival; for example, the PMF is required for the exchange of 
metabolites and other ions (34), the localization of cell division and cytoskeletal proteins (35), 
protonation of the peptidoglycan layer (36), and the regulation of autolysis (37). We therefore 
hypothesized that P. aeruginosa requires ATP to maintain its PMF during fermentation. 
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Figure 6. Response of P. aeruginosa PA14 to drugs that disrupt the proton-motive force. 
Error bars represent the standard error of at least three independent experiments. 
100% survival represents approximately 4 × 108 CFU/mL. (A) Anaerobic survival of 
P. aeruginosa PA14 after two days of anaerobic incubation with 40 mM pyruvate. At the 
start of anaerobiosis, potassium nitrate (50 mM), DCCD (2 mM), and/or CCCP (100 
μM) were added as indicated. DCCD and CCCP were dissolved in ethanol, and so as 
a control ethanol was added to a final concentration of 0.2% where indicated. A culture 
incubated without pyruvate is shown for comparison (−pyruvate). (B) Anaerobic 
survival after two days of anaerobic incubation with 40 mM arginine. At the start of 
anaerobiosis, ethanol (0.2%), DCCD (2 mM), or CCCP (100 μM) were added as 
indicated. (C) Effect of DCCD on membrane polarization. After 24 hours of 
anaerobiosis, 2 mM DCCD was added to cultures surviving anaerobically on 40 mM 
pyruvate (+DCCD, open circles). Since DCCD was dissolved in ethanol, an equivalent 
concentration of ethanol (0.2%) was added to control cultures (+ethanol, closed 
circles). Membrane polarization was monitored over time as described in Methods (for 
an example analysis, see Supplemental Figure 5). Time 0 indicates the addition of 



































































To test this hypothesis, we incubated pyruvate-fermenting cells anaerobically with N,N′-
dicyclohexylcarbodiimide (DCCD), an inhibitor of the proton-translocation channel in the FO 
subunit of ATP synthase (38). DCCD (dissolved in ethanol) was efficient at killing anaerobic P. 
aeruginosa, reducing viability to 0.16% ± 0.07% after two days (Figure 6a). Ethanol from the 
addition of DCCD did not significantly affect survival, as a control culture with 0.2% ethanol 
maintained 88 ± 17% viability (Figure 6a). This suggests that the activity of ATP synthase is 
required for survival during pyruvate fermentation in P. aeruginosa. 
To confirm that the PMF is required for survival, we incubated cells with carbonyl cyanide 3-
chlorophenylhydrazone (CCCP), an ionophore that equilibrates the proton concentration across 
cell membranes and dissipates the PMF (39). CCCP (dissolved in ethanol) reduced the viability 
of anaerobic cultures to below 0.01% after two days (Figure 6a), confirming that the PMF is 
required for survival. 
If the PMF is required for survival, then restoring the PMF should recover survival even in the 
presence of DCCD. Although DCCD will inhibit oxidative phosphorylation, the cells can still 
synthesize ATP through pyruvate fermentation. To recover the PMF after DCCD treatment, we 
incubated cells anaerobically with nitrate, which serves as an alternate terminal electron acceptor 
for the electron transport chain in P. aeruginosa (40,41). Cultures incubated with pyruvate, 
DCCD, and nitrate sustained 46% ± 7% viability after two days (Figure 6a), demonstrating that 
respiration mitigates the killing effects of DCCD. Nitrate also improved the survival of cultures 
that were depolarized with CCCP to 2% ± 1% (Figure 6a). We did not observe significant growth 
after two days in cultures incubated with pyruvate, 0.2% ethanol, and nitrate, although we did 
observe growth after three days (data not shown), suggesting a long lag phase for growth by 
anaerobic nitrate respiration. 
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Because both pyruvate fermentation and the arginine deiminase pathway support anaerobic ATP 
synthesis, we also tested the effects of DCCD and CCCP on cultures surviving anaerobically with 
arginine. Cultures treated with 0.2% ethanol maintained 11% ± 1% viability after two days (Figure 
6b), consistent with the incomplete long-term survival we observed with arginine (Figure 5a). As 
with survival on pyruvate, DCCD inhibited the survival of cultures incubated with arginine, 
reducing viability to 2.8% ± 0.2% (Figure 6b), and 100 μM CCCP reduced viability to below 
0.001% (Figure 6b). This suggests that maintenance of the PMF by the F1FO-ATPase complex is 
a general survival strategy used by P. aeruginosa during fermentation. 
To validate that DCCD caused death by preventing the generation of a PMF, rather than by some 
non-specific mechanism, we used flow cytometry with the dye DiOC2(3) to assess the membrane 
potential of DCCD-treated cultures. DiOC2(3) is a green-excitable dye that accumulates 
intracellularly in polarized cells, where it undergoes a red fluorescence shift that is indicative of a 
membrane potential (42). Since this assay is not quantitative in Gram-negative bacteria (43), we 
assessed the membrane potential qualitatively by comparing DCCD-treated samples to controls 
depolarized with CCCP (for an example analysis, see Supplemental Figure 5). As expected, 
pyruvate-fermenting cells maintained a detectable membrane potential. We observed a time-
dependent depolarization of the cells after treatment with DCCD (Figure 6c), while an ethanol-
treated control remained almost fully polarized (Figure 6c), demonstrating that DCCD prevents 
maintenance of the PMF and induces depolarization of the cell membrane. 
These results indicate that P. aeruginosa uses the ATP generated during fermentation to maintain 
a PMF using the F1FO-ATPase complex, and that the PMF is required for long-term anaerobic 
survival. To integrate our findings, we measured the membrane potential of cells surviving 
anaerobically on glucose in our phenazine redox cycling experiment. After three days of survival, 
38% ± 6% of cells maintained a detectable membrane polarization in the presence of oxidized 
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phenazines, while less than 1% of cells maintained a detectable membrane potential in the absence 
of phenazines. Together, our results suggest that the ATP generated during phenazine redox 
cycling is used to maintain the PMF. 
Discussion 
In this study, we sought an explanation for how phenazines promote anaerobic survival in P. 
aeruginosa be it in planktonic (17) or biofilm (15) cultures. We found that phenazines help P. 
aeruginosa convert glucose and pyruvate into acetate (Figure 2b, 3b). This was an interesting result 
because P. aeruginosa is not known to ferment glucose or other sugars (28,44). Previous studies 
have shown that small molecule electron carriers can couple fermentation to extracellular 
oxidants, leading to the synthesis of more oxidized fermentation products (45-48). Our results 
suggest that phenazines perform a similar role, enabling P. aeruginosa to generate ATP by 
oxidizing glucose into acetate. This anaerobic glycolysis promotes survival but not growth (Figure 
2a), underscoring the importance of studying survival phenotypes independently from growth 
phenotypes. 
In Figure 7, we integrate the known survival pathways and processes in P. aeruginosa with a focus 
on redox homeostasis and ATP synthesis. By comparing phenazine redox cycling, pyruvate 
fermentation, and the arginine deiminase pathway, our combined results suggest that ATP 
synthesis is a key feature of long-term survival. The ATP synthesized during fermentation and 




Figure 7. A metabolic model of survival in P. aeruginosa. The ATP synthesized from 
glycolysis [1], pyruvate fermentation [2], and the arginine deiminase pathway [3] is 
used for essential processes including transcription, translation, and proteolysis [4]. 
The F1FO-ATPase complex hydrolyses ATP to translocate protons across the inner 
membrane [5], thereby generating a proton-motive force. Excess reducing equivalents 
from pyruvate oxidation can be dispensed by converting pyruvate to lactate [6]. 
Phenazines can also regenerate oxidants for metabolism [7]; although NAD(P)H is a 
possible electron donor for phenazines in vivo (Price-Whelan et al., 2007), the dashed 
lines indicate that the nature of this interaction has not been elucidated. Phenazines are 
then oxidized extracellularly [8] and can be reused. Nitrate reductase can reduce 
nitrate to nitrite using electrons from the quinone pool [9], permitting oxidation of 
NADH via NADH dehydrogenase [10], which can result in proton translocation 
depending on which dehydrogenase complex is used. 
During pyruvate fermentation, pyruvate dehydrogenase converts NAD+ to NADH in a pathway 
that allows acetate kinase to synthesize ATP (Figure 1b). NAD+ is regenerated by reducing 
pyruvate to lactate or succinate (Figure 1b). P. aeruginosa produces significantly more lactate than 
succinate during pyruvate fermentation (Supplemental Figure 3) (28), and so lactate synthesis by 
lactate dehydrogenase appears to be the primary pathway for NAD+ regeneration. This effectively 
couples the activities of acetate kinase and lactate dehydrogenase through the NAD(H) pool. As 
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a result, the ΔldhA mutant has an elevated [NADH]/[NAD+] ratio during pyruvate fermentation 
(Figure 4b) and is also unable to maintain ATP levels as high as the WT strain (Figure 4c). 
Phenazine redox cycling can serve as an alternate pathway for redox homeostasis in the ΔldhA 
mutant and restore ATP synthesis (Figure 3c) and survival (Figure 3a). 
In contrast to pyruvate fermentation, ATP synthesis by the arginine deiminase pathway does not 
involve redox reactions (Figure 1c). During anaerobic incubation with arginine, both the WT 
strain and the arcC::MAR2xT7 mutant developed an [NADH]/[NAD+] ratio even higher than 
the ΔldhA mutant did during pyruvate fermentation (Figure 5b). Nonetheless, the WT strain 
maintained ATP levels considerably higher than the arcC::MAR2xT7 mutant (Figure 5c), 
demonstrating that the arginine deiminase pathway can proceed even with large intracellular 
redox imbalances. Despite maintaining a high [NADH]/[NAD+] ratio, cultures incubated with 
arginine were able to survive through the arginine deiminase pathway (Figure 5a). Pyruvate and 
arginine may therefore offer alternative sources of ATP during long-term anaerobic survival. 
The requirement for ATP suggests that P. aeruginosa is not dormant during long-term survival. 
The ATP synthase inhibitor DCCD killed anaerobic PA14 cultures that were fermenting pyruvate 
or arginine (Figure 6a,b) and also depolarized cultures that were fermenting pyruvate (Figure 6c), 
demonstrating that P. aeruginosa actively maintains its PMF using the ATP synthase complex 
during fermentation. Previous studies have shown that survival also requires transcription (49), 
translation (50), and proteolysis (51), all of which consume ATP. By promoting ATP synthesis, 
phenazine redox cycling can therefore facilitate a variety of cellular processes that are required for 
long-term survival. 
We do not yet know how native phenazines such as PCA are reduced in vivo. Phenazines oxidize 
NAD(P)H in vitro (52), and so PCA might directly oxidize NAD(P)H within the cell. Redox 
cycling compounds such as phenazines are oxidants of flavins and iron-sulfur clusters (53), and so 
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metabolic enzymes such as NADH dehydrogenase, pyruvate dehydrogenase, or pyruvate oxidase 
might also reduce phenazines. Synthetic electron shuttles such as anthraquinone-2,6-disulfonate 
and paraquat do not support anaerobic survival by redox cycling because they are reduced slowly 
by P. aeruginosa (17), suggesting that cells specifically reduce native phenazines. Our preliminary 
studies indicate PCA reduction is enzymatically catalyzed, and we are attempting to identify the 
proteins responsible for this activity. 
Consistent with our finding that phenazines can alter metabolism, WT P. aeruginosa cultures 
grown aerobically with glucose secrete pyruvate in the oxygen-limited late stationary phase of 
growth, while phenazine-null mutant cultures do not (18). It was suggested that superoxide or 
pyocyanin radicals may inhibit pyruvate dehydrogenase, leading to pyruvate accumulation in the 
culture supernatant (18). Our results suggest an additional interpretation where glycolysis is 
limited by the availability of intracellular NAD+. By promoting redox homeostasis, phenazines 
might accelerate the conversion of glucose to pyruvate faster than pyruvate can be consumed. 
After the consumption of glucose, the secreted pyruvate can be fermented or oxidized in the 
tricarboxylic acid cycle, depending on the metabolic needs of the cell. 
Together, this work underscores the importance of environmental metabolites that are not always 
accounted for in metabolic pathways. Extracellular electron shuttles, such as phenazines, may 
permit cells to utilize unexpected energy sources by alleviating redox constraints on a pathway. 
An understanding of environmental parameters that interface with metabolism is therefore 
essential to assess the true metabolic potential of some organisms. Furthermore, a distinction 
must be drawn between growth and survival when considering the environment. Numerous 
studies have demonstrated the metabolic versatility of P. aeruginosa (for example, (54,55)), and 
here we have shown how several anaerobic pathways might enable survival under clinically 
relevant conditions. Characterizations of cystic fibrosis sputum indicate the presence of up to 100 
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μM phenazines (23) and significant quantities of nitrate, arginine, and glucose (56). Nitrate 
concentrations may be as high as 350 μM (57) and oxygen levels vary widely (21,58), potentially 
resulting in extended periods of slow growth or quiescence. Given the metabolic heterogeneity of 
biofilms (2) and the likely heterogeneity of infections, P. aeruginosa cells throughout infection 
environments might exhibit a range of growth rates, including survival without replication. As a 
result, understanding the multitude of survival mechanisms used by P. aeruginosa may be key to 
identifying new drug targets. 
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Materials and Methods 
Bacterial strains and growth conditions 
The strains and plasmids used in this study are shown in Supplemental Table 1. For routine 
growth, P. aeruginosa and E. coli were cultured at 37 °C in lysogeny broth (LB) containing 10 g/L 
tryptone, 5 g/L yeast extract, 10 g/L NaCl, and optionally 15 g/L agar for solid medium. S. 
cerevisiae was cultured at 30 °C in YPD medium containing 10 g/L yeast extract, 20 g/L peptone, 
20 g/L D-glucose, and optionally 20 g/L agar for solid medium. Specific experimental growth 
conditions are described where appropriate. For aerobic growth, liquid cultures were shaken at 
250 rpm. 
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Construction and verification of P. aeruginosa mutants 
Unmarked deletions in P. aeruginosa PA14 were constructed using a modification of previously 
described methods (59). Briefly, PCR was used to amplify approximately 1-kilobase fragments 
flanking the target gene. Homologous recombination in yeast was used to assemble these 
fragments into the sacB-counterselectable suicide shuttle vector pMQ30. The knockout vector 
was transformed into E. coli DH5α, and triparental mating with DH5α and E. coli 
HB101/pRK2013 was used to conjugate the constructed knockout vector into PA14; 
merodiploids containing the chromosomally integrated vector were selected on cetrimide agar 
(HiMedia) containing 100 μg mL−1 gentamicin sulfate. Merodiploids were cultured overnight in 
nonselective LB, and resolved merodiploids were then selected on LB agar plates with 10% 
sucrose. Potential deletion mutants were screened using colony PCR with primers flanking the 
target gene, and clean deletions were confirmed by DNA sequencing of the PCR product 
(Retrogen). Transposon insertions were verified using colony PCR with primers flanking the 
annotated transposon position. Primer sequences for constructing and confirming the genetic 
mutants used in this study are listed in Supplemental Table 2. 
Phenazine redox cycling survival 
The assay for anaerobic survival enabled by phenazine redox cycling was performed as previously 
described (17). Briefly, strains of PA14 deleted in the core phenazine biosynthesis operons 
(∆phz1/2) (12) were grown overnight in LB. The overnight cultures were used to inoculate 250 
mL of LB in 1-L flasks to an OD500 of 0.05. At early stationary phase (OD500 of 2.8) the cells were 
pelleted, washed twice aerobically in MOPS-buffered medium (100 mM 3-(N-
morpholino)propanesulfonic acid (MOPS), 3.5 μM FeSO4, 43 mM NaCl, 3.7 mM KH2PO4, 9.3 
mM NH4Cl at pH 7.2), and resuspended to a concentrated OD500 of 70 before being transferred 
to a nitrogen-only atmosphere (MBraun Unilab glove box). There, 1 mL of concentrated cells was 
added to sealed glass vessels containing 100 mL of anoxic MOPS-buffered medium amended with 
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75 μM phenazine-1-carboxylic acid and 20 mM D-glucose or 40 mM sodium pyruvate. To oxidize 
PCA, a graphite rod (Alfa Aesar #14738) working electrode was poised at a potential of +207 mV 
vs. NHE against a homemade platinum mesh counter electrode, which was placed in buffer within 
an attached small chamber separated from the bulk solution by a glass frit. Electrochemical 
parameters were maintained by a potentiostat (Gamry). An Ag/AgCl electrode (BaSi #RE5B) 
was used as the reference electrode. Anaerobic cultures of cells were stirred vigorously and 
maintained at 31˚C for the duration of the experiment, with daily sampling for colony forming 
units. Phenazine turnover was confirmed by the accumulated charge over the duration of the 
experiment as previously described (17). 
Pyruvate and arginine survival 
For measuring anaerobic survival using pyruvate or arginine as a sole carbon source, cultures were 
grown overnight at 37 °C in a minimal medium containing 14.15 mM KH2PO4, 35.85 mM 
K2HPO4, 42.8 mM NaCl, 9.3 mM NH4Cl, 1 mM MgSO4, 7.2 μM FeCl2 and trace elements (60), 
and 40 mM sodium pyruvate or 40 mM arginine (pH adjusted to 7.2 with NaOH or HCl). 
Overnight cultures were diluted at least 100-fold with fresh medium to an OD500 of 0.01 and 
incubated at 37 °C in shaking flasks to an OD500 of 0.4. After centrifuging the culture for 15 min at 
5000×g, the supernatant was removed and the pellet was transferred to a glove chamber (Coy) 
containing an atmosphere of 15% CO2, 80% N2, and 5% H2. The pellet was washed twice with 
fresh anoxic medium and then resuspended to a final OD500 of approximately 0.4 in rubber-
stoppered tubes. The sealed tubes were incubated at 37 °C in the anaerobic chamber without 
shaking. 
Viability counting 
For measurements of colony forming units (CFU), 20 μL of each culture was sampled 
anaerobically and then serially diluted in aerobic phosphate-buffered saline. Relevant dilutions 
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were plated in drips of 10 μL on LB agar plates and incubated aerobically for 24 hours at 37 ˚C. 
The average of at least 4 pipetting replicates was taken as the CFU count for a given CFU 
measurement. 
Measurement of NAD+, NADH, and ATP 
The method for measuring NAD+ and NADH in this study was based on established protocols 
(18,61). For each condition, two 1-mL samples in 1.7 ml tubes were centrifuged for 1 min at 
maximum speed (16,000×g). The supernatant was removed and 200 μL of either 0.2 M HCl (for 
NAD+ extraction) or 0.2 M NaOH (for NADH extraction) was added and mixed by vortexing. 
The samples were then incubated for 10 minutes at 55 °C, cooled on ice, and partially neutralized 
drop-wise with 200 μL of 0.1 M NaOH (for NAD+) or 0.1 M HCl (for NADH). Cell debris was 
pelleted by centrifugation (5 minutes at maximum speed) and 150 μL of the supernatant was 
transferred to a fresh tube for immediate analysis. To assay the amount of NAD+ or NADH in 
each sample, 5 μL of sample was added to 90 μL of the reagent mix in a 96-well microtiter plate. 
The reagent mix contained 2x bicine buffer (1.0 M, pH 8.0), 1x water, 1x 40 mM EDTA, 1x 100% 
ethanol, 1x 4.2 mM thiazolyl blue, and 2x 16.6mM phenazine ethosulfate. The 96-well plate was 
then heated to 30 °C. To initiate the colorimetric assay, 5 μL of a 1 mg mL−1 solution of alcohol 
dehydrogenase II (Sigma A3263) in 0.1 M bicine pH 8.0 was added to each well. A BioTek 
Synergy 4 plate reader was used to incubate the plate at 30 °C and record the absorbance of 
reduced thiazolyl blue at 570 nm every minute for 30 minutes. The rate of increase in absorbance 
at 570 nm over time was used as the measure of NAD(H) concentration. Unknown 
concentrations of NAD+ and NADH were determined from the slope and intercept of a standard 
curve derived from known concentrations of NADH. 
For ATP measurement, 20 μL of culture was added to 180 μL of dimethyl sulfoxide (DMSO) to 
quench and dissolve the cells. The sample was then diluted with 800 μL of 0.1 M HEPES (pH 7.5) 
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and stored at −80 °C for up to 7 days. ATP was quantified by mixing 25 μL of sample with 25 μL 
of Promega BacTiter-Glo reagent in a 96-well opaque white microtiter plate. The BacTiter-Glo 
reagent uses luciferase to produce luminescence in an ATP-dependent manner. Total 
luminescence was measured at 30 °C in a BioTek Synergy 4 plate reader. In control experiments 
using pure ATP, DMSO had no effect on luminescence at a final concentration of 9% (data not 
shown). Unknown concentrations of ATP were determined from the slope and intercept of a 
standard curve derived from known concentrations of ATP. 
Assessment of membrane potential 
The membrane potential was measured qualitatively using the dyes 3,3′-diethyloxacarbocyanine 
iodide (DiOC2(3)) and TO-PRO-3. Cultures were diluted at least 100-fold into a 
permeabilization buffer containing 100 mM Tris, 1 mM EDTA, and 80 mM NaCl (pH adjusted 
to 7.4 using HCl). DiOC2(3) and TO-PRO-3 (both dissolved in DMSO) were then added to a 
final concentration of 30 μM and 100 nM, respectively. For depolarized controls, CCCP 
(dissolved in DMSO) was added to a final concentration of 15 μM. The final DMSO 
concentration did not exceed 2%. The samples were incubated for 2-5 minutes at room 
temperature and then analyzed on an Accuri C6 flow cytometer. DiOC2(3) fluorescence was 
measured using excitation at 488 nm and emission at 530 ± 15 nm (FL1) and 610 ± 10 nm (FL3). 
TO-PRO-3 fluorescence was measured using excitation at 640 nm and emission at 675 ± 12.5 nm 
(FL4). Intact cells were gated on a log-scale scatter plot of FL4 vs. FL2 (585 ± 20 nm) for further 
analysis. Cells with a membrane potential were distinguished by an increased red/green 
(FL3/FL1) fluorescence ratio relative to depolarized controls. For an example analysis, see 
Supplemental Figure 5. 
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High performance liquid chromatography 
Metabolite samples were collected by centrifuging 550 μL of culture and passing the supernatant 
through a 0.2 μm nylon centrifugal filter. Samples were stored at −80 °C until analysis. Pyruvate, 
acetate, and succinate were quantified using an Agilent 1100 Series HPLC. A G1312A binary 
pump was used to a draw a continuous flow of 8 mN H2SO4 at 0.6 mL/min through a G1322A 
degasser. Samples were injected using a G1313A autosampler, and separation was effected using 
an Aminex HPX-87H column (Bio-Rad). Each sample was analyzed using a G1315A diode array 
detector to measure the UV absorbance at 206 nm referenced to 260 nm (bandwidth 16 nm) with 
a total run time of 25 min. Retention times for analytes were validated with single species 
standards. For each analyte, standards ranging from 0 to 40 mM were used to calibrate peak area 
against a known concentration. Data were analyzed using the ChemStation software (Agilent). 
SUPPLEMENTAL MATERIAL 
Methods 
RNA isolation and qRT-PCR analysis 
Gene transcription was analyzed as previously described (Kreamer, N.N.K., Wilks, J.C., Marlow, 
J.J., Coleman, M.L., and Newman, D.K. (2012) J Bacteriol 194: 1195–1204). To stabilize mRNA 
prior to analysis, 1 mL of culture was mixed with 1 mL of RNAprotect (Qiagen) and the sample 
was stored at −80 °C until analysis. An RNeasy Mini Kit (Qiagen) was used to extract total RNA 
from the samples according to the manufacturer’s protocol, including the optional DNase 
treatment step. cDNA was synthesized using the isolated RNA as a template for the iScript DNA 
Synthesis Kit (Bio-Rad) according to the manufacturer’s protocol. The synthesized cDNA was 
used as a template for quantitative PCR (Real Time 7500 PCR machine, Applied Biosystems) 
using SYBR green with the ROX detection system (Bio-Rad). The primers used were: for recA, 
TCTACGGCAAGGGCATCTAC and TCCAGTACCGAACCGATTTC; for clpX, 
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CCTGTGCAATGACATCATCC and TTCTTGTCACGCTGGTTGAG; for poxB, 
GAACAATGCCTCGCTGAA and TGGCCGAACTCGATCTT; for aceE, 
GGCATGGAAGGCATGTT and GGAAGCCGAACATCGAATAG. Ct values for the PCR 
reactions were determined using the 7500 Fast System SDS Software. 
Ion chromatography 
To quantify pyruvate, lactate, acetate, and succinate, we used ion chromatography on a Dionex 
DX-500 ion chromatography system. A continuous flow of ultrapure water (18.2 megaohm, 
produced from a milliQ Gradient system, Millipore) at 1.00 mL/min was maintained with a 
Dionex GP40 pump, passed through an anion trap column to remove remaining anionic 
impurities, then through a potassium hydroxide eluent generator cartridge controlled by an EG40 
module and subsequently through a six-port value configured for sample loop injection. A 10-
microliter sample loop was loaded from a Dionex (Sunnyvale, CA) AS40 autosampler. Separation 
was effected on Dionex AG-19 (4x50 mm) and AS-19 (4x250mm) columns in series, the eluent 
was returned to neutral pH with a SRS-300 suppressor operating at 50 mA, and finally analytes 
were detected with a conductivity cell monitored by an ED-40 detector in conductivity mode. The 
suppressor was operated in eluent recycle mode. The hydroxide gradient began at 0.01 mM KOH 
11 minutes before injection and was held at that concentration until injection. The concentration 
was increased linearly to 6.0 mM at 15 minutes, then to 15.0 mM at 25 minutes, and finally to 38 
mM at 35 minutes where it was held for 3 minutes. Data were analyzed with Chromeleon 6.8 
(Dionex). 
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C h a p t e r  4  
BIOCHEMISTRY OF PHENAZINE REDUCTION 
This chapter is adapted from: 
Glasser, N. R., Wang, B. X., Hoy, J. A., and Newman, D. K. (2017) The pyruvate and α-
ketoglutarate dehydrogenase complexes of Pseudomonas aeruginosa catalyze pyocyanin and 
phenazine-1-carboxylic acid reduction via the subunit dihydrolipoamide dehydrogenase. Journal 
of Biological Chemistry 292, 5593-5607. 
Abstract 
Phenazines are a class of redox-active molecules produced by diverse bacteria and archaea. Many 
of the biological functions of phenazines, such as mediating signaling, iron acquisition, and redox 
homeostasis, derive from their redox activity. While prior studies have focused on extracellular 
phenazine oxidation by oxygen and iron, here we report a search for reductants and catalysts of 
intracellular phenazine reduction in Pseudomonas aeruginosa. Enzymatic assays in cell-free lysate, 
together with crude fractionation and chemical inhibition, indicate that P. aeruginosa contains 
multiple enzymes that catalyze the reduction of the endogenous phenazines pyocyanin and 
phenazine-1-carboxylic acid in both cytosolic and membrane fractions. We used chemical 
inhibitors to target general enzyme classes and found that an inhibitor of flavoproteins and heme-
containing proteins, diphenyleneiodonium, effectively inhibited phenazine reduction in vitro, 
suggesting that most phenazine reduction derives from these enzymes. Using natively purified 
proteins, we demonstrate that the pyruvate and α-ketoglutarate dehydrogenase complexes 
directly catalyze phenazine reduction with pyruvate or α-ketoglutarate as electron donors. Both 
complexes transfer electrons to phenazines through the common subunit dihydrolipoamide 
dehydrogenase, a flavoprotein encoded by the gene lpdG. Although we were unable to co-
72 
crystalize LpdG with an endogenous phenazine, we report its X-ray crystal structure in the apo 
form (refined to 1.35 Å), bound to NAD+ (1.45 Å), and bound to NADH (1.79 Å). In contrast to 
the notion that phenazines support intracellular redox homeostasis by oxidizing NADH, our work 
suggests that phenazines may substitute for NAD+ in LpdG and other enzymes, achieving the 
same end by a different mechanism.  
Introduction 
Over a century ago, Pseudomonas aeruginosa was identified as the source of a blue pigment 
observed in infected wounds (1). This pigment, a phenazine derivative known as pyocyanin 
(Figure 1), was the first natural organic molecule shown to undergo one-electron reduction (2-
4). This distinctive property inspired early studies into bacterial respiration. As early as 1931, 
Friedheim and Michaelis demonstrated that pyocyanin stimulates oxygen consumption and 
carbon dioxide production in both P. aeruginosa (5) and human tissue (6), and so initially 
pyocyanin was considered an accessory respiratory pigment analogous to quinones (5). This 
interpretation predated an understanding of the electron transport chain, and today pyocyanin is 
understood to alter redox homeostasis more generally (7,8) though methanophenazine can 
substitute for quinones in the electron transport chains of certain methanogenic archaea (9). 
Later researchers recognized that reduced pyocyanin and other phenazines react with molecular 
oxygen to form toxic superoxide radicals (10). Phenazines also poison cells by oxidizing iron-
sulfur clusters (11), short-circuiting electron transfer (12), covalently modifying proteins (13), 
and intercalating into DNA (14). This broad spectrum of toxicity became the focus of phenazine 




Figure 1. Chemical structures and redox chemistry of the redox-active substrates 
employed in this study. 
Our interest in phenazines stems from the discovery that the P. aeruginosa phenazines can reduce 
extracellular minerals (15,16). Rather than merely inhibiting the growth of competing organisms, 
we hypothesized that phenazine “antibiotics” could directly benefit P. aeruginosa by promoting 
iron acquisition and redox homeostasis (17,18). This hypothesis has motivated several 
experiments that illustrate physiological functions for the endogenous phenazines of P. aeruginosa. 
We previously showed that phenazine redox cycling promotes anaerobic survival on glucose 
(19,20). Although P. aeruginosa does not ferment glucose, phenazines serve as an electron 
acceptor that enables glucose oxidation to acetate with concomitant ATP synthesis (20). We also 
showed that phenazines, by acting as electron shuttles, expand the habitable zone of colony 
biofilms into the anoxic portion (8). These findings paint a nuanced view where phenazines are 
multi-functional molecules, in some contexts possessing antibiotic activity and in others 
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In addition to pyocyanin, P. aeruginosa synthesizes at least six other phenazine derivatives. The 
precursor molecule, phenazine-1-carboxylic acid (PCA) (Figure 1), is synthesized from chorismic 
acid by enzymes encoded in the homologous phzABCDEFG1 and phzABCDEFG2 operons 
(21,22). Additional enzymes catalyze structural modifications of PCA to pyocyanin, phenazine-
1-hydroxide, and phenazine-1-carboxamide (22). Other endogenous P. aeruginosa phenazines 
have been observed with amination (23) and sulfonation (24) modifications, although the 
pathways for these modifications are unknown. Beyond P. aeruginosa, over 180 naturally 
occurring phenazines have been described in the literature from a variety of bacteria and archaea 
(25). This diverse array of structurally similar molecules suggests particular phenazines might be 
tuned for certain functions or properties. In support of this interpretation, the endogenous P. 
aeruginosa phenazines have different pH-dependent solubilities, toxicities, and reactivities 
towards oxygen and iron (16,26). 
Despite their structural diversity, the key biological functions of phenazines, be it promoting 
anaerobic energy generation or facilitating iron acquisition, derive from their redox activity. The 
environmentally relevant extracellular oxidants, molecular oxygen and ferric iron, are well 
characterized (16). In stark contrast, there is a dearth of information about biologically catalyzed 
phenazine reduction. While pyocyanin and PCA are known to oxidize the electron donors 
NAD(P)H, dihydrolipoamide, and glutathione in vitro (15,27), it is unknown whether this is 
relevant in vivo or whether it is enzymatically catalyzed. To address this unknown, previous work 
in our laboratory attempted to identify phenazine reductases by screening transposon mutants 
(28,29). Mutants in glycerol-3-phosphate dehydrogenase and the cytochrome bc1 complex were 
found to be deficient in pyocyanin reduction (28), but these mutants are generally unhealthy and 
carry a number of pleiotropic effects (28), rendering it impossible to ascribe pyocyanin reduction 
to these proteins from the physiological data alone.  
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As an alternative to our prior genetic screens, in this study we used a biochemical approach to 
identify P. aeruginosa enzymes with endogenous phenazine reductase activity. Our results suggest 
that P. aeruginosa might not express an enzyme evolved to specifically reduce phenazines; rather, 
our findings implicate flavoproteins and/or heme-containing proteins as important non-specific 
catalysts for phenazine reduction. Illustrating this principle, we identified and characterized the 
pyruvate and α-ketoglutarate dehydrogenase complexes as models for flavoprotein-mediated 
phenazine reduction. Our data indicate that under energy-limited anoxic conditions, phenazine 
substitution for NAD+ in these enzymes might contribute to the maintenance of intracellular 
redox homeostasis. 
Results 
Phenazine reduction is catalyzed by cell lysate 
We first asked whether P. aeruginosa produces enzymes that catalyze phenazine reduction. We 
focused on phenazine-1-carboxylic acid (PCA) (Figure 1) because it is the precursor for all 
biological phenazines in P. aeruginosa (22) and it promotes anaerobic energy generation by redox 
cycling (19,20). It conveniently undergoes a color change to bright yellow after reduction (30), 
enabling a colorimetric detection of PCA reduction. To avoid re-oxidation by atmospheric 
oxygen, we monitored PCA reduction using a plate reader housed within an anaerobic chamber. 
Among the many possible intracellular electron carriers, we tested NADH, NADPH, and 
glutathione as electron donors that are important determinants of the intracellular redox state 
(7,31). Compared to pyocyanin, PCA reacts relatively slowly with these donors, minimizing the 
risk of misinterpreting non-enzymatic reduction for enzyme activity. Because phenazines alter the 
metabolic flux of P. aeruginosa (7,20), we reasoned that intermediates of central metabolism might 
also serve as electron donors, and so we also tested pyruvate, citrate, isocitrate, α-ketoglutarate, 
succinate, and malate. We prepared cell lysate from late-exponential phase cultures grown on 
succinate, a preferred carbon source of P. aeruginosa (32). Because phenazines induce a 
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transcriptional response in P. aeruginosa (33), and so may regulate the activity of their endogenous 
reductases, we harvested the cultures several hours after the onset of phenazine production as 
indicated by the blue color of pyocyanin. 
 
Figure 2. Catalytic reduction of PCA by P. aeruginosa cell-free lysate. Each panel 
illustrates a time course of PCA reduction using the indicated electron donor. The line 
and shaded region represent the mean and standard deviation, respectively, from three 
independent assays using lysate prepared from independent cultures. The final 
concentrations in the assay were 1 mM for NADH and NADPH, 5 mM for racemic DL-
isocitrate (to give 2.5 mM D-isocitrate), and 2.5 mM for all other donors. 
In the absence of cell lysate, PCA did not react with the organic acid metabolic intermediates and 
it reacted only slowly with NADH, NADPH, and glutathione (Figure 2). Similarly, in the absence 
of an exogenous electron donor, cell lysate slowly reduced PCA over time (Figure 2), likely 
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deriving some reducing equivalents from metabolites already present within the lysate. Relative 
to lysate or electron donor alone, lysate rapidly reduced PCA when supplemented with NADH, 
NADPH, citrate, isocitrate, pyruvate, or α-ketoglutarate (Figure 2). Glutathione slightly increased 
the rate of PCA reduction, whereas malate and succinate had no stimulatory effect when added to 
lysate (Figure 2). Boiling the cell lysate beforehand effectively eliminated PCA reduction even 
with the addition of exogenous electron donors (Figure 2), demonstrating that the lysate 
catalyzed reduction rather than indirectly accelerating reduction through a change in ionic 
strength or pH. Additionally, we found that adding boiled lysate to un-boiled lysate could further 
accelerate reduction with pyruvate and α-ketoglutarate (Figure 2), suggesting the presence of 
additional cofactors or substrates in cell lysate that are required for PCA reduction. Together, 
these results demonstrate that P. aeruginosa produces one or more enzymes with PCA reduction 
activity. 
We attempted to purify an NADH:PCA or NADPH:PCA oxidoreductase from P. aeruginosa cell 
lysate using anion-exchange, cation-exchange, and hydrophobic interaction chromatography. 
Unfortunately, our efforts were hampered by the abiotic reaction between NAD(P)H and PCA, 
which is greatly accelerated at higher salt concentrations involved in protein chromatography. We 
struggled to locate chromatographic peaks of activity from the high background. To learn more 
about the types of proteins that might catalyze phenazine reduction, we opted to characterize the 
phenazine reduction activity in terms of cellular localization and sensitivity towards chemical 
inhibitors. 
Multiple enzymes can catalyze phenazine reduction 
We wondered whether the electron transport chain catalyzes phenazine reduction, because 
pyocyanin is reported to stimulate respiration (5,6) and phenazines induce morphological 
changes in colony biofilms that are consistent with increased respiration (8). To test if PCA 
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reduction activity derives mostly from the membrane-bound electron transport chain, we 
separated membrane-associated components from the lysate by ultracentrifugation (note that 
some soluble components, such as ribosomes, β-oxidation machinery, and 2-oxoacid 
dehydrogenases, can also be pelleted by ultracentrifugation). We saved the supernatant 
containing soluble proteins and resuspended the membrane pellet with a gentle non-ionic 
detergent. We then tested the three fractions—crude lysate, soluble proteins, and membrane-
associated proteins—for PCA reduction in terms of absolute rate and specific activity. 
 
Figure 3. Fractionation of PCA reductase activity in cell-free lysate. Cell-free lysate was 
fractionated into soluble- and membrane-associated components by 
ultracentrifugation. The fractions were assayed for their ability to catalyze PCA 
reduction. (Left) Each panel illustrates a time course of PCA reduction using the 
indicated electron donor. The line and shaded region represent the mean and standard 
deviation, respectively, from four independent assays using lysate prepared from 
independent cultures. The solid portion of each line indicates the linear region used for 
quantification. (Right) The specific activity for each fraction was determined by 
normalizing the rate of PCA reduction, illustrated with a solid line in the left panels, by 
the protein concentration of each fraction. Error bars represent the standard deviation 
from four independent biological replicates. 
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Both the soluble and membrane fractions contained approximately equal activity, but specific 
activity (activity normalized by protein concentration) was 2-fold greater in the soluble fraction 
relative to the membrane fraction (Figure 3). In the membrane samples, the calculated final 
concentration of reduced PCA (300–350 μM) was greater than the amount initially added to the 
spectrophotometric assay (250 μM) (Figure 3). This artifact may be due to redox-active 
cytochromes absorbing at the same wavelength as PCA, or residual endogenous phenazines 
associated with the membrane, and so our data might overestimate the rate of PCA reduction in 
membrane fractions. Citrate and isocitrate stimulated PCA reduction primarily in the soluble 
fraction (Figure 3). Notably, for the 2-oxoacids pyruvate and α-ketoglutarate, ultracentrifugation 
significantly lowered PCA reduction activity but we did not recover this activity in the membrane 
fraction (Figure 3). Because many enzymes in central metabolism use NAD(P)H as an electron 
carrier, from these data we infer that the cell lysate contains at least two NAD(P)H:PCA 
oxidoreductases that are distributed between the soluble and membrane fractions, with more 
activity residing in the soluble fraction. This implies that the electron transport chain does not 
exclusively reduce PCA in vitro. Additional enzymes might also use citrate, isocitrate, pyruvate, or 
α-ketoglutarate as electron donors. 
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Figure 4. Inhibition of PCA reduction activity in cell-free lysate. Unfractionated cell-
free lysate was assayed for its ability to catalyze PCA reduction in the presence of the 
indicated inhibitors. (Left) Each panel illustrates a time course of PCA reduction using 
the indicated electron donor. The line and shaded region represent the mean and 
standard deviation, respectively, from four independent assays using lysate prepared 
from independent cultures. The solid portion of each line indicates the linear region 
used for quantification. (Right) The specific activity for each fraction was determined 
by normalizing the rate of PCA reduction, illustrated with a solid line in the left panels, 
by the protein concentration of each sample. Error bars represent the standard 
deviation of four independent biological replicates. 
 
We further probed the lysate using three inhibitors: (a) cyanide to inhibit metalloproteins and 
heme-containing proteins (34), (b) diphenyleneiodonium to inhibit flavoproteins and some 
heme-containing proteins (35), and (c) arsenite to inhibit thiol-dependent proteins (36). 
Cyanide only slightly inhibited activity, while diphenyleneiodonium greatly inhibited activity with 
all of the electron donors tested (Figure 4). Arsenite specifically inhibited activity only for 
pyruvate and α-ketoglutarate (Figure 4). Together, the differential localization and inhibitor 
activities suggest that P. aeruginosa lysate contains multiple enzymes that catalyze PCA reduction. 
The strong inhibition by diphenyleneiodonium (Figure 4) further suggests that flavoproteins 
and/or heme-containing proteins may catalyze PCA reduction. 
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Pyruvate and α-ketoglutarate dehydrogenase catalyze phenazine reduction 
Our experiments with cell lysate suggested a role for the pyruvate and α-ketoglutarate 
dehydrogenases in PCA reduction. Not only did pyruvate and α-ketoglutarate stimulate PCA 
reduction (Figure 3), but the pattern of localization and inhibition was consistent with the 
conserved mechanism of the 2-oxoacid dehydrogenase complexes (reviewed in (37,38)). In the 
2-oxoacid dehydrogenase complexes, the E1 subunit, the substrate dehydrogenase, conjugates the 
substrate to thiamine pyrophosphate (TPP) with concomitant decarboxylation. The TPP 
cofactor is regenerated by transferring the substrate onto a lipoamide cofactor covalently attached 
to the E2 subunit. The E2 subunit, dihydrolipoyl transacetylase, then regenerates lipoamide by 
transferring the substrate to CoA, producing dihydrolipoamide. The dihydrolipoamide is finally 
re-oxidized by the E3 subunit, dihydrolipoamide dehydrogenase (DLDH), by transferring 
electrons to NAD+ through a flavin in the form of a tightly bound FAD. 
We recognized that the megadalton-sized 2-oxoacid dehydrogenases can be pelleted by 
ultracentrifugation, which would explain why 2-oxoacid-dependent activity was depleted by 
ultracentrifugation (Figure 3), and the cofactor requirement could explain why activity was not 
recovered in the membrane fraction (Figure 3) because cofactors would remain in the soluble 
fraction. The obligate reduction and oxidation of the lipoamide thiols is consistent with inhibition 
by arsenite (Figure 4). Moreover, oxidation of the lipoamide cofactor requires a flavoprotein 
subunit, consistent with inhibition by diphenyleneiodonium (Figure 4). We therefore asked 
whether the pyruvate and α-ketoglutarate dehydrogenase complexes were sufficient to catalyze 
phenazine reduction, and if so, what electron transfer pathway was employed. 
To answer this question, we isolated the native pyruvate and α-ketoglutarate dehydrogenase 
complexes from P. aeruginosa (detailed in Experimental Procedures). As judged by Coomassie 
staining of an SDS-PAGE gel, the complexes were approximately 90% pure (Figure 5a). The α-
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ketoglutarate dehydrogenase preparation contained no detectable pyruvate dehydrogenase 
(<0.1%), while the pyruvate dehydrogenase preparation contained a small amount of 
contaminating α-ketoglutarate dehydrogenase (approximately 4%) as measured by NAD+ 
reduction activity. 
 
Figure 5. Preparation and characterization of the pyruvate and α-ketoglutarate 
dehydrogenase complexes. (A) A Coomassie Blue-stained SDS-PAGE gel of the 
purified pyruvate dehydrogenase (PDH) and α-ketoglutarate (αKGDH) complexes. 
The three prominent bands represent the three subunits of the complex as labeled. 
PDH: E1 (pyruvate dehydrogenase, AceE), E2 (dihydrolipoamide acetyltransferase, 
AceF), E3 (dihydrolipoamide dehydrogenase, LpdG); αKGDH: E1 (α-ketoglutarate 
dehydrogenase, SucA), E2 (dihydrolipoamide succinyltransferase, SucB), E3 
(dihydrolipoamide dehydrogenase, LpdG). (B and C) PCA (B) and pyocyanin (C) 
reduction by the purified complexes in the absence or presence of the indicated 
inhibitors. The dashed line represents the fitted Michaelis-Menten binding curve.  
The purified complexes catalyzed PCA (Figure 5b) and pyocyanin (Figure 5c) reduction using 
their respective electron donors. We normalized the reaction rate to the protein flavin content (as 





























a large, potentially heterogeneous complex with multiple reaction steps. A Michaelis-Menten 
kinetic model fit to the initial rate of PCA reduction (Figure 5b) yielded a Km of 260 μM and Vmax 
of 32 min−1 for pyruvate dehydrogenase and a Km of 190 μM and Vmax of 40 min−1 for α-
ketoglutarate dehydrogenase. The initial rates of pyocyanin reduction did not depend on the 
pyocyanin concentration (Figure 5c), implying a Km of less than 25 μM for pyocyanin. 
Interestingly, while the pyruvate and α-ketoglutarate dehydrogenase complexes reduced PCA at 
similar rates (Figure 5b), pyruvate dehydrogenase reduced pyocyanin considerably slower than 
did α-ketoglutarate dehydrogenase (Figure 5c). 
Cyanide, diphenyleneiodonium, and arsenite inhibited PCA and pyocyanin reduction by the 
purified complexes (Figure 5b,c). The relative inhibition of the purified complexes mirrored that 
of whole cell lysate (Figure 4), with cyanide partially inhibiting PCA reduction and both arsenite 
and diphenyleneiodonium more fully inhibiting PCA reduction (Figure 5b,c), indicating that the 
2-oxoacid dehydrogenase complexes can account for the activity in lysate. 
In control experiments, PCA and pyocyanin reduction by the purified complexes required all 
known substrates and cofactors. We detected no activity when the electron donor (pyruvate or α-
ketoglutarate), coenzyme A, or magnesium were omitted from the reaction mixture. We observed 
residual activity (<1%) in the absence of TPP, possibly due to co-purification of trace amounts of 
this cofactor with the protein. Although we cannot rule out catalysis by a contaminant in our 
enzyme preparation, the inhibition by arsenite and diphenyleneiodonium, and the requirement 
for the known cofactors of pyruvate and α-ketoglutarate dehydrogenase, indicate that the 2-
oxoacid dehydrogenase complexes directly catalyze PCA and pyocyanin reduction. 
Dihydrolipoamide dehydrogenase catalyzes phenazine reduction 
We next asked which 2-oxoacid dehydrogenase subunit catalyzes phenazine reduction. In the 
absence of CoA, the E1 subunit catalyzes ferricyanide and dichloroindophenol reduction (39,40). 
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However, we observed no PCA or pyocyanin reduction in the absence of CoA, suggesting these 
phenazines are not reduced by the E1 subunit. As the E3 subunit has long been recognized to 
reduce methylene blue (40), a molecule structurally similar to phenazines (Figure 1), and the 
porcine and malarial E3 subunits have been shown to catalyze pyocyanin reduction (27), we 
hypothesized that the P. aeruginosa E3 subunit (dihydrolipoamide dehydrogenase, DLDH) 
catalyzes phenazine reduction. 
 
Figure 6. Phenazine reduction and binding by DLDH homologs of P. aeruginosa. (A) 
Time courses of PCA and pyocyanin reduction by DLDH using both NADH and 
dihydrolipoamide (lipoSH) as electron donors. Solid lines indicate the presence of 2 
μM enzyme. Dashed lines indicate the absence of enzyme. Shaded regions indicate the 
standard deviation of three technical replicates. (B) Affinity of LpdG for PCA and 
methylene blue as measured by fluorescence quenching. The dashed line indicates the 
binding curve fitted to the data. The data points are normalized to the maximum and 




Strain PA14 encodes three DLDH homologs in its genome: LpdG (PA14_43970), Lpd3 
(PA14_63850), and LpdV (PA14_35490) (41,42). We purified His-tagged versions of each 
protein. All three enzymes catalyzed PCA and pyocyanin reduction using both NADH and 
dihydrolipoamide as electron donors (Figure 6a). Phenazine reduction by both dihydrolipoamide 
and NADH—the substrate and product of the physiological reaction, respectively—is consistent 
with the FAD cofactor acting as a bidirectional electron-transfer intermediate, suggesting that 
phenazines interact with the flavin during the catalytic cycle of DLDH. In the context of the full 
2-oxoacid dehydrogenase complexes, we propose that phenazines can substitute for NAD+ as the 
final electron acceptor of pyruvate and α-ketoglutarate oxidation. This contrasts with our previous 
assumption that phenazines serve as an oxidant for NADH (20). 
Before probing the interaction between phenazines and DLDH, we determined the enzymatically 
relevant DLDH homolog for the 2-oxoacid dehydrogenase complexes. Although the pyruvate 
dehydrogenase complex of P. aeruginosa has been purified before (43), the precise identity of its 
constituent DLDH was not determined, and the operon encoding pyruvate dehydrogenase does 
not contain an associated DLDH. In contrast, the operon encoding α-ketoglutarate 
dehydrogenase encodes all three subunits (E1, E2, and E3 (LpdG)). Phenotypic evidence in 
Pseudomonas putida suggests the E3 component of pyruvate dehydrogenase is LpdG, but Lpd3 
may substitute in the absence of LpdG (44). To address this ambiguity, we excised the band 
corresponding to DLDH from an SDS-PAGE gel (Figure 5a), performed an in-gel trypsin digest, 
and analyzed the resulting peptide fragments using LC-MS/MS. As expected from its operon 
structure, the DLDH peptides from α-ketoglutarate dehydrogenase mapped to LpdG (Table 1). 
The DLDH peptides from pyruvate dehydrogenase also mapped to LpdG (Table 1), with only 
0.03% of peptide intensity mapping to Lpd3, indicating that LpdG is the primary DLDH of the P. 
aeruginosa PA14 pyruvate dehydrogenase. We detected no peptides corresponding to LpdV in 
either complex (Table 1). We also confirmed the identity of dihydrolipoamide acetyltransferase 
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in our pyruvate dehydrogenase preparation (Table 1), as this band migrated slower than expected 
for its predicted size of 56.7 kDa (Figure 5a). 
Having established LpdG as the enzymatically relevant DLDH for both pyruvate and α-
ketoglutarate dehydrogenase, we quantified the interaction between LpdG and phenazines in 
more detail. We measured the binding affinity, Kd, by exploiting the intrinsic fluorescence of the 
flavin moiety in the FAD cofactor of LpdG. We anticipated that binding of an aromatic group near 
the flavin would quench fluorescence, thereby providing a direct measure of substrate binding. 
This prediction was borne out experimentally. High concentrations of PCA were sufficient to 
quench fluorescence (Figure 6b), consistent with binding near the flavin. The extrapolated Kd is 
84 mM with a Hill coefficient of 1.95 (Figure 6b). In support of a cooperative model of binding, a 
non-cooperative model (Hill coefficient = 1) required a nonsensical large negative minimum 
fluorescence and an unrealistically large Kd (>1000 mM). In contrast to PCA, the positively 
charged methylene blue quenched fluorescence with a Kd of 170 μM and a Hill coefficient of 1.27 
(Figure 6b). We were unable to apply this method to pyocyanin, which is water-soluble at pH 7.5 
only to approximately 1 mM, or to phenazine-1-hydroxide and phenazine-1-carboxamide, which 
are even less soluble. Hill coefficients of less than two are consistent with the dimeric structure of 
DLDH. Cooperative substrate binding in DLDH has been observed for NADH (45) and may 
originate from the architecture of the active site, which contains residues from both chains of the 
DLDH homodimer (46,47), potentially allowing for substrate binding to induce long-range 
conformational changes within the protein. 
Structural insights into the interaction between LpdG and phenazines 
Although the affinity of the P. aeruginosa LpdG for PCA appears to be low, we were encouraged 
by the comparatively high affinity for methylene blue, and so we attempted to solve the X-ray 
crystal structure of LpdG bound to a phenazine or methylene blue. LpdG crystallized in multiple 
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screens using polyethylene glycol as a precipitant, similar to previously discovered conditions for 
DLDH. During optimization, we discovered a new crystal form in which over 90% of crystals 
diffracted to 1.8 Å or better in the space group P21. One crystal diffracted to 1.43 Å (Figure 7a) 
with a signal-to-noise cutoff of 2.0, which we refined to 1.35 Å using paired refinement (48), 
representing the highest published resolution of any DLDH to date. 
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Figure 7. Structural analysis of LpdG. Where visible, the embedded FAD cofactor is 
shown in red. Protein side chain carbons are shown in purple. (A) Overview of the 
LpdG dimer. The two polypeptides of the biological assembly are shown in shades of 
blue. (B) Close-up of DMSO bound in the lipoamide binding pocket. The orange mesh 
represents the anomalous difference map contoured at 4σ, which highlights sulfur 
atoms and the phosphorous atoms in FAD. The DMSO carbon atoms are shown in 
green. (C and D) Close-up of NADH (C) and NAD+ (D) bound to LpdG. Electron 
density was not visible for the oxidized nicotinamide group in NAD+ and so this group 
has not been modeled. The blue mesh represents the 2mFo − DFc map of electron 
density for FAD and NAD(H) contoured at 1.5σ. The NAD(H) carbon atoms are 
shown in yellow. The dashed line illustrates a hydrogen-bond interaction. (E) Example 
of π-stacking interactions at a surface residue in a crystal soaked with 225 mM PCA. 
The green mesh represents positive density in the mFo − DFc difference map contoured 
at 3σ. (F) Hypothetical illustration of a phenazine (orange) substituting for NADH, 
demonstrating a steric clash with Ile192. The phenazine was placed manually in Coot 
and does not represent a real dataset. 
 
Apart from minor rotamer corrections and the orientations of some surface residues, our model 
of LpdG at 1.35 Å is essentially identical to the previously reported structure at 2.8 Å (the root 

























publication by Mattevi et al. (46) for a full structural description. A noteworthy feature unique to 
our model is the association of LpdG with the cryoprotectant DMSO. We observed two molecules 
of DMSO inside the active site where dihydrolipoamide is postulated to bind (Figure 7b). This 
orientation appears to be stabilized by a sulfur-π interaction between the central sulfur atom of 
DMSO and a histidine sidechain. This configuration might mimic the binding of the 
dihydrolipoamide sulfhydryl groups in the active site of LpdG. Crystals soaked for one hour with 
10 mM NADH or NAD+ yielded electron densities corresponding to the soaked substrate (Figure 
7c,d). As previously observed with human DLDH (49), we could not resolve electron density for 
the nicotinamide group of NAD+ (Figure 7d), suggesting the oxidized cofactor is disordered or 
present in multiple conformations. Statistics for the apo, NAD+-, and NADH-bound structures 
are shown in Table 2.  
Our initial screens yielded no crystals when 2 mM methylene blue or 250 mM PCA was included 
in the protein solution, so for these substrates we focused on soaking into preformed crystals. 
Unfortunately, we observed no electron density assignable to a phenazine after soaking for up to 
one week with 10 mM pyocyanin, 10 mM phenazine-1-carboxamide, 10 mM phenazine-1-
hydroxide, 5 mM methylene blue, or up to 175 mM PCA. We were similarly unsuccessful when 
the soaks included up to 100 mM dithionite or 100 mM dihydrolipoamide to generate the 
reduced forms of LpdG and substrate. Above 200 mM PCA, we observed electron density 
characteristic of a π-stacking interaction between PCA and aromatic residues on the surface of the 
protein (Figure 7e), but this interaction is unlikely to be physiologically relevant because of the 
high PCA concentration it requires. 
90 
 
Figure 8. Site-directed mutagenesis of LpdG. (A) PCA reduction by site-directed 
mutants of LpdG. The initial rate of reduction was normalized by the concentration of 
protein (2 μM) and subtracted by the abiotic rate of reduction as measured without 
protein. Error bars represent the standard deviation of four technical replicates. (B) 
Affinity of site-directed mutants of LpdG for PCA as measured by fluorescence 
quenching. The fluorescence values are normalized to the maximum fluorescence for 
each mutant. 
The crystal structure reveals a carefully structured nicotinamide binding site that sterically 
excludes larger molecules such as phenazines (Figure 7c,d), likely explaining why we were unable 
to obtain crystals bound to a phenazine. In particular, an isoleucine sidechain (Ile192) restricts 
access to the flavin. The smaller nicotinamide moiety of NADH forms a π-stack with the flavin that 
is further stabilized by hydrogen bonding of the amide group with Glu195 and the peptide 
backbone (Figure 7c). Assuming no other conformational changes, extending nicotinamide to 
contain three rings yields a steric clash with Ile192 and disrupts the stabilizing hydrogen bonds 




smaller residue might increase accessibility of the flavin to phenazines, thereby accelerating 
DLDH-catalyzed phenazine reduction. We were also interested in Val191 which sits above the 
flavin–nicotinamide π-stack. In other homologs, and the closely related glutathione reductase, this 
residue is a tyrosine that may regulate NADH binding or reactivity through additional π-stacking 
and compression (50). We therefore generated two site-directed mutants of LpdG: I192G and 
V191Y. Contrary to our expectations, the I192G mutant catalyzed PCA reduction more slowly 
than wildtype LpdG and also appeared to be substrate-inhibited (Figure 8a). The V191Y 
mutation also lowered enzyme activity and conferred substrate inhibition (Figure 8a). The 
mutations did not affect the PCA concentration required to quench LpdG fluorescence (Figure 
8b), demonstrating that the binding affinity remained unchanged in the mutants. Together, these 
results indicate that residues V191 and I192 do not sterically hinder PCA from binding to LpdG. 
Discussion 
The search for phenazine reductases was motivated by our interest in phenazine-mediated 
anaerobic survival and energy generation (19,20). Our work here suggests that, rather than 
possessing an enzyme with specific phenazine reductase activity, P. aeruginosa makes a variety of 
redox-active enzymes that adventitiously reduce phenazines under anoxic conditions. By 
subsequently reacting with molecular oxygen or ferric iron (16), phenazines would enable the 
oxidation of metabolites in a manner independent of the electron transport chain. The electron 
donor for this process could be the metabolite itself, for example pyruvate or α-ketoglutarate, 
without involvement of another cofactor such as NAD(P)H. Through extracellular electron 
transport in a microbial community (8), this mechanism would allow multiple metabolic 
pathways, such as glycolysis or pyruvate oxidation (20), to support energy generation for cells 
locally starved of an electron acceptor (i.e. oxygen or nitrate). 
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We identified the pyruvate and α-ketoglutarate dehydrogenase complexes as phenazine 
reductases (Figure 5) based on activity assays in whole cell lysate (Figure 2) and the pattern of 
fractionation and inhibition (Figures 3,4). We focused on this specific subset of enzymes because 
we previously found that phenazines enable ATP synthesis through the conversion of glucose to 
acetate by serving as an electron acceptor (20). Notably, this pathway requires pyruvate 
dehydrogenase. In our prior work, we hypothesized that phenazines stimulate pyruvate 
dehydrogenase by converting NADH to NAD+ (20), a limiting substrate in the absence of a 
terminal electron acceptor. Our results here suggest that phenazines may instead directly 
substitute for NAD+ in the pyruvate dehydrogenase complex during anaerobic survival. Under 
NAD+-limiting conditions (e.g. hypoxia), phenazines could therefore increase metabolic flux 
through pyruvate dehydrogenase. The phenazine reduction activity of pyruvate dehydrogenase is 
admittedly low (Vmax = 32 min−1 for PCA) (Figure 5), but it may be compatible with the low 
metabolic activities observed in anoxic planktonic models of survival (20,51). 
Importantly, the affinity we measured of pyruvate dehydrogenase for phenazines (Km of 260 μM 
for PCA and <25 μM for pyocyanin) is within the physiological range produced by P. aeruginosa, 
which can reach up to 200 μM within infection contexts (52). We observed a large mismatch 
between the ligand binding affinity of the catalytic subunit LpdG (i.e. Kd, Figure 6b) and the 
concentration required to saturate the reaction rate in the full complex (i.e. Km, Figure 5b,c). LpdG 
is natively associated with the larger complex, and so the rate saturation of the full complex likely 
represents the more physiologically meaningful result. The large disparity in magnitude suggests 
that LpdG is not rate limiting within the full complex, and/or that binding to the complex induces 
substantial changes in the affinity of LpdG for its substrates. Given the high Kd for PCA, we would 
not expect PCA to outcompete NAD+ unless the concentration of available NAD+ were very low, 
but we note that this is precisely the condition where phenazines manifest a physiological benefit 
for P. aeruginosa (7,8,19,20). 
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The phenazine reductase activity of pyruvate dehydrogenase is particularly intriguing in the 
context of biofilm maintenance and development. The inner core of established biofilms is anoxic 
(8,53) and enters a metabolically-repressed state with decreased respiration and increased 
substrate-level phosphorylation (53). In the absence of oxygen, P. aeruginosa can survive by 
mixed-acid fermentation of pyruvate to acetate and lactate (51), a process that is enhanced by 
phenazine redox cycling (20). This suggests a model where cells at the anoxic core of a biofilm 
may use pyruvate dehydrogenase, with phenazines as an electron acceptor and coupled to 
substrate-level phosphorylation, to maintain a basal level of energy generation; reduced 
phenazines could then be re-oxidized at the oxygen-rich surface of the biofilm. In addition to 
maintaining energy generation in anoxic regions of biofilms (8), phenazines can also stimulate 
biofilm formation through iron acquisition (54), extracellular DNA release (55), and other 
unknown mechanisms (54-56). In context of our work here, it is striking that early biofilm 
development in P. aeruginosa requires pyruvate fermentation and redox homeostasis (57). It is 
tempting to speculate that the biofilm-promoting behavior of phenazines and pyruvate 
fermentation could be mechanistically linked through the activity of pyruvate dehydrogenase. 
We do not mean to suggest that pyruvate and α-ketoglutarate dehydrogenase are the only relevant 
phenazine reductases in vivo. Indeed, NADH and NADPH are more effective than the 2-oxoacids 
at stimulating PCA reduction in cell lysate (Figures 2–4). The 2-oxoacid:PCA oxidoreductase 
activity in lysate could be explained by the 2-oxoacid dehydrogenases reducing NAD+ to NADH, 
enabling the activity of an NADH:PCA oxidoreductase. Similarly, the stimulation by citrate and 
isocitrate (Figures 2–4) could result from the downstream production of NAD(P)H. Therefore, 
our results with cell lysate are best interpreted as an upper limit to the overall PCA reductase 
activity of pyruvate and α-ketoglutarate dehydrogenase. With that caveat, we also found that 
diphenyleneiodonium is a strong inhibitor of PCA reduction (Figure 4). Notably, 
diphenyleneiodonium is a known flavoprotein inhibitor that conjugates to reduced flavins via a 
94 
radical-mediated mechanism, although it can also inhibit some heme-proteins (35). This is 
consistent with our finding that the flavoenzyme LpdG, the E3 subunit of the 2-oxoacid 
dehydrogenases studied here (Table 1), directly catalyzes PCA and pyocyanin reduction (Figure 
6). Together, these findings suggest that flavoproteins, and possibly some heme-containing 
proteins, account for the majority of phenazine reductase activity in P. aeruginosa. 
Ultimately, pyruvate and α-ketoglutarate dehydrogenase serve to demonstrate that many electron 
donors, through the activity of their catabolic enzymes, could support phenazine reduction. By 
accepting electrons from flavoproteins, a ubiquitous class of proteins important for metabolism, 
phenazines could potentially alter metabolic flux through a number of pathways. A quantitative 
prediction of this activity de novo is presently impossible. Even for the adventitious reduction of 
oxygen, the most studied side-reaction of flavoproteins, the parameters that govern reaction rates 
(which differ by at least 6 orders of magnitude) are still unclear (58). Mirroring this uncertainty, 
our prediction that sterics are the rate-limiting factor for phenazine reduction by LpdG did not 
hold up to site-directed mutagenesis (Figure 8), suggesting that even for the restricted active site 
of LpdG, the enzyme-specific particulars of electronic structure and transition state are important. 
Beyond enzyme kinetics, phenazine reduction varies by growth phase (7), and so we expect the 
overall effects of phenazines on metabolism to be heavily context-dependent. For example, within 
a heterogeneous and stratified biofilm community, different enzymes likely catalyze phenazine 
reduction under (hyp)oxic and anoxic conditions. The results of this study, indicating that 
oxidized PCA and pyocyanin can substitute for NAD+, allow us to postulate that under strictly 
anaerobic conditions, where NAD+ may be limited (7,20), substitution of phenazines for NAD+ 
in enzymes like LpdG would facilitate redox homeostasis. This is in a manner distinct from what 
we have previously assumed (the coupling of NADH oxidation to phenazine reduction) but 
results in the same net effect: maintenance of a higher NAD+/NADH ratio. Such substitution 
would allow for flux through pathways that would otherwise not proceed, including, but not 
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limited to, energy-generation pathways such as pyruvate oxidation (20). A comprehensive 
understanding of phenazine metabolism in vivo will require a synthesis of biochemical and genetic 




The reagents used for growth media and protein purification were from Sigma-Aldrich or Acros 
Organics and were of ACS grade or better. Pyocyanin was from Cayman Chemicals. Phenazine-
1-carboxylic acid and phenazine-1-carboxamide were from Princeton Biosciences. Phenazine-1-
hydroxide was from TCI America. NAD+, NADH, thiamine pyrophosphate, coenzyme A, MgCl2, 
lipoamide, potassium cyanide, diphenyleneiodonium chloride, and sodium (meta)arsenite were 
from Sigma-Aldrich. Dihydrolipoamide was synthesized from lipoamide by reduction with 
sodium borohydride (59) and stored desiccated at −20 °C. For crystallography, PEG-3350 (50% 
solution) was from Hampton Research and DMSO, HEPES, KOH, and KCl were from Sigma-
Aldrich. Ni-Sepharose and Sephacryl S-400 were from GE Healthcare. CHT hydroxyapatite was 
from Bio-Rad. Thrombin was from EMD Millipore. Other chemicals were from Sigma-Aldrich 
unless stated otherwise. All phosphate buffers were prepared with KH2PO4 and adjusted to the 
appropriate pH with KOH at room temperature. Anaerobic buffers were prepared by autoclaving 
and transferring the still-warm solution into an anaerobic chamber; other anaerobic solutions 
were prepared by dissolving solid compounds with anaerobic buffers within the anaerobic 
chamber. 
Growth conditions 
For routine culturing, P. aeruginosa and Escherichia coli were grown in lysogeny broth containing 
10 g/L tryptone, 5 g/L yeast extract, and 10 g/L NaCl. Solid agar plates contained 15 g/L agar. 
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The succinate minimal medium for P. aeruginosa contained 14.15 mM KH2PO4, 35.85 mM 
K2HPO4, 42.8 mM NaCl, 9.3 mM NH4Cl, 40 mM disodium succinate, 1 mM MgSO4, 7.5 μM 
FeCl2·4H2O, 0.5 μM ZnCl2, 0.5 μM MnCl2·4H2O, 0.1 μM H3BO3, 0.8 μM CoCl2·6H2O, 0.01 μM 
CuCl2·2H2O, 0.1 μM NiCl2·6H2O, and 0.15 μM Na2MoO4. The minimal medium was sterilized 
by autoclaving; to avoid precipitation, the metals were prepared as a separate solution (1000×) 
and added immediately prior to inoculation. All liquid cultures were incubated in a New 
Brunswick Innova 44R incubator at 37 °C shaking at 250 rpm (2.54 cm stroke length). 
PCA reduction by cell lysate 
Wildtype P. aeruginosa PA14 was incubated in 250-mL Erlenmeyer flasks containing 50 mL of 
succinate minimal medium and grown to an OD500 of 2.4–2.8 (approximately 11 hours from a 
starting OD500 of 0.01). The cells were harvested by centrifugation for 15 minutes at 6,800×g, 
washed twice with 1 mL of 50 mM KH2PO4, pH 7.5, and resuspended to a final volume of 1 mL 
with 50 mM KH2PO4, pH 7.5, and 1 mM phenylmethylsulfonyl fluoride (PMSF). The cells were 
lysed by sonication on ice using a ThermoScientific Sonic Dismembrator 550 set to power level 3 
with a pulse setting of 1 s on, 4 s off for 3 min total sonication time. Large debris and unlysed cells 
were removed by centrifugation for 15 min at 8,000×g. Where applicable, membrane-associated 
proteins were separated by ultracentrifugation using a Beckman Optima ultracentrifuge with a 
TLA-100.3 fixed-angle rotor. The lysate was centrifuged for one hour at 70,000 rpm (208,000×g 
average) and the supernatant was saved. The pellet was resuspended by gently pipetting an 
equivalent volume of 50 mM KH2PO4, pH 7.5, with 1% n-dodecyl β-D-maltoside and 1 mM 
PMSF. Undissolved material was removed by centrifugation for 15 min at 8,000×g. Protein 
concentration was measured using the bicinchoninic acid assay (Pierce) (60) calibrated with BSA 
standards (Pierce). Boiled lysate was prepared by placing an aliquot into a boiling water bath for 
5 minutes; the precipitated material was removed by centrifugation at 17,000×g for 5 min. 
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PCA reduction assays were performed inside an anaerobic glove box (Coy) with an atmosphere 
of 3–4% H2 and 97–96% N2. Reactions were performed at 28 °C in a 96-well plate with each well 
containing 50 μL of lysate, 50 μL of electron donor (dissolved in 50 mM KH2PO4, pH 7.5), and 
50 μL of buffer (50 mM KH2PO4, pH 7.5) or boiled lysate. Where applicable, inhibitors were 
added using 2 μL of a 100× stock solution (KCN and NaAsO2 were dissolved in water; 
diphenyleneiodonium chloride was dissolved in DMSO). The reaction was initiated by adding 50 
μL of PCA (1 mM stock in 50 mM KH2PO4, pH 7.5; 250 μM final concentration). The reaction 
was monitored by measuring absorbance at 440 nm using a BioTek Synergy 4 plate reader housed 
within the anaerobic glove box. The reaction progress was normalized against four averaged 
control wells containing 250 μM PCA and 10 mM sodium dithionite as a measure of 100% PCA 
reduction. 
Pyruvate and α-ketoglutarate dehydrogenase purification 
The pyruvate and α-ketoglutarate dehydrogenase complexes were prepared natively from P. 
aeruginosa PA14 ∆phz1/2 (33). This phenazine-null strain was used to minimize the generation 
of reactive oxygen species during the initial stages of purification. Cells were grown in 1 L of the 
succinate minimal medium (with 80 mM disodium succinate to achieve higher cell density) in a 
2.8-L baffled Fernbach flask to an OD500 of 4–6. In a typical preparation, 6 L of cells were harvested 
by centrifugation for 15 min at 8000×g. The cells were resuspended in 200 mL of 50 mM KH2PO4, 
adjusted to pH 7.5 with KOH, with 1 mM EDTA and a cOmplete ULTRA protease inhibitor 
tablet (Roche). The cells were lysed using 3 or 4 passes through an Avestin Emulsiflex-C3 
operating at 20,000 PSI. The lysate was centrifuged for 30 min at 30,000×g and the pellet was 
discarded. In subsequent steps, the activity of the complexes was followed using a reaction mix 
containing 50 mM KH2PO4, pH 7.5, 1 mM MgCl2, 100 μM TPP, 100 μM CoA, 500 μM NAD+, 
and 2.5 mM pyruvate or α-ketoglutarate. Activity was indicated by an absorbance increase over 
time at 340 nm after adding 1–5 μL of lysate or protein to 199−195 μL of the reaction mix. 
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After adjusting the lysate dropwise with 5% acetic acid to pH 6.0 on ice, 0.17 volumes of 2% 
protamine sulfate were added and the mixture was gently stirred on ice for 30 min. The mixture 
was centrifuged for 30 min at 30,000×g and the pellet was discarded. The lysate was further 
clarified by adding 0.2 volumes of ice-cold acetone, stirring the mixture on ice for 15 min, 
centrifuging for 15 min at 30,000×g, and discarding the pellet. The dehydrogenase complexes 
were then precipitated by slowly adding an additional 0.4 volumes of ice-cold acetone. The 
mixture was gently stirred for 30 min on ice and centrifuged for 30 min at 30,000×g. The 
supernatant was discarded. 
The precipitated proteins were dissolved in 50 mL of ice-cold 100 mM KH2PO4, pH 7.5, with 0.5 
mM PMSF. Undissolved material was removed by centrifugation for 15 min 15,000×g. The 
supernatant was applied to a CHT ceramic hydroxyapatite (Type I, 40 μm particle size) column 
(dimensions 2.2×16.5 cm) at a flow rate of 2.0 mL/min using an Äkta Express system at room 
temperature. The column was washed with 2 column volumes of 100 mM KH2PO4, pH 7.5. The 
complexes were eluted at a flow rate of 5 mL/min using a linear gradient over 2 column volumes 
to 500 mM KH2PO4, pH 7.5, with 2 mL fraction collection. Fractions were assayed for pyruvate 
and α-ketoglutarate dehydrogenase activity and pooled accordingly. The complexes were 
concentrated using an Amicon ultra centrifugal filter (30 kDa cutoff) to a volume of less than 1 
mL. The complexes were further purified using gel filtration over a Sephacryl S-400 column 
(dimensions 1.6×38.0 cm) run isocratically with 100 mM KH2PO4, pH 7.5, and 1 mM EDTA at 
0.5 mL/min with an Äkta Purifier system at 4 °C. Fractions containing pyruvate or α-ketoglutarate 
dehydrogenase activity were again pooled and concentrated using an Amicon ultra centrifugal 
filter. Purity was assessed using an SDS-PAGE gel stained with Coomassie Blue. 
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PCA and pyocyanin reduction by purified proteins 
Phenazine reduction by purified proteins was measured using a Thermo Scientific Evolution 260 
Bio spectrometer housed within an anaerobic chamber. PCA reduction was followed at 440 nm 
at 5 Hz with an integration time of 0.2 s. Pyocyanin reduction was followed at 690 nm at 5 or 20 
Hz with an integration time of 0.2 s or 0.05 s, respectively. The extinction coefficients used were 
ε440 = 2206 M−1 cm−1 for reduced PCA, ε440 = 35.4 M−1 cm−1 for oxidized PCA, ε690 = 4306 M−1 cm−1 
for oxidized pyocyanin, and ε690 = 0 M−1 cm−1 for reduced pyocyanin. PCA was dissolved to a stock 
concentration of 20 mM in 300 mM KH2PO4, pH 7.5. Pyocyanin was dissolved to a stock 
concentration of 10 mM in 20 mM HCl. All reactions were performed at 30 °C. The limit of 
detection was approximately 25 μM, corresponding to a change in absorbance of approximately 
0.01 before the rate became non-linear. 
The pyruvate and α-ketoglutarate dehydrogenase complexes were assayed using 0.5–0.9 μM 
LpdG (as measured by flavin content) in 50 mM KH2PO4, pH 7.5, 1 mM EDTA, 3 mM MgCl2, 
200 μM TPP, 200 μM CoA, and 2.5 mM pyruvate or α-ketoglutarate. Where applicable, inhibitors 
were added from a 100× stock solution. The reaction was initiated by adding an equal volume of 
a 2× solution of phenazine. 
DLDH was assayed using 2 μM of protein (as measured by flavin content) in phosphate buffer, 
pH 7.5, with 1 mM EDTA and 1 mM NADH or 1 mM dihydrolipoamide (dissolved in 50% 
isopropanol as a 100 mM stock solution). Because the enzymes required different ionic strengths 
for stability, LpdG and Lpd3 were assayed using 300 mM KH2PO4 and LpdV was assayed using 
50 mM KH2PO4. For PCA, the reaction was initiated by adding an equal volume of 2× PCA; for 




The fluorescence of LpdG was measured in a black half-area microtiter plate using a BioTek 
Synergy 4 plate reader. Each well contained 100 μL of 2 μM protein in 300 mM KH2PO4, pH 7.5, 
with the appropriate concentration of ligand. Fluorescence was measured using a tungsten lamp 
with a 485±10 nm excitation filter and a 528±10 nm emission filter. The background fluorescence 
of a control well, without protein but with the same ligand concentration, was subtracted from the 
protein fluorescence. 
Curve fitting 
Non-linear curve fitting was performed using the curve_fit function from SciPy’s optimization 
package. Fluorescence quenching data were fit with the formula F = ([S]N / ([S]N + KdN)) × (Fs – 
Fo) + Fo, where F is the observed fluorescence, [S] is the substrate concentration, N is the measure 
of cooperativity (Hill coefficient), Kd is the dissociation constant, Fs is the fluorescence at a 
saturating substrate concentration, and Fo is the fluorescence in the absence of substrate. Kinetic 
data were fit with the equation R = Vmax·[S] / (Km + [S]), where R is the rate of reaction, Vmax is the 
maximum reaction velocity, [S] is the substrate concentration, and Km is the substrate 
concentration at half of Vmax. 
Cloning 
Heterologous expression vectors for LpdG, Lpd3, and LpdV were prepared similarly as follows. 
The full ORFs were amplified with PCR from P. aeruginosa PA14 genomic DNA. The forward and 
reverse primers contained an additional stop codon and restriction sites for cloning into the 
Novagen pET-15b expression vector (MilliporeSigma). For LpdG, the forward primer was 
AGAGAGcatatgAGCCAGAAATTCGACGTG and the reverse primer was 
ACACACggatccTTATTATCAGCGCTTCTTGCGGTT. For Lpd3, the forward primer was 
AGAGAGcatatgATGGAAAGCTATGACGTGATCGTG and the reverse primer was 
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ACACACggatccTTATTATCAGTTCTGCATGGCCCG. For LpdV, the forward primer was 
AGAGAGcatatgAGCCAGATCCTGAAGACTTC and the reverse primer was 
ACACACctcgagTTATTATCAGATGTGCAGGGCGTG. The products for LpdG and Lpd3, 
and the pET15b vector, were digested with NdeI and BamHI. The product for LpdV, and the 
pET15b vector, were digested with NdeI and XhoI. The digests were purified using the Qiagen 
PCR Purification Kit and the resulting ORF and plasmid products were ligated together with T4 
DNA ligase. The ligated product was transformed into E. coli Top10 (Invitrogen) and selected for 
on LB agar plates with 50 μg/mL carbenicillin. Individual colonies were cultured and the 
constructed plasmid was isolated using a Qiagen Miniprep Kit and sequenced (Retrogen) to 
verify that no mutations were introduced. The plasmid was then transformed into E. coli 
BL21(DE3) (61) for protein expression. 
Site-directed mutants of LpdG were created by PCR-amplification of the LpdG-pET15b vector. 
The wildtype vector was amplified using primers that contained appropriate mismatches. The 
resulting PCR product was phosphorylated using T4 polynucleotide kinase, blunt-end ligated 
using T4 DNA ligase, and transformed into E. coli Top10 and BL21 as described above. For LpdG 
I192G, the primers were GGCCTGGAGCTGGGTTC and GCCGACGCCGGCGCCGAT. 
For LpdG V191Y, the primers were ATTGGCCTGGAGCTGGGT and 
ATAGCCGGCGCCGATCACAC. 
Dihydrolipoamide dehydrogenase purification 
His6-tagged DLDH homologs and mutants were purified using the same procedure. E. coli BL21 
harboring the expression plasmid (see Cloning) was cultured at 37 °C to an OD600 of 
approximately 0.8 in terrific broth containing 12 g/L tryptone, 24 g/L yeast extract, 4 mL/L 
glycerol, 17 mM KH2PO4, 72 mM K2HPO4, 8 mM MgSO4, and 100 μg/mL ampicillin. A typical 
purification used 1 L of cells grown in a 2.8-L baffled Fernbach flask. All steps after culturing were 
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performed at 4 °C. The cells were harvested by centrifugation for 15 min at 5,000×g. The pellet 
was resuspended in 2.5 volumes of 50 mM KH2PO4, pH 7.5, 200 mM KCl, 50 mM imidazole, and 
1 mM PMSF. The cells were lysed using 3–4 passes through an Avestin Emulsiflex-C3 operating 
at 15,000 PSI and the lysate was clarified by centrifugation for 30 min at 30,000×g. The 
supernatant was applied to a 5-mL HisTrap HP column (GE Healthcare) with an Äkta Purifier 
system running at 3 mL/min. The column was washed with 5 column volumes of 50 mM KH2PO4, 
pH 7.5, 200 mM KCl, and 50 mM imidazole and proteins were eluted using a linear gradient over 
5 column volumes to 50 mM KH2PO4, pH 7.5, 200 mM KCl, and 500 mM imidazole. The yellow 
fractions were pooled, concentrated using an Amicon ultra centrifugal filter (30 kDa) to a volume 
of less than 3 mL, and desalted using a HiPrep 26/10 desalting column (GE Healthcare) into a 
buffer containing 300 mM KH2PO4, pH 7.5. The yellow fractions were again pooled and stored at 
4 °C. All of the preparations were at least 95% pure as judged by Coomassie Blue staining of an 
SDS-PAGE gel. 
For crystallography, LpdG was purified as described above except that protein was purified from 
6 L of cell culture using a 20-mL HisPrep FF 16/10 column (GE Healthcare). Prior to desalting, 
the protein was incubated overnight at 4 °C with 50 U of thrombin (EMD Millipore). The protein 
was concentrated and desalted into 50 mM KH2PO4, pH 7.5, 500 mM KCl, and 20 mM imidazole. 
Uncleaved protein, and other contaminants that bind to the HisPrep column, were removed by 
passing the protein back through the HisPrep column and collecting the flowthrough. The 
flowthrough was applied to a CHT ceramic hydroxyapatite (Type I, 40 μm particle size) column 
(dimensions 2.2×16.5 cm) at a flow rate of 5.0 mL/min. The column was washed with 2 column 
volumes of 100 mM KH2PO4, pH 7.5, and highly pure LpdG was eluted using a linear gradient 
over 2 column volumes to 500 mM KH2PO4, pH 7.5. The yellow fractions were pooled, 
concentrated and desalted into 25 mM HEPES, pH 7.5, with 600 mM KCl, and stored at 4 °C. 
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Flavoprotein concentrations were determined spectrophotometrically. An aliquot of protein was 
first boiled in the dark for 5 min. The precipitated protein was removed by centrifugation, and the 
concentration of liberated flavin was determined using the FAD extinction coefficient of ε450 = 
11300 M−1 cm−1.  
Proteomics 
In-gel digests were performed as previously described (62) and LC-MS/MS analysis was 
performed at the Caltech Proteome Exploration Laboratory (63). 
Crystallography 
Initial crystal screens were performed using vapor diffusion in sitting drop plates. The five screens 
used were Crystal Screen HT (Hampton), Index HT (Hampton), PEGRx HT (Hampton), 
JCSG-plus HT-96 (Molecular Dimensions), and Wizard Classic 1 and 2 (Rigaku). An Art Robins 
Gryphon Nano liquid-handling robot was used to mix 0.2 μL of screen solution with 0.2 μL of 
protein solution (30 mg/mL in 25 mM HEPES, pH 7.5, with 600 mM KCl). The plates were 
sealed with transparent film and incubated at 20 °C. The plates were monitored every several days 
for crystal growth using a stereoscopic microscope. For each well that formed crystals, a secondary 
screen was performed using similar conditions with a wider concentration of salt, pH, and PEG. 
The optimized crystals were grown in a hanging-drop format using Hampton VDX plates with 
sealant and siliconized glass cover slides. Drops were created by mixing 1.5 μL of mother liquor 
with 2 μL of protein solution and 0.5 μL of seed solution. The mother liquor contained 500 μL of 
22% PEG-3350 with 530 mM HEPES at pH 6.1. The protein solution contained 6 mg/mL of 
LpdG (as measured by the BCA assay) in 400 mM HEPES, pH 6.1, with 100 mM KCl. The seed 
solution contained several crystals, crushed by vortexing with a glass bead and diluted 
approximately 1000-fold, in 22% PEG-3350 with 10 mM HEPES, pH 6.5. The pH 6.1 HEPES 
buffers were prepared using a stock of 1 M HEPES with 50 mM MES, and so the final drop 
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solution contained 11% PEG-3350, 400 mM HEPES, 50 mM KCl, and 23 mM MES. The initial 
seed crystal formed under similar conditions at pH 7.5 and was propagated to the lower pH 
through several rounds of crystallization and seeding. Crystals formed as yellow cubes or bricks 
and were apparent after 5 hours at pH 6.5–7.0 or overnight at pH 6.1. The best-diffracting crystals 
were grown for 24−48 hours and were 50–100 μm in each dimension. 
Ligand soaking and cryoprotection were performed delicately because the crystals were highly 
susceptible to cracking from osmotic strength changes. Crystals were first transferred to 8 μL of 
mother liquor on a cover slip. Serial dilutions (2-fold) were created of the soaking or cryo solution 
with the mother liquor, and the crystals were slowly acclimated by mixing in 0.5–1 μL of new 
solution with a pipette tip. The same volume was removed from the drop and iteratively replaced 
until Schlieren lines were no longer visible, and the process was repeated using a higher 
concentration of ligand or cryoprotectant. Typically, batches of 10 crystals were acclimated at a 
time over 30–45 minutes. The final cryoprotection solution contained 50 mM HEPES, pH 7.0, 
20% PEG-3350, 20% DMSO, and the final desired ligand concentration. Crystals were flash 
frozen by plunging into liquid nitrogen. 
Data collection was performed at the Stanford Synchotron Radiation Lightsource, beamline 12-
2. Diffraction images were collected every 0.15° for a full 360° around a single axis (2400 images 
total) using X-rays at 12658 eV. Data completion was frequently low (<90%) because of the low 
symmetry in P21 and the dead spaces between detector tiles of the Pilatus 6M, and so a second 
dataset was collected for each crystal utilizing a detector offset of 10 mm in the X- and Y- 
directions. For well-diffracting crystals with minimal radiation damage, this process was repeated 
with X-rays at 6900 eV to capture the anomalous signal from sulfur. The datasets were integrated 
with XDS (64), scaled together with XSCALE, and then processed with POINTLESS (65), 
merged with AIMLESS (66), and converted to structure factors with CTRUNCATE in the CCP4 
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suite (67). The structure was solved by molecular replacement with Phaser (68) using a search 
model consisting of chain A from the structure 1LPF in the PDB. The structure was refined using 
phenix.refine (69) and ligands (FAD and NADH) were placed using phenix.ligandfit (70). For 
the structure containing NAD+, a fragment of the NAD+ ligand was placed manually in Coot (71) 
because electron density was not apparent for the full ligand. Side chains were trimmed in Coot 
where there was undefined electron density. Further refinement was performed with phenix.refine 
and iterative model building in Coot to the resolution that provided an arbitrary signal-to-noise 
cutoff of 2.0. Paired refinement (48) was then used in 0.05-0.08 Å increments to establish the 
resolution limit of useful data. Riding-hydrogens considerably improved Rfree and overall 
geometry and so they were including in all models. Compared to a simpler TLS model of 
anisotropy, a fully anisotropic model improved Rfree and overall geometry for the apo and NAD+ 
structures, and so these models were refined using anisotropic b-factors. TLS parameters for the 
lower-resolution NADH structure were determined and refined with PHENIX. A large number 
of DMSO molecules, originating from the cryoprotectant, were placed manually in Coot with 
guidance from the low-energy anomalous difference map. The high resolution apo structure 
suggested deviations from planarity in the flavin ring of FAD, and so the final rounds of refinement 
in the apo and NAD+ structures were performed using relaxed planarity restraints for FAD. 
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C h a p t e r  5  
PROFILING THE METABOLOME OF PSEUDOMONAS AERUGINOSA 
Abstract 
Endogenous phenazine are known to alter metabolic flux in P. aeruginosa, but the full scope and 
biochemical basis of this interaction is unknown. To facilitate future studies into the metabolism 
of P. aeruginosa, I have developed several methods using high performance liquid chromatography 
and mass spectrometry to characterize both extracellular and intracellular metabolites. 
Preliminary results show that pyocyanin is not required for pyruvate secretion in P. aeruginosa and 
that pyocyanin alters the secretion of numerous other compounds. Using high-resolution LCMS, 
I show that pyocyanin shifts the chain-length distribution of the secreted 4-hydroxy-2-
alkylquinolones such that longer chains are less abundant and shorter chains are more abundant. 
Quinolones are well-established signaling molecules, and so pyocyanin may indirectly affect cell-
to-cell signaling via the distribution of quinolones. Pyocyanin also alters the production of certain 
glycerophospholipids whose precise identity has not been determined. These results are 
consistent with the notion that phenazines promote redox homeostasis, which might in turn 
promote β-oxidation and drive shifts in the fatty acid pool. I also identified several novel 
sulfonated phenazines and further purified a pyocyanin sulfonate from culture supernatants. 
These phenazines could arise from reactions with reactive sulfur species (sulfite or sulfide) that 
form during sulfate assimilation, raising the prospect that they might be useful markers of in situ 
sulfur metabolism in clinical samples. Finally, I have begun to extend these methods to the analysis 
of intracellular polar metabolites, especially those of central metabolism. Together, this method 




Converging evidence suggests that phenazines, the colorful redox-active molecules secreted by 
diverse bacteria and archaea, significantly alter the metabolic flux of Pseudomonas aeruginosa. For 
instance, during anaerobic survival on glucose, phenazine-1-carboxylic acid (PCA) stimulates the 
secretion of acetate and the production of ATP (1). During aerobic growth on glucose, pyocyanin 
stimulates pyruvate secretion in stationary phase (2). Elucidating the metabolic origins of these 
phenotypes requires tools to characterize both intracellular and extracellular metabolites. In this 
Chapter, I describe my progress towards analyzing complex mixtures of metabolites. With current 
technology, it is not possible to measure every molecule with a single method, and so I will discuss 
three different methods and preliminary insights they have given into the relationship between 
phenazines and metabolism in P. aeruginosa. The first method uses traditional chromatography 
for the targeted quantification of specific organic acids. The second method uses low- and high-
resolution liquid chromatography and mass spectrometry (LCMS) for the untargeted 
identification of unknown molecules in culture supernatants. The third method, which is 
technically challenging and requires further optimization, extends high-resolution LCMS to the 
identification of polar intracellular metabolites. My preliminary results suggest that pyocyanin’s 
metabolic effects on P. aeruginosa are more extensive and indirect than previously appreciated. 
Results and Discussion 
Methods for detecting secreted organic acids 
Small organic acids, such as acetate, succinate, pyruvate, are ubiquitous intermediates in 
metabolism, and many are secreted by microorganisms. When grown on glucose, P. aeruginosa is 
known to secrete α-ketoglutarate during nitrogen limitation (3). It can also secrete pyruvate 
during glucose oxidation (4), and pyruvate secretion during the oxygen-limited stationary phase 
of growth is stimulated by pyocyanin (2). P. aeruginosa also secretes acetate, lactate, and succinate 
when surviving by fermentation on pyruvate (5,6), and it secretes acetate during phenazine-
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mediated anaerobic survival on glucose (1). A method to quantify extracellular organic acids is 
therefore a versatile tool to study metabolism in P. aeruginosa. 
My first attempts to measure organic acids in culture supernatants used ion chromatography on a 
Dionex DX-500 instrument (1), but this method struggled to separate acetate and lactate for 
quantification (Figure 1). For my compounds of interest (primarily pyruvate, acetate, lactate, and 
succinate), I found greater success using high performance liquid chromatography (HPLC), and 
so this method is not fully optimized. However, it may prove superior for quantifying other acids 
or for simultaneously quantifying inorganic anions (e.g. chloride and phosphate). 
 
Figure 1. Separation of organic acids using ion chromatography. The indicated 
compounds were analyzed as described previously (1) (see Supplemental 
Information). (Left) Injection of a mixture of pure standards. (Right) Injection of 
supernatant from an anaerobic culture of P. aeruginosa incubated with pyruvate. Note 
the poor separation of lactate and acetate, which precluded an accurate quantification 
of acetate. 
For better quantification of organic acids, HPLC using an Aminex HPX-87H (Bio-Rad) anion-
exclusion column proved to be simple and effective. I have used this column on multiple 
instruments (Agilent 1100, Waters Alliance, and Beckman Gold) with comparable results, and it 
is my preferred method for studying fermentation (1). This method adequately separates 
pyruvate, acetate, lactate, and succinate in culture supernatants. It can also measure other acids, 



















including α-ketoglutarate, citrate, malate, and fumarate (Figure 2). The method uses a simple 
isocratic elution using 5 mM H2SO4 or 0.2% phosphoric acid with UV detection at 206–210 nm. 
For enhanced signal-to-noise and improved sensitivity, the signal at 206 nm can be referenced to 
260 nm. While the overall chromatographic resolution is not as high as in the ion chromatography 
method (compare peak widths in Figure 1 and Figure 2), some compounds are better resolved 
(note the separation between pyruvate and lactate), and the relative simplicity of this method 
makes it easier for routine use. 
 
Figure 2. Separation of organic acids using HPLC. Organic acid standards (1 mM) 
were dissolved in minimal medium and separated on an Aminex HPX-87H column 
with a Beckman Gold system. Compounds were eluted isocratically using 5 mM H2SO4 
and detected at 206 nm. The chromatograms have been rescaled so that the relevant 
peaks are approximately the same height. The commercial sources of malate and 
succinate appear to be contaminated with fumarate, which absorbs strongly at 206 nm. 
Pyocyanin is not required for pyruvate secretion in P. aeruginosa 
Previously it was hypothesized that pyocyanin might promote pyruvate secretion by inhibiting 
pyruvate dehydrogenase (2). An alternative, but not mutually exclusive, hypothesis is that 
pyocyanin increases the rate of glucose oxidation to pyruvate (1). I attempted to distinguish these 
hypotheses by measuring pyruvate secretion from different carbon sources. If pyocyanin acts by 
inhibiting pyruvate dehydrogenase, then only carbon sources that feed through pyruvate 
dehydrogenase (e.g. glucose, gluconate, and mannitol, but not succinate) should lead to pyruvate 

















secretion. I cultured P. aeruginosa in a minimal medium containing 20 mM glucose, 20 mM 
gluconate, 20 mM mannitol, or 30 mM succinate and monitored organic acid secretion in the 
culture supernatant using HPLC with the Aminex HPX-87H column.  
Representative HPLC traces for these experiments are shown in Figure 3, along with pure 
pyruvate and α-ketoglutarate standards for reference. I did not detect pyruvate secretion in 
glucose as previously described (2); however, I sampled earlier timepoints in a medium that 
contained less glucose and ammonium than previously used. I detected α-ketoglutarate in both 
wild type and ∆phz1/2 cultures growing on succinate and gluconate (Figure 3). I also detected 
pyruvate in ∆phz1/2 cultures growing on gluconate (Figure 3). Mannitol yielded slow growth 
rates (generation time ~2–3 hours) and no detectable organic acid secretion. The identities of α-
ketoglutarate and pyruvate were confirmed by spiking samples with pure standards and observing 
only a single peak, as well as by the full UV–vis spectrum of the peak which showed absorbance at 
~320 nm, a characteristic of α-keto acids. 
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Figure 3. Representative HPLC traces of supernatants from cultures grown on the 
indicated carbon sources. The y-axis represents absorbance at 206 nm (arbitrary units). 
Separation was performed using an Aminex HPX-87H column. The left plots show 
traces from wild type cultures and the right plots show traces from ∆phz1/2 mutant 
cultures. Dashed lines indicate the retention times of α-ketoglutarate (purple) and 
pyruvate (green) (standards at 1 mM in culture medium). The time point of sampling, 
measured from inoculation of the shaking flask, is shown to the right of each trace. 
In shaking flasks, I also did not detect pyruvate secretion using the MOPS-buffered medium with 
50 mM glucose and 93 mM NH4Cl as originally published (2). However, in one experiment, 
increasing the glucose concentration in my medium to 50 mM yielded pyruvate secretion during 
stationary phase (Figure 4). 






















































Figure 4. Pyruvate and α-ketoglutarate secretion in wild type and ∆phz1/2 cultures 
with 50 mM glucose. The plots are arranged as in Figure 3. 
Unfortunately, I was unable to consistently reproduce the pyruvate secretion phenotype. 
Hypothesizing that subtle differences in aeration affected the outcome, I tested cultures 
containing 20, 50, and 100 mL in 250-mL flasks, but none yielded consistent pyruvate secretion 
above a few micromolar. Adjusting the amount of iron in acid-washed glassware (from 7.2 μM to 
30 μM), to control for variable metal concentrations adsorbed to glassware, also did not yield 
pyruvate secretion, nor did increasing the NH4Cl concentration (from 9.3 mM to 30 mM). 
Pyruvate secretion by P. aeruginosa, and its relationship to pyocyanin, appears to be more 
complicated than previously reported (2). The observation of pyruvate in ∆phz1/2 cultures 
(Figures 3 and 4) demonstrates that pyocyanin is not required for pyruvate secretion. During 
aerobic growth, P. aeruginosa metabolizes glucose via gluconate as an intermediate (7,8), and so 
pyruvate secretion during growth on gluconate (Figure 3) is consistent with secretion in glucose. 
It is possible that subtle differences in culture conditions, such as the difference between shaking 
flasks (this study) and shaking tubes (2), differences in flask shape between manufacturers, or lot-
to-lot variations in the chemicals used (note the trace fumarate contamination in some carbon 
sources (Figure 2)), lead to seemingly random variation in the total pyruvate secreted by 
stationary-phase cultures. In addition, the transient nature of pyruvate and α-ketoglutarate 
accumulation (appearing within 2 hours and disappearing within 2 hours later (Figure 3)) may 
lead to false-negatives. Elucidating the specific growth conditions where pyocyanin specifically 












induces pyruvate secretion, and those where it does not, may yield insight into the interaction 
between pyocyanin and metabolism in P. aeruginosa. 
Pyocyanin alters the secretion pattern of quinolones 
While testing different growth conditions, such as changing carbon source or nitrogen availability, 
I observed a range of colors in the cultures including colorless, green, blue, brown, and yellow. 
Inexplicably, the colors sometimes varied between replicate cultures, originating from the same 
medium bottle, in acid-washed flasks from the same manufacturer and incubated adjacently. This 
was true for both wild type and ∆phz1/2 cultures, suggesting the variation is caused partly by 
pigments other than phenazines. I speculated that, even if I could not reproduce pyruvate 
secretion, pyocyanin may regulate the secretion of other metabolites. 
To explore the variation of unknown secreted compounds, I used a reversed-phase HPLC method 
with the Waters Atlantis T3 column. In this method, compounds are eluted in approximate order 
of increasing hydrophobicity. A comparison of supernatants from wild type and ∆phz1/2 cultures 
grown in succinate demonstrates several differentially secreted metabolites (Figure 5a). Note that 
these chromatograms are shown for the wavelength 260 nm; compounds that absorb at lower 
wavelengths are obscured by the background of formic acid in the eluent, and so there might be 
additional unseen differences. Without a pure standard, it is difficult to equate the peaks to an 
absolute concentration.  
Interestingly, I observed only trace amounts of 1-hydroxyphenazine in my cultures (Figure 5a and 
others not shown). This demethylated pyocyanin derivative is frequently cited as an endogenous 
phenazine of P. aeruginosa (9,10). Based on my results and a review of the literature, it seems that 
P. aeruginosa may not directly produce significant amounts of 1-hydroxyphenazine. Rather, this 
compound might originate from the abiotic base-catalyzed demethylation of pyocyanin. 
Pyocyanin biosynthesis begins with methylation of PCA to form 5MPCA by the enzyme PhzM. 
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This reactive intermediate is converted to pyocyanin by the oxidative decarboxylase PhzS. It has 
been suggested that PhzS can also act on PCA to directly produce 1-hydroxyphenazine. However, 
it was also noted that the ∆phzM mutant produces considerably less 1-hydroxyphenazine than the 
wild type (10), a peculiar result when one might expect this mutation to increase the PCA 
available for direct decarboxylation to 1-hydroxyphenazine. These experiments were performed 
in unbuffered Pseudomonas isolation agar or Pseudomonas broth (10). In my hands, growth of 
P. aeruginosa in such unbuffered media, including lysogeny broth (LB), leads to alkalization of the 
medium to pH ~9, presumably from the release of ammonium during the catabolism of amino 
acids in peptone or other protein digests. At basic pH, pyocyanin spontaneously demethylates to 
form 1-hydroxyphenazine (11). While PhzS may act slowly on PCA to form 1-hydroxyphenazine, 
the decreased production by the ∆phzM strain is readily explained if most 1-hydroxyphenazine 
originates from pyocyanin. 
The differences observed between wild type and ∆phz1/2 cultures (Figure 5a) might be caused 
by phenazines. Alternatively, phenazine biosynthesis could deplete the shikimate and chorismite 
pools (12), leading to indirect changes in shikimate- or chorismite-derived compounds. To test if 
phenazines directly alter the secretion of metabolites, I complemented ∆phz1/2 cultures with 
pyocyanin at approximately the same OD500 where phenazine biosynthesis is induced. Some of 
the differences between wild type and ∆phz1/2 cultures were recapitulated by pyocyanin addition 
(Figure 5b), clearly demonstrating that pyocyanin stimulates the accumulation of some 
metabolites and inhibits the accumulation of others. The remaining differences between wild type 
and ∆phz1/2 cultures (the peak differences that weren’t recapitulated by pyocyanin addition) 
might be caused by the other endogenous phenazines (e.g. phenazine-1-carboxylic acid and 
phenazine-1-carboxamide), but this has not been confirmed. 
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Figure 5. Analysis of succinate-grown culture supernatants using reversed-phase 
chromatography. The y-axis represents absorbance at 260 nm (arbitrary units). Peaks 
representing the endogenous phenazines are labeled with black arrows (pyo, 
pyocyanin; PCN, phenazine-1-carboxamide; PCA, phenazine-1-carboxylic acid; 1-
HP, 1-hydroxyphenazine). Peaks unique to a condition are indicated with 
appropriately colored arrows. (A) Comparison of wild type (blue) and Δphz1/2 
(green) culture supernatants incubated for 20 h. (B) Comparison of Δphz1/2 (green) 
and Δphz1/2 with exogenous pyocyanin (purple) culture supernatants. After 10 h of 
growth (OD500 ~ 1), pyocyanin was added to a concentration of 100 μM. Cultures were 
sampled after an additional 10 h. The stock of pyocyanin was contaminated with small 
amounts of 1-hydroxyphenazine. Compounds of interest are numbered in order of 
discussion in the main text. 
To characterize the unknown compounds, I collected mass spectrometry data in the same HPLC 
runs with a Waters Acquity QDa detector using electrospray ionization in both positive and 
negative scanning modes, yielding mass information accurate to ~0.2 Da. I then analyzed 
representative samples with a similar chromatography method on a Waters Xevo G2-XS QTof 
mass spectrometer, providing mass accuracy to within 5 ppm, sufficient to establish a probable 
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chemical formula. By comparing masses and UV-spectra between the methods, I could assign 
formulas to the peaks labeled in Figure 5. I also used the XCMS package (13) to identify peaks 
within each dataset, identifying up to 800 putative compounds within each sample depending on 
the parameters used. Most of the masses represent unknown compounds with no reasonable hits 
in the METLIN database (14). Notable exceptions include hits for pyochelin, rhamnolipids, the 
Pseudomonas quinolone signal, and nucleotide monophosphates. I used short chromatography 
runs for the high-resolution data, making it difficult to analyze the fragmentation patterns for every 
identified mass, and so here I focus my discussion only on the peaks labeled in Figure 5. 
Compound 1 has absorbance peaks at 270, 279, and 313 nm. It yields the ions 160.03751− and 
162.05751+, consistent with the neutral formula C9H7NO2. The UV spectrum matches precisely 
with that of 2,4-dihydroxyquinolone (15) (Figure 6), which has previously been detected by LC-
MS/MS in P. aeruginosa cultures (16). When grown on glucose, this compound was nearly absent 
in the Δphz1/2 cultures but abundant in wild type cultures (data not shown). 
 
Figure 6. Structure of compound 1, 2,4-dihydroxyquinolone. 
Compound 2 has an absorbance peak at 341 nm. QDa detected the ions 260.21+ and 258.31−. 
Xevo detected 260.16671+ and 258.14701−, consistent with the neutral formula C16H21NO2. Based 
on the UV-spectrum and mass, this compound is likely the Pseudomonas quinolone signal (PQS, 
2-heptyl-3-hydroxy-4-quinolone) or HQNO (N-oxo-2-heptyl-4-hydroxyquinoline) (Figure 7). 
Further analysis suggests this peak may be an artifact of the chromatography. While two peaks of 
mass 260.17 were observed on the Atlantis T3 column with the QDa detector (Figure 8), only a 
122 
single peak of this mass was observed in the Xevo dataset. I have observed that several aromatic 
compounds, including pyocyanin, elute as multiple peaks (Figure 8), possibly because they 
interact with other aromatic analytes bound to the column. The samples were analyzed on the 
Xevo after the QDa, and so alternatively, the compound of interest (PQS or NQNO) degraded 
over time. 
 
Figure 7. Possible structures of compound 2. (Left) 2-heptyl-3-hydroxy-4-quinolone 
(the Pseudomonas quinolone signal, PQS). (Right) N-oxo-2-heptyl-4-
hydroxyquinoline (HQNO). 
 
Figure 8. Potential chromatography artifacts, detected by mass spectrometry, where 
certain compounds elute as two or more well-defined peaks. These traces represent 
extracted ion chromatograms from QDa data (positive mode) with a Waters Atlantis 
T3 column. 
Compound 3 has an absorbance peak at 338 nm. QDa detected masses of 314.01+, 298.21+, 
276.21+, and 573.31+, with 276.21+ being the most abundant. The high-resolution mass spectrum 
yielded the following ions and corresponding formulas: 










276.1609 C16H22NO3 274.1454 C16H20NO3 
258.1500 C16H20NO2 218.1549 C14H20NO 
178.0500 C9H8NO3 175.0271 C9H5NO3 
162.0547 C9H10NO3 148.0400 C8H6NO2 
160.0395 C9H6NO2 120.0450 C7H6NO 
146.0599 C9H8NO 92.0506 C6H6N 
144.0440 C9H6NO   
134.0599 C8H8NO   





The rows in bold illustrate all of the fragments from a previous study (17) that reported the 
putative structure 3-heptyl-2,3-dihydroxy-4-quinolone (Figure 9), a possible identity of this 
compound. 
 
Figure 9. Putative structure of compound 3, 3-heptyl-2,3-dihydroxy-4-quinolone, 
based on comparison to the mass spectrum from a previous study (17). 
Compound 4 has absorbance peaks at 267 and 329 nm. QDa detected masses of 292.11+ and 
120.11+, and 290.21−. Xevo yielded the following ions and corresponding formulas: 
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+ − 
292.1554 C16H22NO4 290.1403 C16H20NO4 
  246.1499 C15H20NO2 
  218.1549 C14H20NO 
  125.0966 C8H13O 
  92.0503 C6H6N 
 
This compound eluted close to PQS (or HQNO), making it difficult to discern the appropriate 
fragmentation pattern in the positive channel, but it ionized well in the negative channel and gave 
easily identifiable fragments. The loss of CO2 (290 → 246), a mass difference not observed in 
compound 5, suggests the presence of a carboxylic acid group in a similar molecule; however, 
addition of a carboxylic acid to the heptyl chain produces a hypothetical molecule that is 2 Da too 
small to match the data. It is more abundant in the absence of pyocyanin (Figure 10). 
Analysis using XCMS also revealed the following compound: 
+ − 
291.1714 C16H23N2O3 289.1563 C16H21N2O3 
246.1497 C15H20NO2 271.1459 C16H19N2O2 
147.0554 C8H7N2O 246.1502 C15H20NO2 
130.0287 C8H4NO 146.0243 C8H4NO2 




This compound was also more abundant in the absence of pyocyanin (Figure 10), along with a 
related compound with a shorter alkyl chain. These compounds may be hydroxylated and 
aminated derivatives of compound 5, with the observed fragments resulting from a more complex 
rearrangement (17,18). Nonetheless, the smaller mass fragments are consistent with a quinolone. 
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Figure 10. Derivatives of quinolones that are more abundant in the absence of 
pyocyanin. The compounds were detected by high-resolution LC-MS/MS. The y-axis 
represents intensity (arbitrary units). Two traces from independent succinate-grown 
∆phz1/2 supernatants are shown for the absence (black) and presence (blue) of 100 
μM pyocyanin. 
A more detailed inspection of the high-resolution datasets suggests that pyocyanin affects the 
distribution of several quinolone derivatives (Figure 11). Cultures with pyocyanin had increased 
amounts of shorter 4-hydroxy-2-alkylquinolones (HAQs), while cultures without pyocyanin 
produced more of the longer chain length derivatives (Figure 11). Cultures without pyocyanin 
also produced more of the putative 3-alkyl-2,3-dihydroxy-4-quinolones. The relative abundance 
of PQS appeared unchanged (Figure 11). 
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Figure 11. LCMS-based characterization of quinolones in duplicate succinate-grown 
∆phz1/2 (black) and ∆phz1/2 + 100 μM pyocyanin (blue) culture supernatants. The 
y-axis represents signal intensity (arbitrary units). 
Quinolones are signaling molecules in P. aeruginosa (19,20) that are required for the full 
expression of phenazines (21,22). The Pseudomonas quinolone signal, 2-heptyl-3-hydroxy-4-
quinolone, and HHQ, 4-hydroxy-2-heptylquinolone, induce a transcriptional response by 
binding to the regulator MvfR, and both are required for the maximal expression of pyocyanin 
(23). The data presented here suggest that this regulatory network might act reciprocally, with 
pyocyanin altering the expression of multiple quinolones, particularly HHQ (Figure 11). While 
the literature focuses primarily on PQS, HHQ, and HQNO, P. aeruginosa produces several dozen 
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related molecules with varying chain lengths (17,20) (Figure 11), and here I have detected still 
others with additional hydroxylation and amination modifications (Figure 10). Depending on the 
response of MvfR to these modifications and varying chain lengths, pyocyanin could exert a 
regulatory effect through the action of quinolones. 
Pyocyanin induces a direct transcriptional response in P. aeruginosa by activating the 
transcriptional regulator SoxR (24), but none of the reported targets appear related to quinolone 
biosynthesis. Quinolones are synthesized from anthranilic acid by conversion to 2-
aminobenzoylacetate, which is then joined with a fatty acid and cyclized to form the 2-alkyl-4-
quinolone (25). The related molecule 2,4-dihydroxyquinolone (Figure 6) originates from the 
spontaneous cyclization of 2-aminobenzoylacetate (25). The alkyl chain originates directly from 
fatty acids, as demonstrated by the incorporation of isotope-labeled octanoic acid (25). It has 
been further suggested that the fatty acids incorporated into quinolones originate from β-
oxidation, not de novo synthesis, because intermediates of synthesis are covalently bound to the 
acyl carrier protein, and labeled decanoic acid was incorporated into quinolones with a shorter 
chain (25). Together, these results suggest that pyocyanin may alter the secreted quinolones 
(Figures 10 and 11) by altering β-oxidation and the fatty acid pool in stationary phase cultures. 
Because β-oxidation produces a large excess of reducing equivalents, pyocyanin might stimulate 
β-oxidation by promoting redox homeostasis (2), consistent with the production of shorter-chain 
quinolones in cultures with pyocyanin (Figure 11). In addition, XCMS identified several 
differences in pyocyanin-treated cultures that are likely phospholipids (not shown). Although 
these are only preliminary findings, requiring confirmation by additional replicates and more 
thorough statistics, along with investigations into the effects of carbon source and growth phase, 
this hypothesis is well-suited for the application of LCMS-based lipidomics and may yield new 
insights into the regulatory mechanisms of phenazines. 
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Identification and purification of novel phenazine sulfonates in culture supernatants 
The remaining peaks labeled in Figure 5, compounds 5–8, all had absorbance peaks near 269–280 
nm and 393 with spectra nearly identical to that of pyocyanin. For both compounds 5 and 6, QDa 
identified the same ions 334.91+, 3191+, 320.01+, 255.11+, 188.21+, and 333.11−, suggesting they are 
isomers of each other. Xevo detected the following ions: 
+ − 
335.0347 C16H22NO4 335.0314 C14H11N2O6S 
319.0400 C14H11N2O5S 333.0173 C14H9N2O6S 
275.0495 C13H11N2O3S 318.0300 C14H10N2O5S 
274.0421 C13H10N2O3S 317.0218 C14H9N2O5S 
271.0725 C14H11N2O4 305.0210 C13H9N2O5S 
255.0776 C14H11N2O3 303.0062 C13H7N2O5S 
  273.0316 C13H9N2O3S 
  259.0162 C12H7N2O3S 
  195.0541 C12H7N2O 
 
These compounds were undetectable in the ∆phz1/2 strain (Figure 5), even with exogenous 
pyocyanin, suggesting they are not adducts of pyocyanin, but their UV-spectrum and mass 
fragmentation into 1951− (the same mass as 1-hydroxyphenazine) suggest they are phenazine 
derivatives. Based on a more thorough investigation into compound 7, I propose that compounds 
5 and 6 are sulfonated derivatives of 5-methylphenazine-1-carboxylic acid (5MPCA) (Figure 12), 




Figure 12. Proposed structures of compounds 5 and 6.  
This interpretation is consistent with the prominent mass peak at 3191+ (bold in the table above). 
The peak for 3171− was barely distinguishable from the background noise in the mass spectrum, 
likely because the formation of three charged groups in such a small molecule is disfavored during 
electrospray ionization. The higher masses 3351+, 3331−, and 3351− represent formic acid adducts 
of smaller fragments. 
Compound 7 yielded the following ions and corresponding formulas: 
+ − 
291.0447 C13H11N2O4S 289.0284 C13H9N2O4S 
263.0490 C12H11N2O3S 274.0045 C12H6N2O4S 
227.0824 C13H11N2O2 246.0112 C11H6N2O3S 
210.0789 C13H10N2O 210.0426 C12H6N2O2 
199.0870 C12H11N2O 182.0478 C11H6N2O 
184.0631 C11H8N2O   
157.0762 C10H9N2   
 
Based on the similarity of the UV-spectrum to that of pyocyanin, and the mass fragmentation 
pattern, I hypothesized that this compound is a pyocyanin sulfonate (Figure 13). This hypothesis 
was guided by a few key features of the mass spectrum. The fragmentation 291 → 263 represents 
loss of the ketone group (through a radical-mediated rearrangement) as seen in other cyclic 
ketones (27). I also observed the loss of the N-methyl group (289 → 274) and the sulfonate group 
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(291 → 210). Other fragmentations with the loss of SO2 likely involve a rearrangement that retains 
one of the oxygen atoms of the sulfonate. I did not observe a fragment corresponding to the loss 
of SO4, which argues in favor of a sulfonate (CSO3H) rather than a sulfate (COSO3H) group. 
 
Figure 13. Proposed structure of compound 7, pyocyanin sulfonate. 
Guided by this hypothetical structure, I attempted to purify the putative pyocyanin sulfonate from 
a P. aeruginosa culture. As determined by HPLC, pyocyanin bound to the hydrophobic resin 
SP850 but the sulfonate derivative did not. The anion-exchange resin 1X8 (Dowex) adsorbed the 
remaining pyocyanin and the putative sulfonate from the SP850-treated supernatant. Washing 
the 1X8 resin with water eluted surprisingly pure pyocyanin (Figure 14a) in the pink (acidic) 
form. Following a second wash with acetonitrile, I eluted the sulfonate using 10% acetonitrile in 
water with 5% formic acid to yield relatively pure compound 7 (Figure 14a). The similarity 
between the UV–vis spectra supports the conclusion that the compound is a pyocyanin derivative 




Figure 14. (A) Overlaid traces of purified pyocyanin and pyocyanin sulfonate, 
demonstrating a difference in retention time. The y-axis represents absorbance at 280 
nm (arbitrary units). (B) Overlaid UV–vis spectra of pyocyanin (blue) and pyocyanin 
sulfonate (green). The spectra were collected from a Waters 2998 HPLC detector and 
represent the acidified forms of pyocyanin (in 0.1% formic acid). 
I attempted to scale-up the purification by treating culture supernatant directly with 1X8, eluting 
the pyocyanin sulfonate with 5% formic acid, and further purifying the compound using semi-
preparative HPLC. I obtained approximately 0.5 mg of compound from 2 L of glucose-grown wild 
type culture supernatant. I was unable to collect an interpretable 1H-NMR spectrum because of 
many interfering peaks that resembled peptides. Contaminating proteins or small peptides may 
have co-purified with the anion-exchange chromatography and eluted similarly in the preparative 
HPLC; the analytical HPLC (Figure 14a) used formic acid in the eluent, which obscures the UV 
signal below approximately 250 nm, making it difficult to detect such contaminants. Further 
purification and a larger scale will be required to obtain NMR-confirmation of the proposed 
structure (Figure 13). 
Finally, compound 8 yielded the following ions and corresponding formulas: 
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371.0013 C13H11N2O7S2 368.9868 C13H9N2O7S2 
356.9851 C12H9N2O7S2 354.9709 C12H7N2O7S2   
305.0245 C13H19N2O5S   
290.0011 C12H6N2O5S   
262.0054 C11H6N2O4S   
260.9975 C11H5N2O4S   




Based on the mass spectrum, and analysis of compounds 5–7, this compound appears to be a 
disulfonate derivative of pyocyanin. Closer inspection of compound 7, the pyocyanin sulfonate, 
suggests it may elute as two closely related molecules with a split HPLC peak. I hypothesize that 
compound 8 is the doubly sulfonated version representing the two isomers of compound 7. 
Biological aromatic sulfonates, as in Figure 13, are extremely rare in the literature. A notable 
exception is an old report of aeruginosin B, a modification of 5MPCA by both amination and 
sulfonation (28), which has been claimed as only known example of a biological aromatic 
sulfonate (29). The sulfonated phenazines reported here (Figures 12 and 13) may have the same 
origin as aeruginosin B. While I have not fully elucidated the position of the sulfonate, a task which 
will require NMR spectroscopy and/or direct synthesis, the structures drawn (Figure 12 and 13) 
represent the locations known to be targeted by nucleophiles in previous reports. Specifically, it 
has recently become appreciated that amines and thiols can covalently conjugate to phenazines 
(30,31), and even ammonia can modify 5MPCA to produce aeruginosin A (26). Aeruginosin B 
was reported to form spontaneously from aeruginosin A in the presence of sulphite (32,33) along 
with a second disulfonated derivative (33). As noted in its original characterization, “aeruginosin 
B may be an artefact arising through the biological reduction of sulphate to sulphite and its 
133 
reaction with aeruginosin A” (33). P. aeruginosa assimilates sulfate by first incorporating it into 
ATP as 5′-adenylyl sulfate, where the sulfate is then reduced to free sulfite and then to sulfide (34), 
and so phenazine sulfonates may represent a side-reaction with the sulfite intermediate. 
Alternatively, they might be generated from a reaction with sulfide (HS−) followed by oxidation 
with molecular oxygen or reactive oxygen species. As 5MPCA is an intermediate of pyocyanin 
synthesis, the accumulation of sulfonated 5MPCA suggests that sulfonation might protect the 
intermediate from the decarboxylating enzyme that produces pyocyanin (PhzS). Pyocyanin 
sulfonate was observed even in the Δphz1/2 strain, demonstrating that it can be produced from 
pyocyanin directly rather than deriving from sulfonated 5MPCA. 
If sulfonated phenazines originate via an uncatalyzed reaction with reactive sulfur species (e.g. 
sulfite and sulfide), their accumulation in lung sputum or other infection contexts could provide 
a useful marker of sulfur metabolism in situ. Hydrogen sulfide has been detected in sputum 
samples from patients with cystic fibrosis (35), and hydrogen sulfide has been shown to promote 
antibiotic resistance in P. aeruginosa (36), making it a particularly noteworthy sulfur species. In 
contrast to the direct detection of sulfur species, reaction products with phenazines (or other 
molecules) could give a preserved record of sulfite or sulfide accumulation over time. Extraction 
of such compounds from complex samples may prove difficult. Phenazines are generally extracted 
using organic solvents such as chloroform or ethyl acetate, but the sulfonated derivatives and 
5MPCA are highly water soluble, possibly explaining why the diversity of sulfonated phenazines 
has not been reported before. However, phenazines have been quantified directly from filtered 
sputum (37), and so detection by LCMS might enable a simple path to sulfonate detection in 
complex clinical samples. 
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Detection of intracellular polar metabolites 
HPLC often utilizes columns containing C18-derivatized silica (“reversed phase”), which 
provides excellent chromatography for hydrophobic molecules using solvents that are compatible 
with mass spectrometry. A major technical hurdle for the analysis of small polar molecules (e.g. 
pyruvate, ATP, glucose) is their poor retention on traditional C18 columns. While alternative 
separations are possible based on underivatized silica (“normal phase”), ion-exchange, or ion-
exclusion, these methods generally involve solvents, additives, or salt concentrations that are 
incompatible with mass spectrometry. 
Hydrophilic interaction liquid chromatography (HILIC) has gained popularity for its ability to 
separate polar compounds for mass spectrometry. In HILIC, a column derivatized with polar 
headgroups (e.g. amides, amines, carboxylates) is equilibrated with organic solvent containing a 
small portion of water. The water preferentially associates with the polar groups in the column, 
providing a water-enriched layer that polar analytes can partition into. Polar analytes can then be 
eluted using an increasing concentration of water. In the case of charged head groups (e.g. amines 
and carboxylates), this can be combined with weak ion exchange for a hybrid mode of 
chromatography. Several groups have successfully applied such a hybrid HILIC-anion exchange 
approach for the quantification of polar metabolites. Here I briefly report my efforts towards 
adapting this method to the instrumentation available at Caltech. 
The published method (38), developed a decade ago, uses a long (250 mm) Phenomenex Luna 
NH2 column with a relatively large particle size (5 μm). To fully utilize the improved separations 
available on more modern UPLC instruments, I attempted a similar method using a shorter (150 
mm) column with a smaller particle size (3 μm). This column provided unacceptably long 
retention times for multiply phosphorylated compounds (e.g. ATP), which translated to poor 
sensitivity, but many compounds behaved well. Increasing the pH to ~9.6 (to reduce the portion 
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of protonated NH2 groups on the column) enabled faster elution and better sensitivity for 
negatively charged compounds. 
Using this optimized method (described in Materials and Methods), I have detected many 
intracellular metabolites from crude extractions with minimal sample preparation. The extracted 
ion chromatograms for representative metabolites are shown in Figure 15. However, detailed 
comparisons between pyocyanin treated and untreated Δphz1/2 cultures have been unsuccessful. 
I have struggled to obtain suitable sensitivity for many metabolites (e.g. succinate and other TCA 
cycle intermediates), possibly due to ion suppression from the ammonium acetate in the method. 
Analysis with XCMS often detects differences in compounds that are likely glycerophospholipids, 
but their precise structure is unknown. In addition, I have observed that while organic solvents 
solubilize nearly the entire pellet from E. coli cultures, they leave behind most P. aeruginosa cell 
material. Extraction from filters also fails to solubilize most of the visible P. aeruginosa colony 
growth, suggesting that the poor sensitivity is a symptom of poor extraction. Over-extraction can 
also reduce sensitivity through ion suppression (39), and so extraction efficiency will likely need 
to be optimized for the compounds of interest. 
 
Figure 15. Extracted ion chromatograms for representative metabolites (left, 
intermediates of glycolysis; right, nucleotide phosphates) from P. aeruginosa. The y-axis 
represents signal intensity (arbitrary units). 
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Despite the technical challenges, my preliminary results suggest a suitable method for intracellular 
polar metabolite characterization in P. aeruginosa is within reach. Such a method will allow 
absolute quantification (40) (via 13C labeling with coinjection of 12C standards) or direct 
comparisons between two conditions (by mixing 12C-labeled samples with 13C-labeled samples). 
This will enable direct measurements of metabolic flux and any changes induced by phenazines. I 
predict that phenazines will preferentially affect the flux through specific pathways, which will 
indicate potential enzyme–phenazine interactions and may even reveal the relevant phenazine 
reductases in vivo. 
Conclusions 
Metabolomics is a powerful discovery tool. Using a simple HPLC method that works on virtually 
any instrument, organic acid quantification in culture supernatants can be a routine procedure. 
Although the relationship between pyocyanin and pyruvate secretion is still unclear, organic acid 
analysis nonetheless revealed the qualitative fact that pyocyanin is not essential for pyruvate 
secretion. While it is less accessible and costlier to operate, HPLC with high resolution mass 
spectrometry revealed an astounding number of unknown compounds secreted by P. aeruginosa. 
By comparing two conditions (with and without pyocyanin) to winnow the list to differentially 
secreted compounds, I identified quinolone secretion as a potential indirect target of pyocyanin. 
Using similar analyses in different comparisons, LC-MS/MS will likely be a cornucopia of low-
hanging fruit for follow-up study. With additional optimization, this approach can be extended to 
in vivo metabolites and metabolic flux studies, providing a new and powerful tool to study the 
physiological effects of phenazines. 
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Materials and Methods 
Strains and Culture Conditions 
The two P. aeruginosa strains used were wild type PA14 (41) and the mutant ∆phz1/2 (24), which 
has clean deletions in the phzA1B1C1D1E1F1G1 and phzA2B2C2D2E2F2G2 operons and does 
not produce endogenous phenazine-1-carboxylic acid. These strains were cultured as previously 
described (5) (repeated here from Chapter 4). For routine culturing, P. aeruginosa was 
maintained with lysogeny broth containing 10 g/L tryptone, 5 g/L yeast extract, and 10 g/L 
sodium chloride. Solid agar plates contained 15 g/L agar. The minimal medium contained 14.15 
mM KH2PO4, 35.85 mM K2HPO4, 42.8 mM NaCl, 9.3 mM NH4Cl, 1 mM MgSO4, 7.5 μM 
FeCl2·4H2O, 0.5 μM ZnCl2, 0.5 μM MnCl2·4H2O, 0.1 μM H3BO3, 0.8 μM CoCl2·6H2O, 0.01 μM 
CuCl2·2H2O, 0.1 μM NiCl2·6H2O, and 0.15 μM Na2MoO4. The minimal medium was sterilized 
by autoclaving; to avoid precipitation, the metals were prepared as a separate solution (1000×) 
and added immediately prior to inoculation. The carbon source was also added after autoclaving 
(to a final concentration of 20 or 50 mM glucose, 30 mM disodium succinate, 20 mM sodium 
gluconate, or 20 mM mannitol). 
For metabolite analysis, a 5-mL culture was grown overnight to an OD500 of at least 1.0. The 
culture was then diluted to an OD500 of 0.01 in 50 mL of fresh medium in a 250-mL flask (VWR 
#10536-914 or Fisher #FB500250) covered with aluminum foil. All liquid cultures were incubated 
in a New Brunswick Innova 44R incubator at 37 °C shaking at 250 rpm (2.54 cm stroke length). 
Ion Chromatography 
Ion chromatography was performed as previously described (1) (Chapter 3). 
Organic Acid Analysis 
For sample collection, 1 mL of culture was centrifuged for 2 min at 16,873×g. To inhibit microbial 
growth, 600 μL of sample was mixed with 600 μL of 2% phosphoric acid. The sample was 
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incubated at 4 °C and precipitated material (primarily phenazine-1-carboxylic acid) was removed 
by additional centrifugation for 2 min at 16,873×g, and 1 mL of the supernatant was transferred 
to an HPLC sample vial. 
Analysis was performed using a Beckman Gold HPLC equipped with a model 126P solvent 
module, a model 168 photodiode array detector, and a model 508 autosampler. The column used 
was an Aminex HPX-78H (Bio-Rad) ion exclusion column (7.8×300 mm, 9 μm particle size). 
Organic acids were separated isocratically at 0.4 mL/min using 5 mM H2SO4 in water with a 
sample injection volume of 20 μL. Detection was performed at 206 nm referenced to 260 nm. The 
total run time per sample was 30 min. Similar separations could be performed on an Agilent 1100 
system as described previously (1) (Chapter 3) or on a Waters Alliance system with a 2695 
separations module and a 2998 photodiode array detector. An eluent with 0.2% phosphoric acid 
performed similarly to 5 mM sulfuric acid on the Alliance system. 
Supernatant Analysis 
To analyze other compounds in culture supernatants, samples were collected as for organic acid 
analysis except that 2% formic acid was used instead of 2% phosphoric acid. Analysis was 
performed using a Waters Alliance system with a 2695 separations module, a 2998 photodiode 
array detector, and a QDa quadrupole mass spectrometer detector (connected to the outlet of the 
photodiode array detector). The column used was a Waters Atlantis T3 C18 column (2.1×100 
mm, 3 μm particle size) equipped with a VanGuard cartridge holder and Atlantis T3 VanGuard 
cartridge. The injection volume was 5 μL and the flow rate was 0.3 mL/min. Solvents A and B both 
contained 10 mM ammonium formate adjusted to pH 3.0 with formic acid, with A being 100% 
water and B being 20% water and 80% acetonitrile. Compounds were eluted using a linear 
gradient of 0% to 100% B over 0–10 min, 100% B over 10–12 min, and 0% B over 12–20 min. 
UV–vis data were collected from 200 to 600 nm on the 2998 photodiode array detector. Mass 
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scans from 50 to 700 Da in both positive and negative ionization modes were collected 
simultaneously using the QDa detector with a cone voltage of 5 V and a capillary voltage of 1.5 
kV. The instrument was controlled using the software Empower (Waters). 
Supernatant Analysis by High Resolution LC-MS/MS 
Representative samples from the culture supernatants were additionally analyzed on a Waters 
Acquity I-Class system with an Acquity UPLC PDA detector and a Xevo G2-XS QToF mass 
spectrometer. The column used was a Waters Acquity HSS T3 column (2.1×100 mm, 1.8 μm 
particle size). The injection volume was 2 μL and the flow rate was 0.3 mL/min. The column was 
maintained at 30 °C using an Acquity UPLC column heater. Solvent A was 0.1% formic acid in 
water and solvent B was 0.1% formic acid in acetonitrile. Compounds were eluted using a linear 
gradient of 0% to 90% B over 0–5 min, 90% B over 5–5.5 min, and 0% B over 5.5–8 min. UV–vis 
data were collected from 200 to 500 nm on the PDA detector. Mass scans from 50 Da to 800 Da 
in positive and negative ionization modes were collected in separate runs using the Xevo QToF 
detector with a cone voltage of 15 V and a capillary voltage of 2.5 kV. A second data channel was 
also simultaneously collected using a collision energy of 30 eV. The desolvation temperature was 
550 °C and the desolvation gas flow rate was 800 L/h. A solution of 20 pg/μL leucine enkephalin 
was used as the LockSpray solution. The instrument was controlled using the software MassLynx 
(Waters). 
Intracellular Metabolite Analysis 
To minimize metabolic perturbations during extraction, P. aeruginosa was cultured on filter discs 
similarly to a previously described method for E. coli (39), except that a smaller 47 mm Nylon 
filter with a 0.2 μm pore size (Millipore) was used. Cultures were grown in minimal medium 
containing 20 mM glucose as described above, and 2 mL of culture was filtered onto the disc. The 
disc was then placed onto an agar plate containing minimal medium with 20 mM glucose and 15 
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g/L noble agar. Filter cultures were grown for 4 h or 18 h at 37 °C. Metabolite extraction was 
performed using a mixture of 20:40:40 water:methanol:acetonitrile with 1% formic acid, similar 
to the previously described method (39). The filters were placed cell-side down into a dish 
containing 2 mL of extraction solution at −20 °C. After 15 min of incubation in the freezer, the 
solution was collected, centrifuged for 5 min at 16,873×g at 4 °C, and 1 mL was transferred to an 
autosampler vial. 
Metabolite analysis was performed on the same Waters Acquity system with a Xevo G2-XS QToF 
detector. The column used was a Phenomenex Luna NH2 column (2.0×150 mm, 3 μm particle 
size). The injection volume was 5 μL and the flow rate was 0.25 mL/min. The injection purge 
solution was 80:20 acetonitrile:water. Solvent A was 20 mM ammonium acetate and 40 mM 
ammonium hydroxide (pH ~9.6) in 90% water and 10% acetonitrile. Solvent B was 20 mM 
ammonium acetate and 40 mM ammonium hydroxide in 20% water and 80% acetonitrile. 
Compounds were eluted using a linear gradient of 85% to 0% B over 0–10 min, 0% B over 10–20 
min, and 85% B over 20–30 min. 
Data Analysis with XCMS 
The XCMS package (13) was used to identify differences between duplicate pyocyanin treated 
and untreated ∆phz1/2 cultures. Lock mass corrected chromatograms were exported using 
DataBridge (Waters) to the CDF format for processing by XCMS. Mass peaks were identified 
using the centWave method with a peak width of 5–10 s, noise cutoff of 1000, a signal-to-noise 
cutoff of 100, and a ppm setting of 10. Retention times were corrected by allowing up to 4 missing 
or extra peaks. 
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C h a p t e r  6  
PYOCYANIN DEGRADATION 
This chapter is adapted from: 
Costa, K. C., Glasser, N. R., Conway, S. J., and Newman, D. K. (2017) Pyocyanin degradation by 
a tautomerizing demethylase inhibits Pseudomonas aeruginosa biofilms. Science 355 (6321), 170-
173. 
My specific contributions were assisting with the PodA protein crystallization and solving the X-
ray crystal structure. 
Abstract 
The opportunistic pathogen Pseudomonas aeruginosa produces colorful redox-active metabolites 
called phenazines, which underpin biofilm development, virulence and clinical outcomes. Though 
phenazines exist in many forms, the best studied is pyocyanin. Here, we describe pyocyanin 
demethylase (PodA), a hitherto uncharacterized protein that oxidizes the pyocyanin methyl 
group to formaldehyde and reduces the pyrazine ring via an unusual tautomerizing demethylation 
reaction. Treatment with PodA disrupts P. aeruginosa biofilm formation similarly to DNase, 
suggesting interference with the pyocyanin-dependent release of extracellular DNA into the 
matrix. PodA-dependent pyocyanin demethylation also restricts established biofilm aggregate 
populations experiencing anoxic conditions. Together, these results show that modulating 
extracellular redox-active metabolites can influence the fitness of biofilms. 
Main text 
Bacteria from phylogenetically diverse taxa secrete colorful redox-active metabolites, such as the 
well-studied phenazines produced by multiple species, including Pseudomonas aeruginosa (1, 2) 
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(Fig. 1A,B). Phenazines can be toxic to other cells but also benefit their producers by facilitating 
extracellular electron transfer and survival in anoxic environments (3-6). These latter functions 
support the growth of antibiotic-resistant biofilms, and P. aeruginosa mutants that cannot make 
phenazines are defective in biofilm development (5). Accordingly, we reasoned that selectively 
manipulating phenazines might present a means to control biofilms. One way to influence 
extracellular metabolites is through active modification or degradation by other organisms (7-9). 
Recently, we described a group of mycobacteria that enzymatically degrade phenazines and 
identified genes that catalyze distinct steps in degradation (9). Here, we focus on the structure 
and function of a previously uncharacterized protein from Mycobacterium fortuitum encoded by 




Figure 1. Biochemical analysis of the PodA reaction. PodA catalyzes the demethylation 
of PYO (A) to reduced 1-OH-PHZ (B). (C) PodA30-162 purifies as a trimer by gel 
filtration chromatography (45.6 kDa). Inset is a denaturing gel demonstrating the size 
of monomeric PodA30-162. Incubations of PodA30-162 with PYO show the conversion of 
the starting material (D) to 1-OH-PHZ and formaldehyde (E). Data are average 
measurements from six reactions and error bars represent one standard deviation 
around the mean. Formaldehyde is derivatized to facilitate detection; the 
derivatization competes with other compounds in the mixture so stoichiometric 
production was not observed. (F) PodA30-162 is active under anoxic conditions, and the 
PYO containing reaction mixture fluoresces under UV illumination. This fluorescent 
product has an emission spectrum (250 nm excitation) consistent with a reduced 
phenazine (G). While both reduced PYO and 1-OH-PHZ have similar emission 
maxima (50 μM phenazine), the magnitude of the peak is consistent with the 
generation of reduced 1-OH-PHZ by PodA30-162. 
 
To characterize its activity, we purified a heterologously expressed, truncated version of this 
protein (lacking a predicted N-terminal, membrane-spanning helix (10)), hereafter referred to as 
PodA30-162 (PYO demethylase), from Escherichia coli (Fig. 1C). PodA30-162 converts PYO to 1-
hydroxyphenazine (1-OH-PHZ) and formaldehyde (Fig. 1D,E), indicating that it functions as a 
demethylase. Generally, enzyme-catalyzed N-demethylations proceed by oxidation of the methyl 
group to formaldehyde with electron transfer to a bound cofactor or iron-sulfur cluster (11, 12). 
Surprisingly, we found that PodA30-162 generates 1-OH-PHZ in the absence of either flavin or 2-
oxoglutarate, which are required for most known N-demethylases (Fig. S1). Additionally, PodA30-
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dependent Rieske-iron type demethylases (13). Kinetic analysis suggests that PodA is a high 
affinity PYO demethylase (Km < 1 μM and kcat = 1.20 ± 0.07 s−1) that operates over a wide regime 
of pH (<4.9–8.7) and salt concentrations (0–400 mM) (Fig. S2) with specificity for N-
methylated phenazines (Fig S3). Under anoxic conditions, PodA30-162 catalyzes the formation of a 
reduced phenazine, suggesting that its substrate serves as the electron acceptor (Fig. 1F,G). This 
mechanism has not previously been observed for demethylases (11, 12). We propose the 
following reaction for PodA, wherein oxidized PYO (PYOox) is converted to reduced 1-OH-PHZ 
(1-OH-PHZred) (Fig. 1A,B):  
C13H10N2O (PYOox) + H2O ⟶ C12H10N2O (1-OH-PHZred) + CH2O 
To test this model and better understand how PodA30-162 reduces its substrate, we solved the X-
ray crystal structure at 1.8 Å resolution (Table S1) by molecular replacement using a search model 
generated by Robetta (14-16) (Fig. S4). PodA30-162 crystalized as a trimer in the asymmetric unit 
(Fig. 2A). Crystal formation occurred only in the presence of 1-OH-PHZ, which was visible in a 
putative solvent-exposed active site (Fig. 2B,C). We found no evidence of a bound cofactor or 
metals in the electron density of the active site (Fig. S5) further supporting the hypothesis that 
PodA catalyzes a novel demethylation reaction. Within the active site, there are several charged 
and polar residues (D68, D72, H121, E154, and Y156) and a nearby disulfide that are candidate 
catalytic residues (17); additionally, 1-OH-PHZ appears to bind via a π-π stacking interaction 














































































































































Figure 2. 1.8 Å crystal structure of PodA30-162. (A) View of the PodA30-162 trimer with 1-
OH-PHZ bound. The PodA active site (B) is solvent exposed (C) and contains 
charged and polar residues. There is a nearby disulfide ~3.5 Å from 1-OH-PHZ. (D) A 
proposed reaction mechanism based on the residues present in the active site. The 
model predicts that D72, E154, and Y156 are necessary for methyl deprotonation. 
H121 protonates the unmethylated N atom of the pyrazine ring, and D68 reprotonates 
H121. Formation of the negatively charged phenolate ion promotes product release 
due to an unfavorable electrostatic interaction (red dashed circle). D72 and E154 
remain protonated, acidifying the active site to assist in formation of hydroxylated PYO 
(Fig. 1A) in the next catalytic cycle. (E) Hydrolysis of the product is spontaneous and 
occurs after release from the active site. 
Based on the active site structure, we propose a mechanism relying on the presence of H121 
functioning as an acid and D72, E154 and Y156 collectively functioning as a base (Fig. 2D). PYO 
binds in the phenol tautomeric form (Fig. 1A). Deprotonation of the methyl group results in 
iminium ion formation and concomitant reduction of the pyrazine ring, with the second nitrogen 
atom protonated by H121. H121 is then reprotonated by PYO’s hydroxyl group (pKa of His ~6 
versus PYO ~5). The unfavorable interaction between the negatively charged phenolate ion and 
D68 drives product release. We hypothesize that PodA catalyzes the tautomerization of PYO to 
an iminium ion that is susceptible to hydrolysis outside of the enzyme: the structure indicates that 
the active site cannot accommodate both the substrate and a water molecule (Fig. 2B–E) (11). 
D72 and E154 remain protonated in this scenario, acidifying the active site, perhaps to ensure that 
PYO is in the hydroxylated form in subsequent reaction cycles (Fig. 1A). This scheme highlights 
the significance of the hydroxyl group of PYO to recharge PodA for subsequent reaction cycles 
and to drive product release. An alternative substrate, methoxyphenazine methosulfate (methoxy-
PMS), which lacks the hydroxyl group, displays an initial burst of activity followed by a slower 
steady state (Fig. 3A), which is consistent with our model.  
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Figure 3. Molecular analysis of the PodA reaction mechanism. (A) An alternative 
substrate — methoxy-PMS, inset — is demethylated by PodA30-162, but the reaction 
rate slows significantly after an initial burst, highlighting the importance of the hydroxyl 
group of PYO for catalysis and/or driving product release after deprotonation. Data 
are averages from triplicate measurements and error bars represent one standard 
deviation from the mean. (B) Residues in the PodA active site (Fig. 2B) were mutated 
and the resulting proteins purified; H121A, D68A, E154A, D72N, Y156F, and the 
C88A, C102A (C to A) double mutant all purify as a trimer by gel filtration 
chromatography. (C) Mutant proteins were pure as assayed by reducing SDS-PAGE. 
(D) Activity of mutant proteins shows that the disulfide bond is not essential for 
activity. Y156F has ~25% wild type activity, and all other residues appear essential for 
catalysis. 
To probe the proposed mechanism, we performed mutagenesis for each of the putative catalytic 
residues. H121A, E154A, D68A, and D72N mutants all formed a trimer (Fig. 3B,C) but had <10% 
wild type activity, consistent with the postulated catalytic mechanism (Fig. 3D). Y156F formed a 
trimer but retained ~25% wild type activity, consistent with this residue facilitating proton transfer 
to D72 and E154 but not being essential. A possible alternative mechanism could utilize the 
disulfide in the active site forming a covalent adduct with the phenazine, in analogy to some 
flavoproteins (18). However, our mutagenesis results indicate that the disulfide bond near the 
active site is not essential for catalytic activity although it may be important for structural stability 



























































































Because PodA requires only water and substrate for activity (Figs. 2D,E, S1, and S2), we 
hypothesized that it could degrade PYO during active production by P. aeruginosa (Fig. S7). 
PodA30-162 addition to P. aeruginosa planktonic culture results in the conversion of PYO to 1-OH-
PHZ in both rich and minimal medium (Fig. S8). Encouraged by these findings, we assessed the 
impact of PodA on biofilm formation. Extracellular DNA (eDNA) comprises >50% of the P. 
aeruginosa biofilm matrix (19), and recently PYO was shown to drive eDNA release (20, 21) 
which is important early in biofilm development (19). We hypothesized that PodA30-162 might 
inhibit P. aeruginosa biofilms in part by attenuating DNA release, thereby removing an important 
matrix component and changing biofilm architecture. Because PYO does not completely block 
DNA release (20, 21), it is also possible that downstream PYO-DNA interactions may be 
important. We checked whether PodA30-162 could access PYO in the presence of DNA, as PYO is 
a known DNA intercalator (22); PodA30-162 catalyzed PYO demethylation in this context (Fig S8). 
We grew P. aeruginosa biofilms for 5 hours, staining them with DAPI to image biofilm structure. 
HPLC analysis of supernatants confirmed the conversion of PYO to 1-OH-PHZ by PodA30-162 in 
these cultures (Fig. 4A). Overall biofilm formation, as assayed by surface coverage (22), was 
reduced by PodA30-162 but not by the inactive PodA control (Fig. 4B-D), consistent with a role for 
PYO in early biofilm development. As previously shown, treatment with DNase independently 
inhibited biofilms (22). Interestingly, DNase or PodA30-162 treatment inhibited biofilms to the 
same extent, and dual treatment did not have an additive effect (Fig. 4D). 
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Figure 4. PodA30-162 inhibits biofilm formation and anoxic fitness of P. aeruginosa. (A) 
Phenazines were measured by HPLC in biofilm supernatants after 5 hours of growth. 
PCA, phenazine-1-carboxylic acid. (B) P. aeruginosa forms a robust biofilm in the 
presence of inactivated PodA30-162 after 5 hours. (C) In the presence of PodA30-162, 
biofilm surface coverage was decreased. Surface coverage was 43.5 percent compared 
with 82.7 percent in the absence of PodA30-162 in the representative images shown. Scale 
Bars = 20 μm. (D) Surface coverage was lower in the presence of PodA30-162 (p < 10−6 
vs. PodA-inactive, two-tailed Student’s t-test). DNase addition decreased surface 
coverage (p < 10−3 vs. PodA-inactive), but DNase and PodA30-162 combined did not 
have an additive effect (p > 0.05), consistent with an interaction between PYO and 
eDNA in supporting biofilms (22). Data are averages of 12 replicates taken from 
independent cultures. Error bars represent one standard deviation around the mean. 
∆phz, PA14 mutant incapable of making phenazines. (E) Top down and (F) side views 
of P. aeruginosa grown embedded in 0.5% agar blocks for 27 hours. Scale bars = 200 
μm. Oxygen depletion occurs at lower depths as a result of biological consumption 
outpacing diffusion from the surface, resulting in decreased biomass. (G) Oxygen 
diffusion model predicting the shape of the oxycline in agar blocks. Cell densities were 
estimated at 108.7 cells mL-1 based on aggregate number and volume. Modeling this 
concentration and 2-fold higher and lower densities suggests that oxygen depletion 
occurs ~300 μm ± 100 μm below the agar surface. Dashed red line indicates the 
approximate oxic-anoxic interface. (H) Biofilm aggregates detected at 10 μm 
increments below the agar surface. At depths near the oxic/anoxic interface (dashed 
red line), total biomass begins to decline. In assays treated for the last 5 hours with 
PodA30-162, there is an apparent biomass defect specifically at anoxic depths compared 
to untreated and inactive PodA treated controls, consistent with the importance of 
PYO for anoxic survival in P. aeruginosa. Data are averages of six independent 
experiments and error bars represent one standard deviation around the mean. Open 
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In addition to impacting early stages in biofilm development, phenazines can expand the habitable 
zone within established biofilms (5, 23). As P. aeruginosa biofilms mature, cells in deeper layers of 
the biofilm begin to experience oxygen limitation and redox stress (4, 23); these cells are believed 
to be slow growing and are highly resistant to antibiotics (24). Phenazines facilitate anoxic survival 
and alleviate redox stress (3, 25). Because PYO reacts with oxygen more efficiently than 1-OH-
PHZ (26), we hypothesized that PodA activity might decrease anoxic fitness by disrupting PYO 
dependent electron shuttling to oxygen. To capture key features of in vivo biofilm aggregates (27, 
28), cells were grown suspended in agar blocks at 37 °C for 22 hours to establish an oxygen 
gradient before a 5 hour treatment with PodA30-162 (Fig. 4E,F). Owing to constraints imposed by 
the incubator, we were unable to measure oxygen gradients directly, so we used a previously 
validated model to estimate the oxic-anoxic transition zone (29). Modeling our aggregate 
population indicated that anoxia occurs ~300 μm below the surface as a result of microbial 
consumption (Fig. 4G), consistent with what is known about oxygen diffusion into in vivo biofilms 
(29). We observed a decrease in detectable aggregates at depths 300–400 μm below the agar 
surface; additionally, cultures treated with PodA30-162 had a sharper decline in detectable 
aggregates below this depth (Fig. 4H). There was no significant difference in aggregate numbers 
above the predicted oxic-anoxic transition zone. How PYO demethylation restricts the aggregate 
population is unknown. 
In conclusion, the discovery of a PYO demethylase that simultaneously catalyzes substrate 
reduction shows that redox-active pigments can participate in their own enzyme-catalyzed 
modification. Though PodA is the first member of a new class of tautomerizing demethylases that 
utilizes an oxidized substrate as the electron acceptor, this reaction is reminiscent of reduced flavin 
acting as the electron donor in its own destruction in vitamin B12 biosynthesis (30). It seems likely 
that the processing of other redox-active pigments and cofactors may operate by a similar 
mechanism where the redox activity of the substrate enables catalysis. That PodA can inhibit P. 
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aeruginosa at different stages of biofilm development raises the possibility that selective 
degradation of extracellular electron shuttles may facilitate treatment of intractable infections. 
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SUPPLEMENTAL MATERIAL 
Materials and Methods 
Strains, medium and growth conditions. 
Primers, strains and plasmids are listed in Table S2 (31-33). All expression constructs were 
derivatives of the IPTG inducible plasmid pET-20b(+) (Novagen). The gene for 
MFORT_14352 lacking the N-terminal 29 amino acids (podA30-162) was PCR amplified from 
Mycobacterium fortuitum ATCC 6841 using primers listed in Table S2 and first placed into the 
NdeI and PstI sites of plasmid pSD5 (34) to verify expression of a His tag construct in a vector we 
used previously for podA expression in Rhodococcus sp. JVH1 (9). Primers encoded both a TEV 
protease cleavage site and a 6x-His tag on the C-terminus. Activity was observed in the Escherichia 
coli cloning strain, so we transferred the podA30-162 construct to an E. coli expression vector for 
further analysis. PCR product was digested with NdeI and NotI and ligated into digested pET-
20b(+) before transfer into E. coli BL21(DE3) cells by electroporation (33). Mutant proteins 
were generated by PCR amplifying pET-20b(+) containing podA30-162 with primers encoding the 
relevant mutation (Table S2). Product was cut with DpnI to remove WT vector, phosphorylated 
with T4 polynucleotide kinase, and ligated to generate a circular mutant protein expression 
construct. For D72N and Y156F mutants, DNA fragments encoding the mutation were 
synthesized (Integrated DNA Technologies) and cloned into pET-20b(+) as for the wild type 
sequence. Enzymes for cloning were purchased from New England Biolabs. Constructs were 
transferred to E. coli BL21(DE3) for expression. All mutations were confirmed by Sanger 
sequencing (Laragen and Retrogen). When necessary, 100 μg mL-1 carbenicillin was included in 
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all growth media to maintain selection for the plasmid. To measure the effect of PodA30-162 on 
phenazine production in planktonically grown P. aeruginosa, cultures were grown overnight in 5 
mL volumes of tryptic soy broth (TSB) or succinate minimal medium (arginine medium recipe 
from Glasser et al., 2014 with 40 mM sodium succinate in place of arginine) (3) in the presence 1 
μg mL-1 PodA30-162. Cells were removed by centrifugation and supernatants were analyzed by 
HPLC as previously described (9). See below for a description of biofilm growth of P. aeruginosa 
PA14. 
To induce protein expression, an overnight culture was inoculated 1/1000 in Terrific Broth (BD 
Difco). Cultures were grown in baffled Erlenmeyer flasks (1 L culture per 3 L flask) at 37 °C with 
150 rpm agitation in a shaking incubator (Innova 44 shaking incubator, New Brunswick). After 
3-4 hours, the temperature was changed to 16 °C and cultures were induced with 50 μM (final 
concentration) IPTG and left to incubate overnight. Cells were then pelleted by centrifugation, 
flash frozen in liquid N2, and stored at −80 °C for up to 1 month before protein purification. 
Generation and analysis of phenazines 
Pyocyanin (PYO) was purified directly from cultures of P. aeruginosa PA14 grown on succinate 
minimal medium using a previously established protocol (31). Briefly, culture supernatants were 
first extracted with 0.4 volume dichloromethane (DCM). DCM extracts were treated 1:1 with 
0.01 M HCl to acidify PYO and extract it back into the aqueous phase. Finally, 1 M NaOH was 
added to pH7, and PYO was extracted back into DCM and dried in vacuo. This crude preparation 
was used for routine analysis of FPLC fractions for activity. To further purify PYO, extracts were 
dried and purified by reverse phase HPLC as described (26, 31). 1-hydroxy-phenazine (1-OH-
PHZ) was manufactured by TCI America. Phenazine-1-carboxylic acid (PCA) and phenazine-1-
carboxamide (PCN) standards were purchased from Princeton Biomolecular Research, Inc. 
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Phenazines from culture supernatants were analyzed and measured by HPLC as described 
previously (6, 9). 
Protein extraction and purification 
Frozen cell pellets were thawed at room temperature and suspended in 25 mL wash buffer (200 
mM KCl, 20 mM imidazole, Tris, pH 7.6). Cell suspensions were homogenized in an Emulsiflex 
device (Avestin). Cell debris was removed by centrifugation (Avanti J-25 centrifuge, J-series JA-
25.50 rotor, Beckman-Coulter) at 50,000 xg and supernatant was applied to a nickel GE 
Healthcare HisTrap HP 5 mL nickel column on a GE Healthcare ÄKTAxpress FPLC. All protein 
purification steps were carried out at room temperature. The column with bound protein was 
washed with wash buffer until the UV (280 nm) trace stabilized below 20 mAU. Proteins were 
eluted across a gradient of 20-500 mM imidazole applied over 10 column volumes. PYO 
demethylase activity generally eluted around 300 mM imidazole. Eluted protein was concentrated 
to ~3 mL (Amicon Ultra-15 centrifugal filters, Ultracel 3K MWCO) and treated overnight with 
1% wt/wt TEV protease (35) while dialyzing (Spectra/Por Biotech Dialysis membrane, MWCO: 
3.5-5 kD) into buffer containing 200 mM KCl and 20 mM Tris, pH7.6 at 4 C. Samples were run 
back through the nickel column and PYO demethylase activity was collected in the flow through. 
Protein was concentrated to 250-500 μL (Amicon Ultra – 0.5 mL centrifugal filters, Ultracel – 3K 
MWCO) and loaded on a GE Healthcare HiLoad 16/60 Superdex 200 prep grade gel filtration 
column and run at 1 mL min-1 with gel filtration buffer (100 mM CaCl2, 20 mM Tris, pH 7.6). 
CaCl2 in the buffer was necessary for maximal PodA30-162 activity. Activity eluted after ~83 mL. For 
applications requiring highly purified PodA30-162 (e.g., crystallography), an acid precipitation step 
(400 mM phosphate/citrate, pH 4.2) was added either before or after gel filtration 
chromatography to precipitate trace contaminants that were not apparent by SDS-PAGE. PYO 
demethylase activity remained in the supernatant. For acid precipitation, sample was dialyzed into 
20 mM Tris, pH 7.6 between steps to avoid mixing CaCl2 and phosphate buffers. Purified PodA30-
161 
162 was dialyzed into 20 mM Tris, pH7.6 and stored at 4 °C; protein remained stable with no 
apparent loss of activity for as long as tested (up to 4 months). To determine the approximate 
molecular weight of purified proteins, the elution peak was compared to Bio-Rad gel filtration 
standards run across the same column with gel filtration buffer. Mutant proteins were purified on 
the same day as wild type and fractions where activity was seen in wild type were also collected for 
mutant preparations. Protein quantification was carried out by Bradford assay (36) (Quick Start 
1x Bradford Dye Reagent, Bio-Rad) using pre-diluted Bovine Serum Albumin standards (Thermo 
Scientific) to establish a standard curve. A purification from 6 liters of culture typically yielded 1-
2 mg protein. Purified proteins were routinely subject to SDS-PAGE using 4-20% Mini-
PROTEAN TGX precast protein gels (Bio-Rad) and stained with Coomassie Blue. All protein 
preparations were colorless, indicating that flavins were not present in the purified protein. 
Enzyme activity and analysis 
PYO demethylation by PodA30-162 was first determined by HPLC analysis as described previously 
(6, 9). To detect formaldehyde evolution, 150 nM protein was mixed with 50 μM PYO in 1 mL 
of 20 mM Tris pH 7.6 amended with 200 μL Nash reagent (2 M ammonium acetate, 50 mM acetic 
acid, 20 mM acetylacetone) and incubated at 55 °C until the reaction proceeded to completion 
(37, 38). The products were determined by HPLC using the same method as used for phenazine 
quantification. To monitor the formation of reduced phenazine, protein and 50 μM PYO were 
placed into an anaerobic chamber (Coy Laboratory Products) under an atmosphere of H2/N2 
(5:95) and left overnight before allowing the reaction to proceed. To generate reduced PYO and 
1-OH-PHZ, 50 μM were mixed with 1 mM sodium dithionite. The formation of reduced 
phenazine products was assayed visually under UV illumination (39). A BioTek Synergy 4 
microplate reader (BioTek) plate reader in the anaerobic chamber was used to measure the 
emission spectrum of products with excitation at 250 nm.  
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To determine the activity of PodA30-162 in the presence of glycerol, salts, or varying pH, 30 nM 
protein was suspended in 500 μL buffer, 40 μM PYO was mixed with 2x solution containing the 
buffer of interest (500 μL), and solutions were preheated to 30 C. For pH range measurements, 
the following buffers were used (40 mM, adjusted with KOH): acetic acid, pH 4.9; MES, pH 5.4 
and 5.7; HEPES, pH 6.1; Tris, pH 6.9 and 7.5; Bicine, pH 7.8, 8.3 and 8.7; CHES, pH 9.4. To 
measure reaction rates, cuvettes containing the 2x PYO solution were placed in an Evolution 
260Bio UV-Vis spectrophotometer (Thermo Scientific) and 500 μL of 30 nM protein was added 
at time 0 (15 nM protein and 20 μM PYO, final concentration). Reaction progress was monitored 
by measuring absorbance at 313 nm (40) every 0.5 seconds for 5 minutes. To measure kinetic 
parameters (kcat, Km) 15 nM protein was used in a reaction buffer of Bicine, pH 7.8; reactions were 
monitored as before with measurements every 0.2 seconds. The rate from the first 10 seconds of 
the reaction was used for the determination of kinetic parameters. Kinetic parameters were 
calculated in Microsoft Excel using the Solver plug-in and fitting data to ideal Michaelis-Menten 
plots with non-linear regression of experimental data (41). For measurements of the rate of 
methoxy-PMS demethylation, 300 nM protein was used and methoxy-PMS loss from the reaction 
mixture was monitored at 500 nm wavelength. methoxy-PMS was purchased from TCI America. 
For assays with mutant proteins, 60 nM protein was used. The stimulatory effects of flavin or 2-
oxoglutarate addition was determined by adding 25 μM flavin or 2-oxoglutarate to 20 μM PYO 
and 15 nM PodA30-162 and monitoring the reaction. 
Experiments testing alternative substrates were carried out using in 1 mL reaction volumes 
containing 20 mM Tris (pH 7.6) and 50 μg mL-1 PodA30-162. Alternative substrates tested were 10-
methylphenothiazine (Alfa Aesar), phenazine methosulfate (Alfa Aesar), methoxyphenazine 
methosulfate (TCI America), and 4-keto-N-ethylphenazine. 4-keto-N-ethylphenazine was 
synthesized from phenazine ethosulfate (Sigma-Aldrich) by incubating under fluorescent light 
overnight followed by purification by HPLC as described (6, 42). As phenazine methosulfate is 
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light sensitive and spontaneously converts to PYO in the presence of light, all reactions were 
carried out in the dark, and activity was assessed by end point analysis by HPLC after 4 hours (9). 
Protein crystallography, X-ray diffraction and analysis 
Crystallization screens were performed with the JCSG+ screen (Molecular Dimensions) using 
vapor diffusion in sitting drop format with assistance from the California Institute of Technology 
Molecular Observatory. A Crystal Gryphon liquid-handling robot (Art Robins) was used to mix 
0.2 μL of screen solution with 0.2 μL of protein solution (5 mg mL-1 in 20 mM Tris, pH 7.6 
amended with 200 μM 1-OH-PHZ in DMSO (1% final concentration)). Crystals formed in 
JCSG+ conditions C1, C6, and D12 after 3 days at 20 °C. Varying the salt and polymer 
concentrations in a 24-well plate showed that JSCG+ condition C1 gave robust crystal growth in 
vapor diffusion sitting drop format using 2 μL drops in Micro-Bridges (Hampton Research). 
Protein (5 mg mL-1) was mixed with mother liquor (1μL:1μL) composed of 20% w/v PEG 8000, 
200 mM NaCl, 200 μM 1-OH-PHZ, 1% DMSO, and 100 mM sodium phosphate dibasic/citric 
acid, pH 4.2. Crystals generally formed within 3 days at 20 °C and were rod shaped with typical 
dimensions of 50 x 50 x 100 μm. Crystals were equilibrated into a cryoprotectant solution (12% 
w/v PEG 8000, 20% w/v PEG 300, 100 mM NaCl, 100 μM 1-OH-PHZ, 0.5% DMSO, and 50 
mM sodium phosphate dibasic/citric acid, pH 4.2) by gradually replacing the sitting drop solution 
with cryoprotectant solution over the span of 10–15 minutes. Crystals were then mounted in a 
nylon loop and flash frozen in liquid nitrogen. 
Data collection was performed at 100 K at the Stanford Synchrotron Radiation Lightsource 
(SSRL) beamline 12-2 equipped with a PILATUS 6M Pixel Array Detector. X-ray diffraction data 
were collected at 12,000 eV with a beamstop distance of 32.7 mm and a detector distance of 280 
nm. Images were collected every 0.15° for a full 360° of rotation around a single axis (generating a 
total of 2400 images). For well-diffracting crystals, an additional dataset was collected at 7,000 eV 
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to capture the anomalous signal from sulfur and calcium. Diffraction images were integrated and 
scaled using the XDS package (43). To ensure maximum data completion, the two highest quality 
datasets were combined using XSCALE and further processed using POINTLESS, AIMLESS and 
CTRUNCATE in the CCP4 software suite (44-48). The structure was solved by molecular 
replacement in PHASER (49) using a search model derived from a structural prediction by 
Robetta (14-16) with disordered loops trimmed in Coot (50). A preliminary model was 
constructed using phenix.AutoBuild (51) and refined using phenix.refine (52, 53) and model 
building in Coot to yield a model with Rfree = 0.22. LigandFit (54, 55) analysis in PHENIX (56) 
was used to model 1-OH-PHZ into the active site of PodA30-162 with refinement restraints 
generated using elBOW (simple optimization method) (57). The model was modified in Coot to 
trim side chains with poor electron density coverage. A highly coordinated water molecule was 
identified by phenix.refine as a potential calcium atom, presumably originating from the inclusion 
of 100 mM CaCl2 during the final protein purification step. Analysis of the anomalous difference 
map from a low-energy dataset supported this identification (Fig. S5) and so the corresponding 
water molecules were replaced with calcium atoms and metal-coordination restraints were 
generated with phenix.metal_coordination via ReadySet!. The final rounds of refinement were 
performed using TLS groups (58) generated by phenix.refine and hydrogen atoms set in their 
riding positions to yield a final model of Rfree = 0.195. Figures were rendered with PYMOL version 
1.7.2.1, Schrödinger, LLC. 
Biofilm experiments 
For all experiments involving inactivated PodA, either the E154A mutant or PodA30-162 that was 
subjected to a 1 hour treatment at 98° C was used. To test the ability of PodA30-162 to degrade PYO 
in the presence of DNA, genomic DNA (gDNA) from P. aeruginosa PA14 was used in modified 
versions of previously described assays (59). For experiments using DNA pellets, 0.5 mg of gDNA 
was pelleted in the presence of 300 mM sodium acetate, pH 5.2 and 70% ethanol. Pellets were 
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washed with 70% ethanol and dried. 200 μL of 800 μM PYO was added to the gDNA pellet 
without mixing and left to sit at room temperature for 6 hours to allow for diffusion of PYO into 
the gDNA pellet. The pellet was washed once with 70% EtOH, and submerged in a solution 
containing 10 mM Tris, pH 7.0 and 40% isopropanol. The pellet remained blue, consistent with 
an association of PYO with DNA. PodA30-162 was added to the isopropanol solution to a final 
concentration of 2 μg mL-1 and left to sit for 3 hours to allow for the reaction to proceed. Tubes 
were imaged before and after PodA30-162 treatment. For experiments using solubilized gDNA, a 
400 μg mL-1 solution of gDNA was mixed with PYO and allowed to equilibrate for 6 hours. The 
PYO gDNA mixture was amended with 1 μg mL-1 PodA30-162 and loss of PYO was monitored on a 
BioTek Synergy 4 microplate reader (BioTek) plate reader at 690 nm. Standards were included 
to quantify PYO loss over time. 
To assess biofilm formation in the presence of PodA30-162, biofilms were grown in Nunc Lab-Tek 
chambered coverglass slides (8-well, 0.8 cm2 area, supplier #155411) using a modified protocol 
(22). PA14 was inoculated into succinate minimal medium and grown overnight to stationary 
phase. Cells were resuspended in fresh medium and diluted to a starting OD500 of 0.5 in succinate 
minimal medium. PodA30-162 (2 μg mL-1, final concentration) or DNase (20 μg mL-1) (22) was 
added and 250 μL was added to each well of the 8-well chambered coverglass. Cultures were 
grown for 5 hours at 37 °C and 100 rpm (Innova 44 shaking incubator, New Brunswick) in a 
humidified chamber. After incubation, liquid was removed from each well by drawing with a pipet 
tip placed in the corner of each well and chambers were washed twice with 400 μL of biofilm wash 
(Tris buffer, pH 7.6 and 100 mM NaCl) to remove planktonic and loosely bound cells. Attached 
biomass was stained by adding 450 μL biofilm wash containing 10 μg mL-1 DAPI (4’,6-diamidino-
2-phenylindole) (Santa Cruz Biotechnology). Surface associated biomass was imaged on a Leica 
TCS SPE confocal microscope with a ACS APO 40x/1.15 oil immersion objective. A 405 nm 
solid-state laser was used for excitation, and data was collected from 420-500 nm. Images were 
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collected from the same relative position in each well along the mid-point of the outer edge on the 
opposite edge from where the washing pipet was placed. Images were collected as 10 μm Z-stacks 
(10 slices) to image the biofilm in its entirety over a surface area of 40,000 μm2. All Z-stacks were 
collected in 8-bit mode with 1024x1024 scan format and a line averaging of 2. A sum intensity 
projection was produced from each Z-stack using ImageJ software (60). Images were then 
thresholded to include pixels with a maximum intensity value >0.15x the maximum possible 
intensity, and thresholded images were used to determine surface coverage of each biofilm. Data 
were collected from 12 biological replicates.  
Biofilm aggregate experiments 
To test the effect of oxygen limitation in the presence of PodA30-162, biofilm aggregates were grown 
embedded in 0.5% noble agar blocks containing succinate minimal medium. Cultures were grown 
overnight to stationary phase in LB, washed once with succinate minimal medium, and 
resuspended to OD600 1.0. Samples were diluted 1:100 in agar at 44°C and 175 μL was transferred 
to Nunc Lab-Tek chambered coverglass slides (8-well, 0.7 cm2 area, supplier #155409). After the 
agar solidified, aggregates were grown for 22 hours in a humidified chamber at 37°C before 
PodA30-162 (2 μg mL-1, final concentration) was added to the top of the agar for an additional 5 
hours at 37°C. After treatment, 1 μL of stain from ThermoFisher LIVE/DEAD BacLight Bacterial 
Viability Kit in 50 μL ddH2O was added to the top of the agar for 12 minutes before microscopic 
analysis. SYTO-9 from the LIVE/DEAD stain kit was used in place of DAPI to minimize 
background fluorescence. Biomass was imaged with a Leica TCS SPE confocal microscope with 
a ACS APO 10x/0.30 objective. A 488 nm solid-state laser was used for excitation, and data was 
collected from 510-550 nm. Images were collected across a 500 μm Z-stack with a 10 μm step size. 
All Z-stacks were collected in 8-bit mode with 512x512 scan format and a line averaging of 2. 
Biomass was quantified in ImageJ software (60) by identifying the Z-slice with the highest average 
fluorescent intensity (generally ~200 μm below the agar surface), and setting the pixel threshold 
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using the default ImageJ thresholding parameters at the Z-slice equivalent to the 100 μm depth. 
The number of particles in each slice of the Z-stack was determined using this threshold value and 
counting particles >10 μm2 in area. To compare biofilm aggregate biomass from different 
experiments, all Z-stacks were normalized by depth so that the Z-slice with the highest average 
staining intensity was considered the mid-point of the 3D reconstruction. This processing allowed 
for comparison of datasets collected on different days with slightly different staining intensities 
and different Z-plane starting coordinates. Particle numbers for each slice were averaged between 
independent experiments and plotted against depth to quantify biofilm aggregates. Only 
experiments with between 400 and 600 aggregates at the plane of peak stain intensity were used 
for averaging and statistical analysis; this ensured equivalent biomass was present in each 
experiment. 
Oxygen diffusion modeling 
To model oxygen diffusion into agar blocks embedded with P. aeruginosa aggregates, we utilized 
the oxygen diffusion model from (29). Cell numbers were estimated by determining the average 
number of aggregates present and calculating the average volume of a given particle with the 
ImageJ 3D-object counter plug-in (61). Given these values, average cell number per mL was 
estimated by dividing the volume of total detected biofilm aggregates by the average volume of a 
P. aeruginosa cell (62) yielding a cell density estimate of 5 x 108. This cell density value is consistent 
with the overnight growth of P. aeruginosa in succinate minimal medium. Oxygen diffusion was 




Fig. S1. PodA30-162 activity is not stimulated by the presence of flavins or 2-oxoglutarate 
(25 μM) in a reaction containing 15 nM PodA30-162. Flavins are known cofactors for 
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Fig. S2. PodA30-162 activity is minimally inhibited by the presence of glycerol (A) or salt 
(B,C). (D) PodA is active over a wide pH range, but loses activity at pH above ~9. Data 
are from duplicate measurements and data was collected for 5 minutes in a reaction 
mixture containing 20 μM PYO and 15 nM PodA30-162. (E) Analysis of PodA30-162 
reaction rate, V, across a range of PYO concentrations in a reaction containing 15 nM 
PodA30-162. Reaction rates are from data collected during the first 10 seconds after 
enzyme addition. The detection limit of PYO was 0.5 μM; therefore, PYO 
concentrations below the Km of the enzyme were not tested. However, based on the 
shape of the curve of a best fit to an ideal Michaelis-Menten plot, the apparent Km is 
below 1 μM. Data are from three independent protein preparations. Each color 








































































































Fig. S3. Alternative substrate utilization by PodA. Methylated substrates and their 
predicted demethylated products are shown. Mixtures were analyzed by HPLC (right 
graphs) after 4 hours to determine the resulting products of each reaction. Standards 
for each product were run to determine retention times (indicated for each molecule 
with arrows). Only N-methylated phenazines were altered by incubation with PodA30-
162. 4-keto-N-ethylphenazine and 10-methylphenothiazine were not demethylated or 













































Fig. S4. Overlay of the Robetta structure prediction model (red) with the initial, solved 
structure of PodA30-162 (Rfree = 0.22 structure described in the methods) (blue). While 
PodA30-162 crystallized as a trimer in the asymmetric unit, only the A chain monomer is 
shown here. RMSD of the C-alpha backbone: 2.23 Å vs. Robetta prediction. A version 
of the Robetta prediction model with trimmed loops was used to as the search model 
for molecular replacement (RMSD: 2.11). The N and C terminal extensions on the 




Fig. S5. Electron density maps of the PodA active site and coordinated calcium ion. (A) 
Fo-Fc map of the missing density for 1-OH-PHZ before ligand modeling and 
refinement (contoured at 3.0 sigma). Only the density within 5 Å of the active site 
residues is shown to highlight the missing ligand density. (B) Zoomed in view of the 
density around select residues in the active site (2Fo-Fc map, blue – contoured at 1.0 
sigma). The anomalous difference map for the entire monomer is shown (orange map 
– contoured at 5.0 sigma), but density is only apparent around a calcium ion located 
~16Å from the bound phenazine. Density for the bound 1-OH-PHZ molecules was 
apparent in each of the three subunits. Only the active site of the A chain monomer is 
shown here. There is no apparent density to support the presence of additional 
cofactors or metal atoms. (C) Zoomed in view of the loop containing the coordinated 
calcium ion. 
Calcium 








Fig. S6. (A) Both the C to A (C88A, C102A) and a C to S (C88S, C102S) double 
mutants show activity in cell-free lysates of E. coli BL21(DE3) expressing the protein 
of interest. While activity was always apparent in cell-free lysates, it was unstable and 
often lost upon further purification. (Note: the data for the C to A mutation in panels 
A-D of Figure 3 are from a rare preparation where protein remained active throughout 
purification.) C to S has less apparent activity than C to A, but serves as an independent 
confirmation of the phenotype. Cell lysates of the E154A mutant show that the loss of 
PYO is not due to an activity inherent to E. coli; furthermore, the accumulation of 1-
OH-PHZ by both C to A and C to S lysates was confirmed by HPLC. (B) Reducing 
and (C) non-reducing SDS-PAGE of mutant PodA30-162 proteins. Under reducing 
conditions, PodA30-162 and mutant proteins all have similar migration through SDS-
PAGE. Under non-reducing conditions, the presence of a disulfide bond leads to 
slightly faster migration through SDS-PAGE for all proteins except the C to A double 
mutant. 
1 hr 
























Fig. S7. (A) Dose dependence of PodA30-162 activity in overnight cultures grown in TSB 
in the presence of the indicated amount of enzyme. Enzyme was added at the start of 
the culture and remained stable throughout the incubation period. (B) The phenazine 
biosynthetic pathways of P. aeruginosa (40). There is no known direct route for 
conversion of PYO or 1-OH-PHZ to PCA or PCN. Therefore, the response of P. 
aeruginosa to PodA30-162 addition in Fig. S8 must be due to active regulatory control of 
the overall distribution of phenazines. 































Fig. S8. PodA30-162 alters phenazines in P. aeruginosa culture. PodA30-162 alters phenazine 
concentrations in both TSB (A) and succinate minimal medium (SMM) (B). Data are 
averages from quadruplicate measurements and error bars represent one standard 
deviation around the mean. bd, below detection (< 0.5 μM). (C) Total phenazine 
concentrations in TSB and SSM as summed from panels A and B. While the 
distribution of phenazines is altered by PodA30-162 in TSB, total concentrations remain 
constant. (D) PYO associated with precipitated DNA is not protected from PodA30-162. 
(E) Inactivated PodA30-162 does not demethylate PYO. (F) Solubilized DNA does not 
block PodA30-162 activity. 200 μM PYO was incubated in the presence or absence of 400 
μg mL-1 DNA (a stoichiometric excess). While these data do not preclude the 
possibility that PYO is loosely associated with DNA and may freely dissociate, and 
PodA may act on this solubilized PYO, they do confirm that DNA does not protect 

























































Table S1. Data collection and refinement statistics for PodA30-162 
Space group P21 21 21
Cell dimensions   
    a, b, c (Å) 65.33, 72.98, 79.7
    α, β, γ (°)  90, 90, 90














No. reflections used in 
refinement 35987 (3544) 
Rwork / Rfree 0.168(0.271) / 0.195(0.283)
No. non-hydrogen atoms 2905
    Macromolecules 2644
    Ligands 48
Average B factor 36.5
    Macromolecules 36.1
    Ligands 36.4
    Solvent 42.0
R.m.s. deviations 
    Bond lengths (Å) 0.007
    Bond angles (°) 0.94
Ramachandran plot statistics (%)
    Favored 98
    Allowed 2.5
    Outliers 0
 
Two crystals were used for data collection. 
Values in parentheses are for highest-resolution shell. 
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Table S2. Strains, primers and plasmids used in this study. 
Strain Reference 
Pseudomonas aeruginosa PA14 (32) 
P. aeruginosa ∆phz (31) 
Escherichia coli BL21(DE3) (33) 
  
Plasmid Description 
pET20b(+)-podA30-162 podA30-162 expressed from the IPTG inducible promoter of pET-20b(+) 
pET20b(+)-podA30-162, D68A D68A mutant podA30-162 expressed from the IPTG inducible promoter of pET-20b(+) 
pET20b(+)-podA30-162, D72N D72N mutant podA30-162 expressed from the IPTG inducible promoter of pET-20b(+) 
pET20b(+)-podA30-162, 
C88A,C102A 
C88A,C102A double mutant podA30-162 expressed from the IPTG inducible promoter of pET-20b(+) 
pET20b(+)-podA30-162, 
C88S,C102S 
C88S,C102S double mutant podA30-162 expressed from the IPTG inducible promoter of pET-20b(+) 
pET20b(+)-podA30-162, H121A H121A mutant podA30-162 expressed from the IPTG inducible promoter of pET-20b(+) 
pET20b(+)-podA30-162, E154A E154A mutant podA30-162 expressed from the IPTG inducible promoter of pET-20b(+) 
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C h a p t e r  7  
CONCLUSIONS 
Summary 
This thesis presents mechanistic insight into how phenazines promote anaerobic survival in 
Pseudomonas aeruginosa. From a physiological perspective, phenazines support redox homeostasis 
by coupling metabolism to an extracellular oxidant. While the rate of electron transfer may be 
orders of magnitude lower than when the electron transport chain is used directly, it is still 
sufficient to support survival. By dissipating reducing equivalents, phenazines enable P. aeruginosa 
to oxidize otherwise unusable substrates with concomitant ATP synthesis. In the case of pyruvate 
and glucose metabolism, the pyruvate dehydrogenase complex, through the subunit 
dihydrolipoamide dehydrogenase, can use phenazines as a direct substitute for NAD+. Other 
enzymes may also catalyze NADH oxidation using phenazines as an electron acceptor. The ATP 
is used partly to maintain a membrane potential through the reverse action of the ATP synthase 
complex. The efflux of reduced phenazines might also drive proton translocation to support a 
membrane potential. As revealed by metabolite measurements, redox homeostasis by phenazines 
might also lead to changes in the fatty acid pool, which could have indirect effects through the 
action of quinolone signaling. In the natural environment, other organisms, such as Mycobacteria, 
likely consume or modify phenazines to produce complex inter-species interactions that we are 
only beginning to discover. 
Future Directions 
Pyocyanin and pyruvate secretion 
My motivation for revisiting pyruvate secretion in P. aeruginosa was to employ it as a probe for 
intracellular metabolism. While it was previously reported that pyocyanin stimulates pyruvate 
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secretion, this phenotype appears to be highly dependent on the culture conditions. In my hands, 
I observed pyruvate secretion more consistently in the absence of pyocyanin. Together with my 
findings in Chapters 3 and 4, which suggest a deep connection with the pyruvate dehydrogenase 
complex, I suspect that elucidating the relationship between pyocyanin and pyruvate secretion 
will yield new insights into how phenazines shape metabolism. 
As previously hypothesized, my data in Chapter 4 indicate that pyocyanin might inhibit pyruvate 
dehydrogenase. This interpretation comes from a comparison of phenazine reduction rates 
between pyruvate dehydrogenase and α-ketoglutarate dehydrogenase. Both reduced phenazine-
1-carboxylate at about the same rate, yet pyruvate dehydrogenase reduces pyocyanin more slowly 
than α-ketoglutarate dehydrogenase. As pyocyanin reduction does not appear to be the rate-
limiting step in these complexes, it is possible that pyocyanin inhibits a subunit upstream of 
dihydrolipoamide dehydrogenase, for example by allosteric regulation or competitive inhibition 
with thiamine pyrophosphate. Revisiting these kinetic assays might be informative once specific 
conditions are defined where P. aeruginosa consistently secretes pyruvate. 
Fatty acid metabolism 
I have noticed a great deal of circumstantial evidence suggesting that pyocyanin affects fatty acid 
metabolism in P. aeruginosa. This hypothesis was even foreshadowed by Friedheim himself, who 
wrote, “The pyocyanine catalysis is not indiscriminately effective in all oxidations, but only in the 
oxidation of certain substances closely associated with the bacterial body” (The Journal of 
Experimental Medicine, 1931). In addition to some of Friedheim’s pioneering results, two 
noteworthy pieces of evidence are as follows. 
First, I observed an excess of acetate production in P. aeruginosa surviving anaerobically with 
pyruvate. Instead of the expected 1:1 ratio of acetate to lactate, I observed closer to 40–45% 
acetate and 55–60% lactate. Where do the excess reducing equivalents come from? I also observed 
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acetate secretion even in the ∆ackA mutants. Where does the extra acetate come from? Moreover, 
∆ackA-pta mutants survived worse than ∆ackA mutants. Why is pta important? All these 
questions are readily answered if β-oxidation, which produces acetyl-CoA and a large excess of 
reducing equivalents, is important for long-term survival in P. aeruginosa. Tantalizingly, two 
independent TnSeq experiments in separate anaerobic conditions, one with phenazines and one 
with pyruvate, both identified certain β-oxidation genes as essential for long-term survival (David 
Basta and Scott Saunders, personal communication). Phenazines may be instrumental for 
dissipating the excess reducing equivalents generated by β-oxidation. 
Second, while developing my metabolomics methods, I noticed numerous glycerophospholipids 
in culture supernatants, and some of these appeared differentially regulated by phenazines. 
Identifying the precise chain lengths and desaturation patterns of these lipids will require a more 
concerted effort. I also observed that pyocyanin leads to a reduction in the overall chain length of 
quinolone signals, suggesting a connection to fatty acid metabolism that is consistent with the 
known redox effects of phenazines. 
Phenazine reductases and transporters 
What are the relevant phenazine reductases in vivo? My results implicate flavoproteins as non-
specific reductases, but it is possible that a small subset of enzymes account for most of the activity. 
Metabolic flux measurements might identify these enzymes. If phenazines stimulate flux through 
specific pathways, such as glucose oxidation, possibly only under oxidant-limiting conditions, 
then one or more enzymes in that pathway might use phenazines as an electron acceptor. Even if 
the results are not so readily interpretable, compared to testing specific enzymes in vitro or 
mutants with pleiotropic effects, metabolomics has the potential to provide a more direct view of 
the metabolic effects of phenazines. 
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A related unknown is the subcellular localization of phenazines. It is surprisingly difficult to 
remove pyocyanin from a culture by centrifuging cells and washing the pellet. Other students and 
I have noticed that P. aeruginosa retains the reduced form of pyocyanin. This might be simply 
because the reduced form is more hydrophobic and sticks preferentially to membranes, or it could 
arise from a selective mechanism of transport. Where phenazines partition into the cell dictates 
the relevant in vivo reductases. For example, if phenazines accumulate mostly in the periplasm, 
then pyruvate dehydrogenase might not be particularly significant, but if P. aeruginosa actively 
concentrates phenazines in the cytoplasm, then pyruvate dehydrogenase could be highly relevant. 
Diffusion and retention 
A common question that arises when discussing phenazine redox cycling is whether diffusion 
alone is sufficient to explain the electron transfer rates we observed. A simple model of diffusion 
at steady-state, the best-case scenario, shows that it is. This model can be extended to include 
losses to diffusion or degradation and production over time. The equations quickly become 
intractable to solve for exact solutions, but they are approachable through numerical methods. 
Additional laboratory measurements of diffusion and electron-transfer rates in biofilms will help 
to constrain the equations and produce physically meaningful results. It might be that phenazines 
in situ cycle faster than can be explained by diffusion, possibly because they are embedded in a 
conductive matrix such as DNA or humic substances. 
Environmental relevance 
Depending where and how one looks, phenazines exert phenotypic effects in just about any assay. 
Which of these effects are environmentally relevant, and which are simply artifacts of the 
laboratory? Despite over 150 years of research, a definitive “purpose” of phenazines—by which I 
mean the selective pressures that drove the original evolution of phenazines biosynthesis, and the 
broad dissemination by horizontal transfer of the phenazine biosynthesis gene clusters—remains 
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elusive. As we learn more about how phenazines shape microbial communities, we may recognize 
certain patterns or molecular markers, such as correlations between phenazines and ferrous iron, 
that indicate specific functions are especially important in the environment. 
